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The detailed understanding of human immunodeficiency virus type 1 (HIV-1) 
pathogenesis can yield insights relevant to the design of more effective therapeutics 
against the virus in infected individuals. In this work, two aspects of HIV evolution 
relevant to pathogenesis were evaluated using Bioinformatics approaches. Firstly, the 
interaction of the virus with the cytotoxic T-lymphocyte immune response mediated 
by human leukocyte antigens. The cytotoxic immune response is one of the major 
forces exerting selection pressure on the HIV-1 protein sequence and a key predictor 
of disease progression. Here, (i) the relationship between the cytotoxic immune 
response and sequence variation, (ii) virus immune escape patterns across major 
infected populations and (iii) adaptive evolution of the virus following its 
transmission from chimpanzee to humans were analysed. The virus sequence and 
immune response data were obtained from public databases and collaborating 
laboratories. Phylogeny-based codon models and entropy were used to estimate 
selection pressure and sequence variability per site. Sequences of the immunogenic 
Nef and Gag proteins from HIV-1 subtype C, obtained from a Southern African 
cohort showed frequent immunogenicity in conserved regions. However, in 
comparison to an equivalent subtype B dataset, the human leukocyte antigens from 
this cohort were poorly characterized in public databases and their sequence binding 
preferences were poorly predicted by publicly available sequence motifs. Several 
previous studies have shown that HIV-1 protein sequences adapt to cytotoxic immune 
responses mediated by human leukocyte alleles that are common in host populations. 
Here, the relationship between HLA allele frequency and viral evolution was assessed 
using data from major infected populations. Results suggest that immune responses 
not only remove potential epitopes in unconstrained regions but also drive the 
evolution of functionally constrained regions of the virus. Evidence of adaptation of 
HIV-1 to two human leukocyte antigen alleles following cross-species transmission 
from chimpanzee was also observed.  
 
Secondly, the extent of purifying selection pressure acting on synonymous sites of the 
virus nucleotide sequence was investigated. This has not been previously done despite 
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lifecycle and hence are expected to be under pressure to remain conserved. Viral 
reference sequences from the major subtypes of HIV-1 were obtained from the Los 
Alamos HIV databases. Using phylogeny-based codon models to obtain the rate of 
synonymous substitutions, synonymous sites within twenty-three known functional 
and novel motifs were found to be under purifying selection pressure. This thesis 
exposes previously ignored evolutionary characteristics of the synonymous sites of 
virus nucleotide sequences and contributes new findings to the understanding of the 
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Even though AIDS was discovered more than 20 years ago (Masur et al.,1981), there 
is no cure for HIV-1 infection to date. Tireless efforts to fully understand the 
pathogenesis of the virus in humans and to develop a vaccine for the pandemic are in 
progress.  The infection of humans with HIV-1 is puzzling in that the virus causes 
AIDS and subsequently death yet its natural hosts, the chimpanzee, from whom the 
zoonotic transmission of the virus to humans occurred, were until very recently found 
not to develop disease. There are obviously some differences in the pathogenesis of 
the virus between these two host species that cause the differences in disease 
outcome. In recent years, the hope for eradicating AIDS in humans has been on 
developing an anti-HIV vaccine that can boost immune responses that are able to 
prevent infection. An ideal vaccine reagent would be a highly conserved and 
immunodominant sequence region that is targeted by protective immune responses 
that stop the replication of the virus across all infected individuals.  
 
Efforts towards understanding the pathogenesis of the virus as well as designing 
potential anti-HIV-1 vaccines are faced with two main challenges. The first is the high 
evolution rate of the HIV-1 genome sequence. The virus mutates and evolves rapidly 
due to (i) errors caused by the virus reverse transcriptase enzyme (Preston et al.,1988) 
(ii) recombination between viral genomes (Vartanian et al.,1991) and (iii) selection 
pressure acting on the viral sequences. The second challenge is the genetic variation 
between infected human hosts. With the exception of identical twins, each individual 
human has unique genetic make up. The genetic diversity causes inter-patient 
differences in the specific anti-HIV immune responses, resulting in variation in the 
diversifying selection pressure exerted upon the virus sequence. Hence different 
evolutionary patterns arise on the HIV-1 sequences thereby increasing the diversity of 
the virus. Various pathways of the immune system are involved in the response 
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response in particular has been found to be very important in anti-HIV responses.  
The CTL immune response is mounted against viral peptides presented by human 
leukocyte antigen (HLA) molecules. The HLA molecules have been found to lead to 
varying selection pressures on the HIV-1 sequence and some of them correlated with 
HIV/AIDS disease progression. There is therefore need for detailed analysis of CTL 
immune responses-related selection pressures acting on the HIV-1 sequence and how 
it has influenced the evolution of the HIV-1 sequences since the zoonotic transmission 
from chimpanzee.  
 
Much focus has been devoted to evaluating selection pressures acting on the protein 
sequences of HIV-1 in relation to immune responses. It had been assumed that the 
only selection pressure acting on the virus sequence is that which affects the encoded 
protein sequence, that is, affects codon sites that can alter amino acids. However, past 
evidence for the correlation of synonymous substitution rates and disease progression 
in HIV infection proved otherwise (Lemey et al.,2007). In addition, the virus has 
numerous motifs on the nucleotide sequence (Peterson et al.,1996; Van Lint et 
al.,1994; Wolff et al.,2003), which function to regulate gene expression and thus 
synonymous sites within such motifs can also be under some selection pressure. 
Therefore selection pressures affecting both the synonymous sites as well as those 
affecting the protein sequence need to be evaluated in order to improve the 
understanding of HIV-1 pathogenesis in humans. The detailed understanding of all 
aspects of the pathogenesis of the virus in humans can provide clues as to why AIDS 
develops and can subsequently lead to the development of better anti-HIV 
therapeutics. 
 
1.2 Aims and Objectives 
 
This PhD was done in order to contribute to scientific research aimed at 
understanding some aspects of HIV-1 pathogenesis in humans. The overall aim of the 
work was to evaluate the evolution of the virus sequence at both the synonymous sites 
and at the amino acid level. The early stages of the virus life cycle are regulated by a 
number of motifs of the nucleotide sequence and hence the rate of evolution at such 
motif regions could be restricted in order to preserve their functions. Thus it is 
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under selection pressure. In the second case, the evolution of the amino acid sequence 
is evaluated in respect to selection pressures exerted by the CTL immune response.  In 
particular, to understand in detail the evolution of the sequence sites that contain 
immunogenic epitopes, the overview of virus immune escape patterns in different 
infected populations and the extent of selection pressure exerted by HLA molecules 
since the time the virus first infected humans. 
  
There are four analysis chapters (chapters 3 through to 6) in this thesis each reporting 
analyses carried out towards one of the following specific objectives: 
 
(i) to evaluate the  extent of selection pressure acting on the synonymous sites of 
HIV-1 protein-coding genes, i.e. sites that reflect selection pressure acting on the 
nucleotide sequence only and not that acting on the amino acid level 
 
(ii) to determine the sequence variation and evolution at immunogenic regions of the 
HIV-1 sequence and relate the observed CTL immune responses to patient HLA 
genotypes  
  
(iii) to investigate the adaptation of HIV-1 to specific CTL immune responses through 
immune escape mutations in different global human populations 
 
(iv) to evaluate how HIV-1 has adapted to CTL immune responses directed by 
specific HLA alleles following its transmission from chimpanzee to humans 
 
1.3 Thesis Layout 
 
The background and a review of the literature related to areas covered in this thesis 
are presented in Chapter 2 to form a basis for understanding the rest of the thesis. 
This chapter starts by introducing the evolution and diversity of HIV-1 followed by 
the biology of its lifecycle in an infected cell. The main causes of rapid evolution of 
the HIV-1 sequence as well as examples of commonly used methods for measuring 
the rate of evolution or determining selection pressure acting on the sequence are 
outlined. A summary of the human immune response, a major force exerting selection 
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response pathway is laid out since it is one of the major determinants of HIV/AIDS 
disease progression and a main focus of this thesis. Methods for determining peptides 
that are targeted by the CTL response and previously published findings regarding 
immune escape and disease progression are also reviewed. This chapter concludes 
with challenges facing studies directed towards understanding the pathogenesis of 
HIV-1 and designing vaccines against HIV infection. 
 
The evolution of synonymous sites of the nucleotide sequence is evaluated in 
Chapter 3. Here, for the first time, the extent of selection pressure acting on the 
synonymous sites across the whole HIV-1 genome is evaluated. As synonymous 
substitution rates have been shown to vary across sites, it is expected that sites that 
carry out important regulatory functions are under selection pressure to remain 
conserved in order to preserve their functions. Also, purifying selection pressure, 
which causes synonymous sites to be conserved, has been shown to cause false 
detection of positive selection. Therefore, this chapter presents work that was aimed at 
identifying all synonymous sites of the HIV-1 coding regions that are highly 
conserved across the 11 major subtypes of the HIV-1. Alignments of non-recombinant 
sequences of HIV-1 genes were downloaded from the Los Alamos HIV sequence 
database (Leitner et al.,2005). Known and novel regions under purifying selection 
pressure were identified and puplished to provide a reference source for studies that 
analyse positive selection pressure in HIV-1 sequences, so that false positive 
inference of positive selection resulting from purifying selection at synonymous sites 
can be avoided.  
 
Chapter 4 investigates the relationship between the CTL response and the evolution 
and variation of the HIV-1 sequence. In particular, the relationship between the 
frequency of immune responses and sequence variability and the consistency of 
observed immune responses with patient HLA alleles. Ideal vaccine reagents are 
immunodominant peptides located in highly conserved regions of the virus sequence 
and eliciting protective immune responses across different individuals. The raw data 
used in this chapter were provided by two collaborating research groups headed by 
Professor Carolyn Williamson at the University of Cape Town and by Dr Clive Gray 
at the National Institute for Communicable Disease. The data comprised of CTL 
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subtype C showing responses to the immunodominant Nef and Gag proteins of HIV-
1. The autologous sequences isolated from the respective individuals were used for 
analysing conservation. Human leukocyte antigens (HLA) alleles, which are the key 
components that direct the CTL immune pathway, were provided from each patient. 
Two independent sequence analysis approaches were used to determine sequence 
variation along sites that are frequently recognised by the CTL immune response 
across the individuals in the cohort. The observed immune responses are also related 
to the corresponding patient HLA genotype and comparisons made with a 
comparative dataset from a subtype B infected North American cohort.  
 
HIV-1 is known to mutate as a way to escape binding of HLA molecules and 
recognition by the CTL immune response (Kawashima et al.,2009). Immune escape 
mutations have been observed in regions bound by specific HLA alleles (Brumme et 
al.,2007). In Chapter 5, an overview of the way the virus sequence has adapted to the 
HLA alleles of different infected human populations is evaluated. The chapter 
explores whether HIV-1 mostly adapts to HLA alleles that occur more frequently in a 
population. Common HLA alleles are likely to mediate immune responses more 
frequently across different individuals. In such a case, if an escape mutation arises, the 
causative immune response in individuals who are subsequently infected by the 
mutant virus strain may prevent reversion of the mutant residue to wildtype and can 
cause the escape form to become fixed. The chapter also investigates whether 
adaptation mostly occurs in sites that have no functional constraints and hence can 
freely vary as compared to those sites that carry out important functions such that any 
mutation compromises viral fitness. The HIV-1 sequences from different population 
regions, the HLA frequencies in the corresponding populations as well as the 
sequence patterns required for HLA alleles to bind were obtained from public 
databases (Korber et al.,2006; Leitner et al.,2005; Meyer et al.,2007).  
 
In Chapter 6 a more detailed approach is used to determine HIV-1 adaptation to HLA 
alleles directing CTL immune responses following the cross-species transmission of 
the virus from chimpanzee to human. In this approach, CTL-directed selection 
pressure is investigated from the time the virus was first exposed to the human host. 
The objective was to identify positive selection that arose from immune escape soon 
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some CTL epitopes. The sequences were obtained from the Los Alamos HIV 
sequence database (Leitner et al.,2005). A structure-based method, which uses amino-
acid pairwise binding potentials was used to identify potential target sites for each 
HLA with an available crystal structure (Altuvia et al.,2004). The chapter therefore 
reports those HLA alleles with known crystal structures that are associated with 
positive selection pressure on CTL targeted regions of the HIV-1 sequence following 
the cross-species zoonosis event. 
 
In Chapter 7, a summary of the conclusions of this study is given. Challenges and 







































Background and Literature Review 
 
2.1 Origin and Diversity of HIV-1  
 
Scientific evidence shows that the human immunodeficiency virus type 1 (HIV-1) 
first infected humans in the early twentieth century through zoonotic transmission 
from the chimpanzee Pan troglodytes troglodytes species infected with simian 
immunodeficiency virus (SIVcpz). (Huet et al.,1990; Korber et al.,2000; Sharp et 
al.,1999; Sharp et al.,2001; Zhu et al.,1998). Further evidence shows that the cross-
species transmission event took place in West-central Africa through blood contact 
between hunters and hunted chimpanzees (Hahn et al.,2000; Sharp et al.,1995). 
Multiple independent zoonosis events are thought to have occurred in the different 
parts of West-central Africa, which gave rise to phylogenetically distinct lineages of 
HIV-1 infecting humans (Gao et al.,1999; Hahn et al.,2000). Currently, there are three 
distinct lineages of HIV-1 sequences that are known to have come from these 
different cross-species events and are named group M (for Main), group O (for 
outlier) and group N (for non-M, non-O) (Figure 2.1) (De Leys et al.,1990; Jonassen 
et al.,1997; Simon et al.,1998).  Of these, HIV-1 Group M is the most pathogenic 
accounting for most of the HIV-1 infections and the AIDS pandemic worldwide. (Gao 



















Figure 2.1: Adapted from (Wain et al.,2007). A phylogenetic tree showing the 
relationship between the three HIV-1 lineages M, N and O (with arrows) and the 
SIVcpz strains, dotted branches show other SIV that are not from chimpanzee Pan 
troglodytes troglodytes species, the countries of origin for some of the SIVcpz 
sequences are indicated as extensions to ‘SIVcpz’ and are CAM – Cameroon, US- 




2.1.1 The diversity and distribution of HIV-1 Group M 
 
HIV-1 Group M has evolved rapidly since the 1930s resulting in diverse strains that 
have been grouped into subtypes based on sequence similarity. There are presently 
eleven major subtypes, A1, A2, B, C, D, F1, F2, G, H, J and K within the Group M 
lineage (Robertson et al.,2000).  Inter-subtype differences of the envelope nucleotide 
sequences are up to 25-30% (Buonaguro et al.,2007; Korber et al.,1998). Most of 
these HIV-1 subtypes are found in the West-central African region where they 
originally diversified from the ancestral group M sequence (Peeters et al.,2000). The 
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The most prevalent subtype, subtype C, which accounts for almost 50% of world 
infections predominates in Sub-Saharan Africa and parts of Asia (Table 2.1.1, Figure 
2.1.1) (Buonaguro et al.,2007; Geretti,2006). The rest of the subtypes are not 
comparably prevalent, with subtype B showing 10% prevalence and the A subtypes 
being 12% prevalent (Buonaguro et al.,2007). Subtype B is widely distributed in the 
developed world which includes North America, Europe and Australia (Peeters et 
al.,2000). Subtype A is found in parts of Europe and in Kenya and the surrounding 
East-African countries. Recombination between different subtypes has been observed 
and occurs when an HIV-1 positive individual is re-infected with a different subtype. 
This has resulted in recombinant sequences that cannot be clearly classified under any 
of the existing subtypes and are referred to as Circulating Recombinant Forms (CRFs) 
(Quinones-Mateu et al.,1999). There are currently more than 10 different CRFs and 
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Group M subtype 




A1 & A2 12.3 
East Africa, East Europe, 
Central Asia 
B 10.42 
USA, Australia, West-Europe, 
Japan 
C 49.91 
Sub-Saharan Africa, India, 
China, Brazil 
D 2.53 Central Africa 
F1 & F2 0.59 
South America, East Europe, 
Central Africa 
G 6.32 Central Africa 
H 0.17 Central Africa 
J 0.14 Central Africa 
K 0.04 Cameroon 
CRF01_AE recombinant 4.69 South-east Asia 
CRF02_AG recombinant 4.77 Central Africa 
CRF03_AB recombinant 0.1 North-Europe 
Other CRFs 8.02 Different parts of the world 
 Table 2.1.1: The HIV-1 group M subtype distribution in human populations. 
Percentages were taken from (Buonaguro et al.,2007). Geographical distribution of 






























Figure 2.1.1 Percentages of HIV-1 group M subtype infections in the world. The 




2.1.2 Differences between SIVcpz and HIV-1 pathogenesis 
 
Even though HIV-1 descended from SIVcpz, the pathogenesis of the two viruses 
differs between humans and chimpanzee respectively. The virus naturally replicates, 
reproduces and multiplies rapidly within a living host cell. Viral loads continue to 
increase in the host if the replication is un-interrupted or not suppressed. In humans, 
the immune response against HIV-1 is usually elevated upon infection causing a 
decrease and subsequent non-uniform fluctuations in viral load (Musey et al.,1997). 
In a host where protective immune responses are mounted, latent stages can be 
observed where viral load is reduced to very low levels (Betts et al.,1999). The 
exhaustion of the immune response however takes place with time resulting in 
uncontrollable increases in viral load and the development of acquired 
immunodeficiency syndrome (AIDS) and subsequently death (McMichael et al.,2001; 
Saksela et al.,1994; Shearer et al.,1997). By contrast, the chimpanzees P t troglodytes 
have in the past observed not to develop AIDS and remain asymptomatic throughout 
infection even in the presence of persistently high viral loads (Pandrea et al.,2008; 
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chimpanzees yet these hosts maintained low immune activation against SIVcpz 
(Silvestri,2008) unlike in humans who show stages of elevated immune responses. 
The high viral loads and low immune activation observed over the past years in 
natural hosts of HIV, the chimpanzees, could indicate a possibility of co-existence 
equilibrium between the virus and its host. However, a most recent study reported 
AIDS-related symptoms in SIV infected chimpanzee (Keele et al., 2009), which could 
indicate that the virus has successfully evaded its natural host but probably much 
slower than in humans, given the previous reports. These major differences observed 
between HIV and SIVcpz pathogenesis could be the result of a combination of both 
the differences in the two hosts’ genetic make-up and sequence differences between 
the viruses themselves. Indeed there are genetic differences between SIVcpz and 
HIV-1 sequences since it is expected that HIV-1 underwent adaptive sequence 
changes to enable it to adapt to the recipient human host after the zoonosis event 
(Wain et al.,2007). 
 
2.2 The Structure of HIV-1 
 
HIV-1 is a virus classified under the retrovirus family and has a RNA genome which 
can be reverse transcribed into DNA (Levy,2007). The genome is a dimmer of two 
RNA molecules. It comprises of nine genes encoding proteins that carry out different 
functions. The nucleotide sequence also contains motifs most of which function to 
regulate gene expression (Pereira et al.,2000). 
 
2.2.1 Genomic organisation of HIV-1 
 
The HIV-1 genome consists of almost ten thousand base-pairs flanked by non-coding 
regions known as the Long-terminal repeats (LTRs), at each end thus forming the 
5`LTR and the 3`LTR (Das et al.,1998). Each of the nine genes is translated using 
either the first, second or third reading frame (Pavesi et al.,1997). The reading frames 
overlap along some regions of the different genes to a maximum of 3 reading frames 
overlapping the same site (Pavesi et al.,1997). The genomic organisation of HIV-1 is 
shown in Figure 2.2.1 with the corresponding reading frames marked. The individual 
genes encode one of three types of proteins, classified according to types of function. 
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encoded by the tat and rev genes and the rest of the genes, namely nef, vif, vpr and 





Figure 2.2.1: The genomic organization of the HIV-1 genome adapted from the Los 
Alamos database (Leitner et al.,2005). The bottom axis shows the position of bases 
numbered based on the HIV-1 HXB2 reference sequence from the Los Alamos 
sequence database (http://www.hiv.lanl.gov/content/sequence/). The reading frame is 
given at the left end of the diagram and the genes translated in each frame are drawn 
on the same row represented by rectangles drawn to scale. The names of proteins 
encoded by the structural genes are given within each rectangle above the 
corresponding coding region. The tat (black rectangles) and the rev (grey rectangles) 




2.2.2 Structural proteins 
 
The gag gene codes for a poly-protein which is cleaved by the virus protease enzyme 
into four structural proteins, the matrix (p17, 132 amino acids) at the N-terminus, 
capsid (p24, 231 amino acids), nucleocapsid (p7, 55 amino acids) and p6 (51 amino 
acids) located at the C-terminus  (Figure 2.2.2) (Frankel et al.,1998). The proteins 
form layers beneath the viral membrane and enclosing the RNA genome. The matrix 
is found beneath the lipid layer of the membrane and is important for the assembly of 
the envelope glycoproteins within the membrane (Gottlinger,2001). The capsid layer 
is directly below the matrix and forms a protective sheath around the genome and 
other proteins associated with the genome. The nucleocapsid directly interacts with 
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assembly of virus particles (Berkowitz et al.,1995).  The highly variable p6 protein 
has been found to play a role in the infectivity and release of new virions (Alexander 





Figure 2.2.2 Schematic drawing of a section of the structure of a mature HIV-1 





The env gene codes for the viral envelope glycoproteins (gp), gp120 and gp41 (Figure 
2.2.2) (Wyatt et al.,1998). The gp120 molecules are the attachment points of the virus 
to CD4 molecules expressed on surfaces of some host cells of the immune system 
(Doms et al, 2000).  The gp120-CD4 interaction triggers a conformational change on 
the gp120 thus fascilitating the binding to adjacent chemokine receptors, CCR5 or 
CXCR4 on the surface of the same host cell (Lapham et al., 1996).  This then 
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the host cell (Cormier et al.,2001; Cormier et al.,2002). The pg120 surfaces are also 
sensitive to neutralizing antibodies of the immune response. Glycoprotein 41 has three 
main functions. The amino terminal domain has a critical role in the actual fusion of 
the virus membrane and the host cell membrane following the attachment of gp120 to 
the receptors on the surface of the host cell (Pascual et al.,2005).  The trans-
membrane domain spans across the cell membrane of the virus and firmly holds the 
gp120 in position (Helseth et al.,1991). The C-terminal region forms a tail which 
slightly extends into the interior of the virus particle and is important for 
incorporation of envelope glycoproteins in the formation of new virions (Murakami et 
al.,2000).   
 
2.2.3 Regulatory proteins 
 
The tat and rev genes code for regulatory proteins. The trans-activating protein (Tat, 
86 amino acids long) interacts with a Tat responsive element within the 3` LTR in the 
regulation of virus replication (Greene et al.,2002). Not all the mRNA of HIV-1 genes 
is fully spliced and some genes like gag are translated unspliced into polyproteins 
(Kimura et al., 2000). Un-spliced mRNA cannot be normally transported through the 
nuclear membrane to the cytoplasm where translation takes place (Peterson et al., 
1996). Therefore, the regulator of viral protein expression (Rev, 116 amino acids 
long) through interaction with a Rev-responsive element, an RNA structure within the 
env gene, functions to facilitate the transport of the unspliced viral mRNA from the 
nucleus to the cytoplasm. (Peterson et al.,1996). 
 
2.2.4 Accessory proteins 
 
The accessory protein Nef (negative factor, 206 amino acids) had been observed to 
carry out a number of functions including down-regulation of expression of CD4 
molecules by HIV infected cells (Foster et al.,2008; Lama et al.,1999). CD4 
molecules are expressed on the surfaces of some white blood cells and contain 
receptors that attach to the viral envelope, together with chemokine receptors, 
enabling fusion and entry of viruses into cells. Therefore, the down-regulation of CD4 
molecules by the Nef protein prevents super-infection of an infected cell, which can 
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protein is the down-regulation of human leukocyte antigen molecules (HLA) 
(Greenberg et al.,1998). HLAs bind to virus peptides and activate anti-HIV immune 
responses therefore the Nef protein protects the infected cell from immune attack. 
 
The virus infectivity factor (Vif, 192 amino acids) protein is essential for the assembly 
of new virus progeny and their ability to infect host cells (Levy,2007). The viral 
protein R (Vpr, 96 amino acids) is important in regulating replication and in the 
import of complexes required for the integration of the virus genome into the host cell 
DNA in the nucleus (Greene et al.,2002). The viral protein U (Vpu, 81 amino acids 
long) contributes to the function of the Nef protein by degrading CD4 molecules that 
are being transported to the cell surface within the endoplasmic reticulum of the 
infected cell (Frankel et al.,1998). The release of virus progeny from infected cells is 
facilitated by Vpu proteins that are bound to the membrane (Schubert et al.,1996).   
    
2.2.5 Functions at the nucleotide sequence level 
 
The genome of HIV-1 also contains a number of motifs that function at the nucleotide 
sequence level within the coding regions (Cochrane et al.,1991; Schneider et al.,1997; 
Schwartz et al.,1992). The non-coding LTR regions (including the regions of the 
3’LTR which also encode for part of the Nef protein) do contain a number of 
transcription factor binding sites and motifs that interact with other proteins in the 
regulation of gene expression such as the Tat responsive element in the 3’LTR (Das et 
al.,1998; Pereira et al.,2000; Quinones-Mateu et al.,1998). Many splice sites and 
splicing regulatory elements are found overlapping with coding regions in other 
reading frames and regulate the alternative splicing of the more than twenty 
transcripts that can be produced from the viral genome (Figure 2.2.5) (Gog et 
al.,2007; Kammler et al.,2006).  The nef, two tat exons and the two rev exons are 
fully spliced as the early products of gene expression (Swanson et al.,1998). The env, 
vif, vpu, vpr and tat can be partially spliced and require the Rev protein for efficient 
transport from the nucleus (Lassen et al., 2006) The unspliced gag and pol mRNA are 
the late products as they require threshold levels of the Rev protein to facilitate their 

















Figure 2.2.5 The organisation of splicing regulatory elements of the HIV-1 genome 
adapted from (Asang et al.,2008). The open reading frames of the HIV-1 genome. B: 
5` splice donor sites labelled D1 to D5 and 3` splice acceptor sites labelled A1 to A7. 




In addition to splice acceptor and donor sites, inhibitory nucleotide sequence motifs 
(abbreviated as INS motifs) have been identified within the gag and pol (cis-
repressive sequence) genes which play roles in negatively regulating gene expression 
(Cochrane et al.,1991; Schneider et al.,1997; Schwartz et al.,1992; Wolff et al.,2003). 
An intragenic nuclease hypersensitive regulatory region (also referred to as HS7) with 
functions similar to that of the LTR has been previously identified within the central 
pol gene and contains transcription factor binding sites (Goffin et al.,2005; Van Lint 
et al.,1994; Verdin et al.,1990). A highly conserved poly-purine tract in the central 
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plus-strand DNA synthesis (Miles et al.,2005; Rausch et al.,2004). The Rev-
responsive element is a nucleotide sequence along the env gene that forms stem loops 
in its secondary structure and directly interacts with the Rev protein in regulating the 
transport of unspliced and partially spliced mRNA from the nucleus to the cytoplasm 
of the infected cell (Hadzopoulou-Cladaras et al.,1989; Hung et al.,2000; Peterson et 
al.,1996; Renwick et al.,1995). The HIV-1 genome is therefore subject to selection 
pressure as both the protein and nucleotide sequence levels.  
 
2.3 The Lifecycle of HIV-1 
 
HIV-1 is transmitted via blood contact and other body fluids such as genital fluid and 
breast milk. It infects cells of the immune system, which include T cells, macrophages 
and other cells containing appropriate receptors on the cell surface that can be bound 
by gp120 molecules of the virus envelope.  However, in addition to the chemokine 
receptors that are bound by the virus, it also has a very high affinity for CD4 
molecules hence HIV-1 mostly infects T cells that naturally express CD4 molecules 
on other surfaces, the CD4+ T cells.  
 
2.3.1 Stages of the HIV-1 life cycle 
 
Like other viruses, HIV-1 only replicates within a living host cell. The first stage of 
its lifecycle is attachment to the host cell and entry. The gp120 molecules on the virus 
envelope attach to chemokine receptors CCR5 or CXCR4 and CD4 molecules on the 
cell surface thus triggering fusion of the two membranes and release of the virus 
contents into the cytoplasm of the host cell (Levy,2007).  The virus reverse 
transcriptase enzyme then reverse transcribes the dimeric RNA genome of the virus 
into DNA within the host cell cytoplasm. The double-stranded DNA is transported 
into the nucleus of the host cell where it is integrated into the host cell genome by the 
virus integrase enzyme (Wu,2004). This enables the virus to take advantage of the 
host cell machinery to express its genes. The host enzymes are used for the 
transcription and translation of the viral DNA.  As mentioned in section 2.2.5, smaller 
exons from nef, tat and rev that are fully spliced are the early products of translation 
since their mRNA is easily transported from the nucleus to the cytoplasm where 
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translated as late products as they require adequate levels of the Rev protein to aid in 
their nuclear export. The protease enzyme is used to cleave poly-proteins such as Gag 
and Pol into individual functional protein products. Copies of the full genome 
unspliced RNA are also exported to the cytoplasm for the formation of new virus 
progeny (Wu,2004). The resulting virus proteins and genomic RNA dimmers are then 
assembled into new virus particles within the cytoplasm. The mature virus progeny 
are released from the infected cell via budding to the host cell after which they 


























Figure 2.3.1 Stages of HIV-1 replication within a human host cell numbered in order 
from 1 through to 9 following the arrows. The stages were adapted from various 
sources (Grigorov et al.,2006; Levy,2007; Nisole et al.,2004; Wu,2004).1; attachment 
of gp120 molecules to receptors on cell surface, 2; membrane fusion and release of 
contents, 3: reverse transcription of viral genomic RNA (v_RNA) to double stranded 
DNA (v_DNA), 4; nuclear transport of v_DNA, 5; integration of v_DNA into host 
DNA, 6: transcription of v_DNA, 7; new viral v_RNA and mRNA transported to 
cytoplasm, translation of mRNA and assembly of new virions, 8; maturation 9; 
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2.3.2 The HIV-1 rate of replication and evolution 
 
HIV-1 has a very high turnover rate, producing an average of about two hundred 
infectious virions within a single infected host cell (Dimitrov et al.,1993). The 
average generation time is two and a half days during which about 1010 virions can be 
produced per day (Perelson et al.,1996). The mutation rate of the virus is very high 
with an approximated 1.7*10-3 nonsynonymous nucleotide mutations per site per year 
(Li et al.,1988). These mutations result mainly from errors made by the reverse 
transcriptase enzyme which is defective of proof-reading and makes approximately 
0.2 errors per genome during each replication cycle (Preston et al.,1988). Therefore 
each virion genome produced after a single lifecycle is not exactly similar to the 
parent virus thus causing a continuous evolution of virus sequences.  The HIV-1 
sequences are also highly recombinogenic because of the dimeric structure of the 
RNA genome which influences recombination between non-adjacent regions of the 
dimmer or between genomes (Sharp et al.,1995; Vartanian JP et al.,1991). 
Recombination occurs more frequenctly during reverse transcription of the minus-
strand when the reverse transcriptase switches templates (Negroni et al., 2000). 
Recombination results in shuffling of sequences, producing new genomic RNA that is 
different from the parent.  
 
The evolution of HIV-1 is also largely influenced by external diversifying selective 
pressures acting on the virus sequence. Regions of the sequence that are of functional 
or structural importance can be under purifying selection pressure to maintain their 
fitness. However, as the virus constantly experiences random mutations genome-wide, 
some of these mutations can confer a fitness advantage and enable the virus to evade 
external selective pressures such as immune attack and thus adapt to its environment. 
The host immune response in humans in particular does exert varying selection 
pressures of viral sequences and the latter have been observed to undergo immune 
escape mutations. In such cases, wildtype residues can be lost and the resultant 
mutants fixed if the latter enable the virus to adapt well to its new host without 
compromising its fitness and viability. Due to different immune responses between 
infected individuals and differences in sequence sites of the HIV-1 sequence that may 
be targeted, immune escape patterns and fixation of mutants can vary widely across 
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the evolution rate and diversity of the virus between infected individuals. The rate of 
sequence evolution and variability of HIV-1 sequences has been found to be directly 
correlated with its pathogenicity and disease progression (Quinones-Mateu et 
al.,1998; Shpaer et al.,1993). 
 
2.4 Determination of the Rate of HIV-1 Evolution 
 
Efforts are being made by scientists worldwide to find a cure for HIV-1 infection.  
One of the greatest challenges to designing effective treatment is keeping up with the 
ongoing rapid evolution of HIV-1 and its increasing diversity. The natural mutation of 
the virus, errors caused by reverse transcriptase, recombination and external selection 
pressure exerted on the virus all contribute to the evolution of HIV-1.  
 
Different regions of the virus evolve at varying rates mainly due to their functional 
differences. Sites that have important functions can be under purifying selection 
pressure to preserve their functions and hence tend to be conserved and evolve slower. 
In contrast, regions of the sequence that have no critical functions such that losing the 
wildtype nucleotides or amino acid residues does not confer a fitness cost can evolve 
more rapidly. As the virus gets transmitted from host to host, it is constantly being 
exposed to new and different selection pressure hence different mutations that enable 
adaptation to recipient hosts arise (Casado et al.,2001). Different humans have 
different genetic make up (except for identical twins) hence adaptive evolution to host 
factors such as the immune response can differ between different viruses thus further 
increasing the diversity between virus sequences. Resistance mutations also arise 
against Anti-HIV therapeutics. Determining the evolution rate of the virus sequences 
is therefore important for studies aimed at understanding HIV-1 pathogenesis. 
Numerous methods have been developed and attempts made to evaluate the evolution 
rates of HIV-1 sequences. These methods enable the inference of evolutionary rates at 
both the nucleotide sequence level and the amino acid sequence level. 
 
2.4.1 Codon models of sequence evolution 
 
The greatest achievement in studying the evolution of protein-coding sequences has 
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phylogenetic relationships of sequences. Two major software packages, Phylogenetic 
Analysis by Maximum Likelihood (PAML) (Yang,2007) and HYpothesis testing 
using PHYlogenies (HyPhy) (Kosakovsky Pond et al.,2005d), are available within 
which various codon models and methods for analysing sequence evolution can be 
implemented. The codon models use phylogenetic trees representing evolutionary 
relationships between the sequences. The selection pressure acting upon each codon 
site of a sequence is usually assessed from the ratio of nonysynonymous (amino acid 
changing) substitutions per nonysynonymous site (dN) to the synonymous (silent 
mutations) substitutions per synonymous site (dS). The dN/dS ratio is also referred to 
as omega (ω). Positive selection is inferred when ω>1, purifying selection when ω<1 
and ω = 1 implies that sites are evolving neutrally. The instantantaneous transition 




 Substitution rate  Nucleotide differences between codon i and codon j 
0 If i and j differ at two or three nucleotide positions 
πj If i and j differ by one synonymous transversion 
κπj If i and j differ by one synonymous transition 
ω(h)πj If i and j differ by one nonsynonymous transversion 
ω(h)κπj If i and j differ by one nonsynonymous transition 
Table 2.4.1a: the instantaneous substitution rate from codon i to codon j in a sequence 
alignment with h number of codons, the approach used by codon models where κπj is 
the equilibrium frequency of codon j, κ = transition/transversion rate ratio and ω(h) is 




The early codon models were simpler, with fewer assumptions but usually less 
detailed and have been improved over the years to recent ones that are more 
biologically accurate especially for rapidly evolving sequences such as those of HIV-
1 (examples in Table 2.4.1b and also reviewed in (Delport et al.,2009)). The early 










  24 
 
 
Muse et al.,1994). In the MG94, the subsitution rates are based on the target 
nucleotide within a codon and in the GY94 they are based on the target codon. Later, 
Yang and colleagues developed the ‘Nonsynonymous rates model’ i.e. allowing site-
to-site rate heterogeneity of nonsynonymous substitution rates (Yang et al.,2000).  
However, dS was assumed to be constant and equal to one across all sites, thus the 
site-to-site variation in ω reflects only the variation in dN.  The proportional model, 
which is the approach used is most previous models assumes that dS and dN are 
proportional such that dN can be obtained from ω*dS e.g. (Yang et al.,2000). 
Following the evidence that dS varies between codon sites (e.g. (Hurst et al.,2001)) 
the MG94 model was modified by (Kosakovsky Pond et al.,2005a) to allow for site-
to-site variation in synonymous substitution rates. Improvements to the latter model 
also included independent and discrete distributions of dN and dS, termed the ‘Dual’ 
model where dN ≠ ω*dS. Therefore this latter model allows for estimation of 
selection pressure acting on the nucleotide sequence independent of that acting on the 
amino acid level, i.e. only affecting dS. Recent developments include a genetic 
algorithm that enables the determination of averaged ω acting on each branch of an 
phylogeny to be used when different lineages are expected to have undergone 
different selection pressures (Kosakovsky Pond et al.,2005b). 
  
The PAML package includes nested models for the formation of a likelihood ratio test 
that compares the statistical fit of models that allow a subset of sites with positive 
selection to the fit of models without positive selection. Frequently used examples are 
the M1 (neutral) and M2 (selection) models developed by (Nielsen et al.,1998). M1 
forms the null model in which ω0 is fixed to 1 and sites assumed to be evolving 
neutrally. M2, for the detection of the selection, is the alternative model where ω is 
estimated from the data with the likelihood compared to that of M1.  The models are 
implemented using the CODEML program available within the PAML package 
(Yang,2007).  These nested models were later improved to M1a (near neutral) such 
that ω0 is estimated from the data and 0<ω0 <1 and M2a (positive selection) which 
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Muse & Gaut, 1994 Constant rates model, single dN across all 
sites, dS = 1 across sites, dN & dS are 
proportional i.e. dN = ω*dS 
M1 (neutral) & M2 
(selection)  
Nielsen & Yang, 
1998 
Nested Models for likelihood 
comparison, M1 (fixed ω0 = 0, ω1 = 1) 
and M2 (ω2 varies among sites & is >0). 
Nonsynonymous Yang et al, 2000 Site-to-site variation in dN, constant dS, 
proportional 
M1a (near neutral) 
& M2a (positive 
selection) 
Wong et al 2004 
 
Improved M1 & M2, where for M1a (ω0 




& Muse, 2005 
Site-to-site variation in dN, Site-to-site 
variation in dS, dual discrete distributions 




Kosakosky Pond & 
Frost (2005) 
As improved MG94 but lineage-specific, 
averaged ω for each branch on a 
phylogeny 
Table 2.4.1b Examples of most frequently used codon models showing the stages of 




2.4.2 Tackling the problem of recombination  
 
Another challenge in the use of codon models was the problem of recombination, 
which is especially frequent in virus sequences. The main problems caused by 
recombination are that firstly the recombination breakpoints can cause a distortion in 
the residue of the sequence itself and may appear as a signal of positive selection. 
Secondly, recombined sequences are usually from different sequences, for example 
from different subtypes in the case of HIV-1, and hence have different phylogenetic 
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inferred separately and the different segments should not be assumed to have the same 
tree (Scheffler et al.,2006). Methods for the detection of recombination have been 
developed in order to identify recombining sequences prior to analysis of selection 
pressure using phylogeny-based methods such as the codon models. One of these 
tools is the Genetic algorithm for recombination detection (GARD) (Kosakovsky 
Pond et al.,2006) available from the HyPhy package and implemented in the 
Datamonkey web server (Kosakovsky Pond et al.,2005c). In order to avoid the 
complication of analysing different recombined segments of a sequence alignment 
separately, Scheffler and colleagues (Scheffler et al.,2006) developed and algorithm 
that allows for use of codon models to detect selection using different tree topologies 
for each recombination segment of a single alignment in a single analysis by 
specifying recombination breakpoints and providing the corresponding trees as input 
to the analysis. 
 
2.4.3 Methods for measuring evolution using amino acid sequences 
 
Phylogenetic methods that measure the evolution rate of amino acid sites from 
alignments of amino acid sequences are also available. For example AAML is a 
PAML program with similar functions as CODEML but takes amino acid sequences 
as input (Yang,2007). Another example is the Rate4Site program developed by 
Mayrose and colleagues (Mayrose et al.,2004; Pupko et al.,2002) for determining 
conserved amino acid sites by calculating evolutionary rates at each site using either 
Bayesian or maximum likelihood methods. Sequence entropy, a measure of disorder 
per amino acid site in an alignment is also commonly used as a measure of amino acid 
variability per site e.g. in (Sato et al.,2007). It is a simplified approach for identifying 
protein regions that are highly conserved.  
 
2.5 Major Pathways of the Human Immune Response  
 
The major obstacle to curbing HIV-1 infection is that it infects cells of the immune 
system, predominantly the CD4+ T cells Chan et al., 1998). Monocytes such as 
macrophages as well as dendritic cells are also infected but to a lesser extent than the 
CD4+ T cells (Levi, 2007). The immune system is the major tool with which the 
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into two main pathways, the innate and adaptive immune responses (Figure 2.5) 
(Todar, 2009). Different arms of the immune system are involved in targeting HIV-1 
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2.5.1 The innate immune response 
 
The innate immune response is the first-line pathway and provides immediate 
protection against pathogens upon infection (Todar, 2009). It therefore targets viral 
pathogens before they infect host cells, by recognising anti-self characteristics on the 
surfaces of the pathogen. Chemicals known as cytokines, produced by cells of the 
immune system circulate in body fluids such as blood plasma, provide a first line of 
attack against exogenous pathogens (Flajnik et al.,2004). Other fluids of the body 
containing both natural (born-with) and acquired immunity (received from other 
source such as vaccination or perinatal transmission) such as saliva, placental fluid, 
tears and milk can also contain immune chemicals that provide innate immune 
responses (Flajnik et al.,2004; Todar, 2009). Some cells of the immune response, 
which include neutrophils, natural killer cells and macrophages also attack whole 
pathogens by either release of chemicals or by engulfing the pathogen (Levy,2007). 
The other most important characteristic of the innate immune response is the 
activation of the cells of the adaptive immune response via cytokines, in response to 
the detection of a foreign pathogen (Flajnik et al.,2004). 
 
2.5.2 The adaptive immune response 
 
The adaptive immune response is a complex of two pathways that function inter-
dependently. One is the humoral immune pathway, which mainly recognises and 
targets exogenous pathogens and the second is the T cell immune pathway that targets 
endogenous pathogens (Todar, 2009). The outline of the two pathways is shown in 
Figure 2.5.2 below. The cells involved in mediating adaptive immunity are produced 
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Figure 2.5.2: The adaptive immune response pathways (Flajnik et al.,2004; 





The humoral, also known as antibody-mediated immunity is mainly directed by B-
cells (developed in the bone-marrow). Activated B-cells produce antibodies which 
function to either neutralise exogenous virus or enhance recognition of the pathogen 
by the T cell immunity. A B-cell activated by the presence of a particular pathogen 
only produces antibodies specific to that pathogen. In neutralisation of HIV-1, 
antibodies bind to specific regions of the surfaces of gp120 molecules of the virus 
thereby neutralising them such that they are not able to infect host cells (Sagar et 
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found to be very high during early HIV-1 infection and correlated with an increase in 
immune escape mutations (Richman et al.,2003). Other evidences have also shown 
that neutralising antibodies play an important role in driving the evolution of HIV-1 
envelop proteins (Frost et al.,2005; Wei et al.,2003). Enhancement involves binding 
of an antibody to the pathogen and thus enabling recognition of pathogen by 
macrophages or dendritic cells which engulf the antibody-pathogen complex 
(Levy,2007; Subbramanian et al.,2002). The macrophage bearing the pathogen, 
referred to as the antigen-presenting cell (APC), triggers its apoptosis or perforin 
killing (Yagita et al.,1992). APC presenting the antibody-bound pathogen on its 
surface can also be targeted by the T cell immunity depending on the presence of 
appropriate receptors on the APC surfaces, which allow for the T cells to bind. APC 
containing molecules known as major histocompatibility complex type 2 (MHCII), in 
particular, are bound by T cells that bear CD4 molecules on their membranes 
(Lanzavecchia,1998).    
 
The T cell immune pathway, also known as cell mediated immunity (CMI), is 
mediated by white blood cells known as lymphocytes that develop in the Thymus glad 
hence known as T cells. There are two types, the CD4+ cells mentioned in the 
previous paragraph and the CD8+ T cells which bear CD8 molecules on the surfaces 
of their membranes. The CD4+ T cells also contain chemokine receptors, the main 
receptors enabling infection by HIV-1. They play an important role in adaptive 
immunity by mainly producing chemicals known as lymphokines which activate the 
proliferation and activation of all the other cells e.g. CD8+, macrophages and other 
CD4+ T cells. As mentioned in the previous paragraph, CD4+ T cells also attack 
antibody-bound pathogens presented on surfaces of APC by simultaneously binding 
to MHCII molecules (Lanzavecchia,1998).  The CD8+ T cells carry out the cytotoxic 
T-lymphocyte (CTL) immune response, which plays a major role in anti-HIV-1 
immune responses. Details of the CTL immune pathway are discussed in the next 
section.    
 
2.6 The Cytotoxic T-lymphocyte Immune Response  
 
The CTLs (CD8+ T cells) are activated to produce chemicals that destroy infected 
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protein peptides of the pathogen and MHC type 1 molecules on the surface of the 
infected cell. The CTLs only bind to peptides bound by MHCI molecules 
(Ohno,1992). Therefore, proteins of the endogenous pathogen within the infected cell 
need to be cut into short peptides that can be bound by MHCs and presented to the 
CTLs on the cell surface (Ohno,1992). MHC molecules specific to humans are known 
as human leukocyte antigens (HLA). Throughout the rest of this thesis, the term 
human leukocyte antigen or HLA will be used to refer to the human MHC type I 
molecules. 
 
2.6.1 Stages involved in the CTL immune response 
 
Proteins of the pathogen are cut down into short peptides by the proteolytic enzymes 
in the cytoplasm during the degradation of some host cell proteins, a process that is 
part of the cell cycle (Ohno,1992). The resulting peptides are engulfed by golgi 
vesicles and transported to the smooth endoplasmic reticulum (ER). Non-self peptides 
are recognised by HLA molecules within the ER and bound in a specific manner 
(Ohno,1992). Each HLA molecule can only bind peptides with specific sequence 
motif patterns that complement the binding groove of the HLA. The HLA-peptide 
complexes within the lumen of the ER are transported to the surface of the infected 
cell. The CTLs, which have been activated by lymphokines produced by CD4+ T 
cells, recognise and bind only to HLA-presented peptides. The interaction of the CTL 
cell receptors with the HLA and peptide activates the CTL to secrete chemicals that 
destroy the infected cell. HIV-1 predominantly infects CD4+ T cells hence increased 
viral replication and cell infection results in the reduction of CD4+ T cell population 
(Boritz et al.,2004). The main steps involved in mounting a CTL immune response 
are presented in Figure 2.6.1. The HLA class I alleles form a major component of the 
cytotoxic T-lymphocyte immune response since the pathogenic peptides can only be 
recognised by the CTL in the context of HLAs (Frahm et al.,2007).  No CTL immune 



















Figure 2.6.1: Schematic representation of the main steps involved in a CTL immune 
response adapted from various sources (Janeway et al.,1997; Levy,2007; Yang et 
al.,1997), 1; proteolysis of self and pathogen proteins, 2; transport to ER via golgi 
vesicles, 3; within ER, HLA-peptide binding, 4; HLA-peptide complexes presented 
on cell surface, 5; recognition and binding by CTLs, 6; production of cytotoxic 
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2.6.2 HLA polymorphism and binding 
 
The HLA gene is found within the short arm of human chromosome 6 (Marsh et 
al.,2000). Three loci within the gene region for HLA class 1 encode the HLA-A, -B 
and -C allotypes, which are the most active in mediating CTL immune responses. 
These three loci are highly polymorphic such that many alleles exist within each HLA 
allotype with specific sequence differences that affect their binding preferences 
(Williams,2001). The HLA-B locus is the most polymorphic comprising the highest 
number of individual alleles, followed by HLA-A and then C (Marsh et al.,2000). 
One of the most accurate methods for HLA typing is use of serological assays where 
antibody-HLA complexes are isolated from serum of multiparous women in which 
the mother’s antibodies are produced against the fetus’ HLA molecules (Marsh et 
al.,2000). The variation of HLA molecules can also be identified using the specific 
different CD8+ T cells that are targeted against HLA-peptide complexes on the 
surfaces of infected cells (Marsh et al.,2000). The antibody-HLA or peptide-HLA 
complexes are then degraded in vitro and sequenced in order to be classified and 
named. The HLA allele nomenclature is commonly represented by the locus (i.e. A, B 
or C), serological type (first two digits, eg. HLA B58) followed by another two digits 
which represent non-synonymous nucleotide substitution differences between alleles 
of the same serological type, e.g. HLA*B5801 and B5802. In some cases, closely 
related HLA alleles which only differ by synonymous nucleotide differences 
observable under high resolution are assigned one more digit (Marsh et al.,2000).  
 
The basic structure of an HLA molecule consists of two identical heavy protein chains 
of about 45kd each (blue and purple beta sheets in Figure 2.6.2) and two identical 
light chains of about 25kd each (light blue and light purple alpha chains in Figure 
2.6.2) (Marsh et al.,2000). The N-terminal half of each heavy chain is bound to one 
light chain via a single disulphide bond at the C-terminal end of the light chain. After 
this bond, towards the C-terminal of the heavy chain, there is a hinge that joins the 
two heavy chains together through another disulphide bond. The C-terminal regions 
of both the heavy and light chains are conserved.  The N-terminal region of each 
heavy chain, situated close to the N-terminal of the light chain and the corresponding 
N-terminal half of the light chain, is variable. Within these variable regions are found 
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differences mostly found at the hyper-variable regions (Figure 2.6.2). The hyper 
variable sites are within the binding pockets of the HLA binding groove, the groove 
being formed by the variable regions of both the light and heavy chains.   
 
The binding pockets known as the B and F pockets (shown by spherical 
representation of amino acid residues in Figure 2.6.2) form the strongest contact and 
binding to the antigenic peptides in a highly specific manner. It has been shown that 
the B and F pockets usually bind to the second and C-terminal positions of an 
antigenic peptide (Madden et al.,1992). Minimal amino acid variations are allowed at 
these major ‘anchor residue’ sites of peptides and less stringency is observed at the 
other positions within the peptide. However, successful binding is also dependant on 
the overall binding energy and morphology of the HLA-peptide complex. The 
extensive diversification of the binding groove region as a result of varying amino 
acid side changes enables the HLA molecules to recognize and present a diverse 
population of antigens thus enabling the immune system to combat various infecting 
pathogens. HLA molecules with closely related sequences and that share some 
common anchor residue preferences have been grouped under the same supertypes 
(Sette et al.,1999). For example, currently, alleles of the HLA-A and B loci, which 
have been extensively characterized have been classified into nine major supertypes, 








































Figure 2.6.2: HLA A*0201 secondary structure obtained from 
http://www.cryst.bbk.ac.uk/PPS2/projects/vun/H2kb_P1P9.gif 
Beta sheets represent heavy chains and alpha chains are the light chains. The residues 
of the B and F pockets of the HLA binding groove are represented in spheres, and the 
positions with respect to the amino acid sequence of the molecule are given for those 
that contact the peptide. The peptide bound in the groove is shown as a red chain with 




2.6.3 Detection of CTL epitopes 
 
Various methods have been developed to determine peptides that are bound by HLA 
molecules. Both biochemical and computational approaches have been used. The 
central point in understanding the host-viral relationships is the evaluation of immune 
responses against HIV-1 and their impact on both the virus and the host.  The primary 
step is the determination of specific peptides on the virus sequence that are targeted 
by specific HLA molecules. The most accurate methods for determination of CTL 
epitopes is the use of biochemical methods such as the frequently used interferon-γ 
ELISpot assays. In these assays, antigenic peptides that bind to peripheral blood 
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(Schmittel et al.,1997).  The isolation of HLA-peptide complexes from cultured B-
cells is also common (Marsh et al.,2000). The HLA-peptide complexes are denatured 
and peptides screened through High Performance Liquid Chromatography or the 
Edman Degradation technique (Marsh et al.,2000). 
 
Although biochemical methods are very accurate and provide complete epitope 
sequences, they tend to be slow and expensive. Computational methods can be useful 
in speeding up the determination of HLA binding regions of protein sequences. 
Anchor residues as well as binding affinity are the key components of computational 
methods for predicting CTL epitopes. The anchor residue motifs themselves aid in 
identifying potential target sites of HLA alleles thereby reducing candidates that can 
be further analysed for optimal binding to HLAs either biochemically or 
computationally. Methods that determine the binding energy between HLA and 
candidate peptides can further reduce the quantity of biochemical tests by identifying 
good binders. Epitopes that bind with highest affinity are likely to be successfully 
transported from the ER to the cell surface of infected cell and elicit strong immune 
responses in vivo. A positive correlation between binding affinity and 
immunogenicity of a peptide has been observed in previous studies confirming the 
importance of binding affinity in predicting HLA binding epitopes (Sette et al.,1994).  
 
The presence of anchor residues in query peptides is also used in combination with 
the determination of binding affinity between a HLA molecule and a peptide (Altfeld 
et al.,2001; Altuvia et al.,2004; Schueler-Furman et al.,2000). In this case, query 
peptides containing known anchor residues recognised by a HLA are analysed for the 
affinity of binding to the HLA molecule. There are a number of methods used to 
determine the HLA-peptide binding affinity. In one example, the half time for the 
dissociation of a HLA-peptide complex is used to measure the strength of binding and 
the longer the time, the higher the affinity (Parker et al.,1994). IC50 values, i.e., the 
concentration of a peptide that inhibits the binding of a standard peptide to an HLA 
molecule by up to 50%, from competitive binding assays, are also used (Altfeld et 
al.,2001). Yet other methods rely on the pairwise binding potentials of amino acids or 
binding free energy between a HLA crystal structure and a peptide (Altuvia et 
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Some computational approaches require the knowledge of known HLA-binding 
peptides as well as those that do not bind in order to classify candidates. One such 
example is the use of machine learning where algorithms learn the binding 
characteristics of known HLA binders and non-binders before testing a query peptide 
(Jojic et al.,2006; Lata et al.,2007).  Query peptides are characterized by how best 
their binding characteristics resemble that of binders and non-binders. Another 
example of a frequently used computational approach is the use of position specific 
scoring matrices (PSSM) (Flower,2007). In PSSM, query peptides are compared 
against an alignment of epitopes known to bind to a HLA and each position of the 
query peptide scored based on its similarity to the alignment. Peptides that meet the 
required threshold scores are assigned as epitopes.  A similar approach but based 
mostly on the presence and high scoring of anchor residues that were derived from 
natural HLA ligands is also used for epitope predictions in the SYFPEITHI database 
(Rammensee et al.,1995) .  
 
2.6.4 Prediction of HLA anchor residue motifs 
 
Amino acid residues located at the second and C-terminus of epitopes that bind to the 
B and F pockets of HLA molecules are known as anchor residues. They form the 
strongest binding points between the HLA and the peptide. As described in section 
2.6.2, each HLA has high selectivity at the B and F pockets when binding to epitopes. 
Therefore, anchor residues are the most important components of peptides and first 
determinants of HLA-peptide binding.  The sequence patterns that contain only the 
anchor residues are known as ‘anchor residue motifs’. An example of an anchor 
residue motif is x-[P]-x-x-x-x-x-x-[WFL] for the B*5301 allele (Yusim et al.,2003). 
The ‘x’ represents any amino acid at that position of the 9-mer peptide. Phenylalanine 
is the anchor residue at position 2 of the peptide. For this HLA allele, each of the 
three residues given in square brackets at the C-terminus position of the peptide is 
preferred.   
 
Anchor residue motifs are important in preliminary predictions of HLA binding 
peptides and have become important in studies of immune escape mutations at the 
anchor sites of peptides. Various methods are being used to predict anchor residue 
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motifs are (i) the identification of residues that frequently occur at anchor sites of 
known epitopes found bound to HLA molecules endogenously e.g. (Boisgerault et 
al.,1996; Falk et al.,1991; Marsh et al.,2000; Seeger et al.,1999b).  Another prediction 
approach is (ii) the inference of a motif to a new HLA based on the similarity of 
residues and side chains at the binding groove to that of a HLA allele with a 
characterized motif e.g. (Honeyborne et al.,2006; Seeger et al.,1999a).  With 
development in computer application in biology,  (iii) structure-based methods for 
which the binding energy between a peptide and the HLA binding pockets have also 
been developed e.g. (Altuvia et al.,2004).  
 
In the latter approach, the amino acids that confer strongest binding energy at the 
anchor positions are assigned as the optimal anchor residues for the specific allele. 
Anchor residue motifs that are predicted using the first two approaches can however, 
be biased by the residues that happen to occur in the viral sequences in which the 
motif was inferred. For instance, the HIV-1 subtypes have an amino acid sequence 
difference of up to 35% in the envelope proteins (Levy,2007; Wain et al.,2007). If 
such regions where the greatest sequence diversity exists are used to predict a motif, it 
is highly likely that the corresponding motif targeted by the same HLA allele at a 
sequence of another subtype could be different. When such motifs are used to predict 
binding regions on a sequence from a different source, optimal epitopes can be missed 
and be assumed to have been lost due to the difference in an anchor residue, which in 
fact does not hinder HLA binding. The third approach however is more universal in 
that the binding is predicted based on first principles of amino acid and protein 




2.7 CTL Immune Response and HIV Disease Progression 
 
The CTL immune response is known to be important in anti-HIV-1 immune responses 
as well as in determining disease progression in infected individuals. In most 
individuals, viral load decreases drastically during early infection after the first 
activation and mounting of CTL immune responses.  This can be followed by a latent 
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decreases to very low levels. Final stages in HIV-1 infection have increasing viral 
load and low levels of CD4+ T-cells, which are the main targets of HIV-1 infection 
(McMichael et al.,2001). This marks the development of AIDS and typically death, in 
the absence of antiretroviral treatment. Host immune responses mediated through 
CTL and HLA alleles may varyingly exert selection pressure on the targeted regions 
of the HIV-1 sequences during infection (Carlson et al.,2008; Carrington et al.,2003; 
Rousseau et al.,2009).  Most of the HLA alleles that exert strong selection pressure 
are from the B locus. The HLA-B alleles have also been found to be frequently 
involved in mediating CTL immune responses against HIV-1 and in determining 
disease progression (Bihl et al.,2006; Kiepiela et al.,2004). Individual HLA alleles 
within a single supertype can lead to different effects on the HIV-1 sequence and 
disease progression. Some HLA alleles are associated with either delayed or rapid 
progression to AIDS in infected individuals.  
 
2.7.1 Long term non-progression in HIV-1 infection 
 
Some HLA alleles have been found to mediate CTL responses that result in protection 
and delayed disease progression to AIDS.  HLA B*5801 is one of the alleles first to 
be recognized for its association with long-term non-progression (LTNP) (Goulder et 
al.,2004). It is frequent in African populations (Marsh et al.,2000) and  targets 
peptides within the Gag protein sequence (Brumme et al.,2008a; Goulder et al.,2004). 
HLA-B2705 targets a peptide within conserved regions of the Gag protein and has 
been found to be associated with a reduction in viral load and protective immunity 
(Kelleher et al.,2001).  HLA B4 allele was also previously found to be associated with 
a prolonged disease-free period in HIV infected individuals bearing homozygosity for 
this genotype (Flores-Villanueva et al.,2001). 
 
2.7.2 Rapid progression to AIDS 
 
On the other hand, some HLA alleles tend to be associated with rapid progression to 
AIDS.  The specific mechanisms by which the presence of these genotypes causes 
rapid progression are not yet well understood.  Examples of such alleles include HLA 
A*2301 which was found to be frequent in individuals who progressed rapidly to 
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Africans and African-American populations and targets peptides located in the Nef 
protein (Marsh et al.,2000). B*5802, with the same serological group as B*5801 
discussed in the previous section, is on the contrary associated with rapid disease 
progression in HIV-1 infections (Ngumbela et al.,2008). The allele is also frequently 
present in persons of African origins (Marsh et al.,2000).  The B*35 genotype, 
frequent in Caucasoid and Amerindian ethnic groups, has been found to cause rapid 
progression to AIDS in Caucasians (Carrington et al.,1999). 
 
 
2.8  Challenges in Designing anti-HIV Vaccines 
 
Despite numerous studies that have been done on the HIV-1 pathogenesis in humans 
as well as development of a number of anti-HIV-1 therapeutics, there is still no cure 
for AIDS.  The current hope lies in vaccines. However, vaccines that completely 
destroy the virus in humans have not been successfully developed yet (Singh,2006). 
Ideally, such a vaccine should boost immune responses that target regions of the 
sequence that are highly conserved and cannot easily mutate, and also prevent further 
replication of the virus.  
 
2.8.1 Host and pathogen diversity 
 
It is more likely to find similar immune responses targeting conserved regions within 
a single population of individuals of the same ethnic group who share common HLA 
genotypes. However, individuals of different ethnic origins usually have large genetic 
differences (Cao et al.,2001) such that the frequency of specific immune responses 
against HIV-1 may differ between the groups (Kawashima et al.,2009; Moore et 
al.,2002; Piontkivska et al.,2004; Travers et al.,2005). This implies that the selection 
pressure exerted on the viral sequences can differ remarkably between the different 
ethnic populations. The varying selection pressures therefore cause variations in 
immune escape mutations and the evolution of the virus sequences thus minimising 
the chances of finding identical and conserved HIV-1 regions across different 
populations. Even though there are highly conserved immunogenic regions in Nef and 
Gag proteins (da Silva et al.,1998; Masemola et al.,2004b) of different subtypes, the 
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not all have a strong protective effect. Even individuals of the same ethnic group have 
different genotypic composition except for identical twins (Draenert et al.,2006), 
hence not all individuals within an ethnic or population group can have similar 
protective immune responses.  Designing a vaccine for each individual or the few 
with similar desirable immune responses AIDS would be ideal but is very expensive 
and not feasible for the whole HIV-1 infected population worldwide. Therefore, an 
ideal vaccine reagent should comprise virus peptides that are conserved across 
different HIV-1 subtypes and elicit protective immune responses across at least most 
individuals in the different ethnic and population groups. The possibility of such a 
vaccine lies in the cooperation of researchers across the world and sharing of 
information on HIV-1 pathogenesis and anti-HIV immune responses. 
 
2.8.2 Research limitations  
 
Indeed, sharing of information has been made possible by the development of public 
databases for data storage. A good example is the Los Alamos HIV databases 
(http://www.hiv.lanl.gov/content/), where information such as HIV-1 sequences, 
epitopes, HIV specific anchor residue motifs for HLA allele binding, HLA supertypes 
and binding specificities as well as related analysis tools are provided. A lot of the 
data in the Los Alamos databases have been collected from various published studies. 
The curators of the database are therefore faced with a challenge of linking data 
isolated from the same infected individual (Learn, Jr. et al.,1996). Obviously, this 
cannot be possible if the source authors use different patient codes in subsequent 
studies of the same individual. This obviously causes limited amounts of longitudinal 
data that is publicly available thus limiting research studies that can monitor the 
evolution of specific sequences overtime. 
 
Problems that may be faced by researchers include the inadequacy of the data in 
equally representing all infected populations and HIV-1 subtypes across the world. 
For example most studies that predict CTL epitopes have been carried out on HIV-1 
subtype B which is most frequent in the developed countries which are better 
equipped to carry out more research analysis.  Such data may not provide accurate 
information for some studies that focus on other subtypes. For example, epitope 
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studies of other subtypes if the provided sequences were obtained from a single 
subtype.  
 
An example of another very useful database is dbMHC which provides the HLA 
anthropology data (Meyer et al.,2007). Estimated HLA frequencies from major 
population groups across the globe are provided. This resource however has its 
limitations too.  In the first, the HLA allele frequencies are based on small population 
samples e.g. the Zulu tribe, a majority population group in South Africa is represented 
by a sample size of 290 individuals (Hammond et al.,2007). Also, not all HLA alleles 
that are found in these populations are provided in the database hence absence of an 
HLA in the database under a particular group does not necessarily mean that the HLA 
genotype is absent in the population. In some cases, the allele frequency is provided 
as belonging to a country as a whole even though people of different ethnic groups 
co-habit in the particular country.  
 
Another major problem with the currently available data is that the HLA genotypes of 
individuals are provided separately from the HIV-1 autologous sequence data isolated 
from the same individual. Datasets comprising of both HLA background and 
autologous sequences of the virus are rarely found in public databases and only in 
small sample sizes. Large datasets of HIV sequences providing the corresponding 
genotypes of the corresponding patients would aid in more accurate analysis of HIV-1 
evolution in relation to immune responses at larger population levels. In addition to 
the need for more studies to characterize host genotypes, there is a need for accuracy, 
consistency, cooperation and rapid depositing of data in order to speed up studies 






















  43 
 
 
Chapter 3  
 
The extent of purifying selection pressure acting on synonymous sites 
of HIV-1 sequences 
 
Foreword 
This chapter describes an analysis that was published in an international journal and 




The ratio of nonsynonymous to synonymous substitution rates (dN/dS) is used to infer 
selection pressure acting on protein-coding sequences. A dN/dS >1 resulting from dN 
being significantly higher than dS indicates positive selection. Such an inference of 
selection pressure assumes that dS is a measure of the neutral rate of evolution against 
which dN, a measure of selection pressure acting at the amino acid level, is compared. 
However, purifying selection acting directly on the nucleotide sequence can lower dS, 
resulting in an underestimate of the neutral rate of evolution. This can cause dN/dS to 
be greater than 1 when there is actually no diversifying selection acting on the amino 
acid level and thus false inference of positive selection. Despite the fact that HIV-1 
has a number of sequence motifs that function at the nucleotide level, the extent of 
purifying selection pressure acting on synonymous sites of the nucleotide sequence 
across the genome has not been evaluated to date. Yet dS is continually being used as 
a measure of neutral evolution in positive selection analysis of HIV-1 sequences. 
Here, site-to-site variation in dS across coding regions of the HIV-1 genome was 
modeled and found to vary significantly within and between genes. Fourteen regions 
of the nucleotide sequence with known functions appeared to be under strong 
purifying selection pressure with significantly lowered synonymous mutations. These 
included an exonic splicing enhancer, the rev-responsive element, the poly-purine 
tract and a transcription factor-binding site. A further five highly conserved regions 
were located within known functional domains. An additional four regions with un-
characterized functions, possibly novel, located in env and vpu were also conserved. 
The coordinates of genomic regions with significantly lower synonymous substitution 
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at the nucleotide sequence level are provided for consideration or exclusion from 




Biological sequences that code for proteins are known to evolve either neutrally or in 
response to selection pressure exerted upon them. Several statistical models of codon 
evolution have been developed for the purposes of analysing the evolution rate of 
codons in protein-coding sequences of different species and pathogens such as viruses 
(Goldman et al.,1994; Muse et al.,1994; Nielsen et al.,1998; Yang et al.,2000). The 
primary application of these models has been the detection of evidence of diversifying 
selection acting on protein coding DNA sequences. Within maximum likelihood or 
Bayesian frameworks these models can be used to identify specific sites at which 
adaptive mutations have occurred.  In the context of virus infections this information 
can be especially useful for identifying immune escape and drug resistance mutations 
(Lemey et al.,2007; Nielsen et al.,1998; Seoighe et al.,2007).  
 
Selection pressure acting on protein-coding sequences is frequently inferred by 
comparing the rate of non-synonymous substitutions per non-synonymous site (dN) to 
the rate of synonymous substitutions per synonymous site (dS). The dN/dS ratio is 
often represented by the symbol ω. Diversifying selection can be inferred when ω is 
greater than one. However, this approach assumes that synonymous substitutions are 
neutral and that the synonymous substitution rate therefore approximates the neutral 
rate of evolution. Several methods exist to determine whether there is evidence that ω 
is greater than one i.e., the gene is evolving under diversifying selection at a subset of 
sites in a protein-coding gene and to identify the sites within the gene at which 
diversifying selection occurs (Choisy et al.,2004; de Oliveira et al.,2004; Nielsen et 
al.,1998; Yang et al.,2000; Zanotto et al.,1999).  
 
Kosakovsky Pond & Muse reported that coding sequences from a wide range of taxa, 
including HIV-1, show strong evidence of variation in the rate of synonymous 
substitution across coding regions (Kosakovsky Pond et al.,2005a). Therefore, the 
assumption that synonymous substitutions are fixed at a constant rate and provide a 
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possible causes of synonymous rate variation. Firstly, if synonymous substitutions are 
indeed neutral, variation in the mutation rate can cause the synonymous substitution 
rate to vary. In such a case, it is possible to include a varying synonymous substitution 
rate in the codon models of evolution and inference of positive selection from 
comparison of the local synonymous and nonsynonymous substitution rates remains 
feasible. Secondly, selection pressure acting to preserve functions that are encoded at 
the nucleotide level can cause a variation in synonymous substitution rate, which 
deviates from the neutral rate. In such a scenario, even a comparison of local 
nonsynonymous and synonymous substitution rates cannot be used to infer positive 
selection because the synonymous substitution rate has deviated from the neutral rate 
of evolution and the standard approach of inferring the action of diversifying selection 
when ω > 1 becomes invalid.   
 
In the second scenario, failure to model variation in synonymous substitution rate will 
result in an overall underestimate of the neutral rate of evolution. This undermines the 
validity of the inference of selection, because nonsynonymous substitution rates are 
compared against a rate, which is no longer a good estimate of the neutral rate, and 
this is likely to result in inference of diversifying selection at a proportion of the sites 
that are actually evolving neutrally. Indeed, as the number of taxa increases, we 
expect a greater proportion of amino acid sites that are evolving neutrally to be 
classified as diversifying selection sites in this scenario.  Alternatively, if the 
synonymous substitution rate variation is modeled and selection inferred when dN is 
greater than the local dS rate then we expect a very high probability of false inference 
of selection at codons where the synonymous positions happen to be functionally 
important and conserved, and the nonsynonymous positions are neutral. Thus, in 
general, in a codon-based method, analysis of selection is unreliable when there is 
purifying selection acting to preserve functions at the nucleotide level. An example 
where an elevated ω was attributable to purifying selection acting on synonymous 
sites was reported by Hurst & Pal (Hurst et al.,2001). 
 
Several examples of sequence motifs within protein-coding sequences that are 
expected to be under purifying selection at the nucleotide level are known in HIV-1, 
many of which are involved in regulating gene expression. In addition to functions of 
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conserved RNA secondary structures (Pereira et al.,2000; Wilkinson et al.,2008). 
Some functionally important regions of the rev-responsive element (RRE) have also 
previously been found to be conserved at the nucleotide sequence level, presumably 
the result of purifying selection pressure to preserve this function (Phuphuakrat et 
al.,2003). If the functional sites of the nucleotide sequence are important for viral 
viability, then they are expected to be preserved by purifying selection resulting in dS 
rates that are lower than the neutral rate of evolution.  
  
While it represents a significant challenge for studies of selection acting on the HIV-1 
amino acid sequence, the variability in the synonymous substitution rate may also 
provide useful information about previously unknown sequence motifs within the 
coding fraction of the HIV-1 genome that function at the nucleotide level. Although 
some variability can be explained by a variable mutation rate, the identification of 
regions of very high conservation that cannot be explained by selection acting on the 
amino acid sequence or by known motifs that function at the nucleotide level has the 
potential to highlight novel functions encoded in the HIV-1 genome. 
 
Here, an existing model of codon sequence evolution (Kosakovsky Pond et al.,2005a) 
was used to provide the first complete overview of site-to-site variation in 
synonymous substitution rate across all coding regions of the HIV-1 genome and 
identify selection pressures likely to be driving this variation. This model allows dN 
and dS to vary independently across sites, ensuring that the estimated dS values 
reflect selection pressure acting upon the nucleotide sequence and not at the amino 
acid level. It is worthwhile to distinguish between selective pressure acting at the 
nucleotide level, affecting both synonymous and nonsynonymous changes, and at the 
amino acid level, affecting nonsynonymous changes only. Unfortunately, quantifying 
the relative contributions of nucleotide and amino acid level effects on 
nonsynonymous changes is highly sensitive to model assumptions. Therefore, this 
study was restricted to the analysis of synonymous changes at the synonymous sites 
of the nucleotide sequence only. Recombination breakpoints were taken into account, 
as explained in the methods section, in order to avoid biased estimates that can result 
from fitting phylogenetic models that do not take recombination into account 
(Anisimova et al.,2003; Shriner et al.,2003). This chapter provides all sites of the 
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sequence and which are likely to cause a substantial reduction in the synonymous 
substitution rate. These are provided with respect to the HXB2 reference strain, to 
enable other researchers to mask these regions from their analyses of positive 
selection acting on HIV-1 genes. 
 
3.3 Materials and Methods 
 
3.3.1 Sequence data 
 
Nucleotide sequence alignments consisting of HIV-1 Group M subtype reference 
sequences were downloaded from the Los Alamos database for each gene of the HIV-
1 genome (Leitner et al.,2005). Each alignment had at least one sequence from each 
of the 11 non-recombinant HIV-1 group M subtypes A1, A2, B, C, D, F1, F2, G, H, J 
and K [Genbank: AB253421, AB253429, AF004885, AF005494, AF005496, 
AF061641, AF061642, AF067155, AF069670, AF075703, AF077336, AF082394, 
AF082395, AF084936, AF190127, AF190128, AF286237, AF286238, AF377956, 
AF484509, AJ249235, AJ249236, AJ249237, AJ249238, AJ249239, AY173951, 
AY253311, AY331295, AY371157, AY371158, AY423387, AY612637, AY772699, 
DQ676872, DQ853463, K03454, K03455, U46016, U51190, U52953, U88824, 
U88826]. The total number of sequences per gene alignment ranged from 32 to 37. 
All regions encoding amino acids in more than one frame were identified and regions 
judged by eye to be unreliably aligned, i.e., positions 6544-6595, 6700-6715, 7318-
7375 of the env gene region, were excluded from the analysis. The HIV-1 genome 
map and sequence annotations available from the Los Alamos database were used to 
identify the regions of the genome that encode proteins in a single reading frame (see 



























Env 88 – 2154  6313 – 8379 37 
Gag 1 – 1295 790 – 2084 37 
Nef 1 – 621 8797 – 9417 32 
Pol 211 – 2955  2296 – 5040 37 
Tat 22 – 138  5851 – 5967 37 
Vif 58 – 519  5098 – 5559 37 
Vpr 61 – 273  5620 – 5832 37 
Vpu 1 – 162  6061 – 6222 37 
Rev  total overlap    
Genome Includes 
overlapping sites 
790 – 9417 36 
Table 3.3.1: Summary of HIV-1 reference sequence data used, the HXB2 genome 




Recombination breakpoints in each alignment were identified using the GARD 
(Genetic Algorithm for Recombination Detection) algorithm implemented in the 
HyPhy (Hypothesis testing using Phylogenies) package (Kosakovsky Pond et 
al.,2005d; Kosakovsky Pond et al.,2006). Evidence of recombination was detected in 
all genes except tat, vpr and vpu. GARD outputs both an alignment showing the 
positions of recombination breakpoints and separate tree topologies for each of the 
sequence alignment segments bounded by these breakpoints.  
 
3.3.2 Synonymous substitution rate estimation 
 
Synonymous substitution rates were estimated using a version of the MG94 codon 
substitution model (Kosakovsky Pond et al.,2005a; Muse et al.,1994). In the version 
used here, synonymous substitution rates were allowed to vary between sites. The 
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discrete categories for each rate, i.e., three dN/dS classes are estimated based on the 
data. The selected models were ran using a HyPhy batch script for analysis of 
selection acting on recombining sequences, which was developed by fellow 
researchers (Scheffler et al.,2006). This method uses separate tree topologies for each 
partition (between recombination breakpoints) of the sequence alignment while 
keeping the rest of the model parameters fixed across all partitions. Mean dS values 
over sliding windows was calculated over three neighboring codons and plotted to 
identify regions with low synonymous substitution rates. 
 
An alignment of HIV-1 subtype C gag sequences from recent HIV-1 infections 
[Genbank: DQ792982-DQ793045] described in one of the publications listed in this 
thesis (Ngandu et al.,2007) was used to further assess the impact of conservation 
acting on synonymous substitutions on inference of positive selection. Positive 
selection was inferred using model M2a of Yang and colleagues (Yang et al.,2005b), 




Simulations were caried out in order to validate whether the observed dS rates per site 
were significantly different from what would be expected by chance. HyPhy was used 
to generate simulated data under a neutral model with trees generated from the 
original alignments (or the tree from the largest un-recombined region for alignments 
where recombination was detected).  The same sequence alignments used as input in 
the initial analysis were used and one hundred simulated datasets were generated for 
each alignment. Each simulated dataset was then analyzed using the Dual Model as 
described above. For each gene the minimum value of mean dS across all sliding 
windows of three neighboring codons, in all of the one hundred simulated datasets, 
was used as a conservative threshold to identify windows of reduced dS in the 
observed data. This stringent threshold and a less stringent one that included 95% of 
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3.4 Results  
 
3.4.1 Evidence for site-to-site synonymous rate heterogeneity 
 
For all genes the Dual Model (Kosakovsky Pond et al.,2005a), which allows 
independent variation of dS and dN had a much better fit to the data than a model 
with constant dN and dS (referred to as the Constant model in Table 3.4.1a) or than a 
model in which only dN varied across sites (the Nonsynonymous model in Table 
3.4.1a). The Akaike Index Criterion is a score that gives a measure of how a model 
fits to the data in comparison to other models being tested. The score is calculated 
using a statistical measure of the maximum likelihood of the model given the data and 
taking into account the number of parameters to be fitted (Akaike, 1987). Too many 
parameters can cause overfitting thus a model with a low AIC, i.e., a high goodness of 
fit yet using the least number of parameters is preferred. Consistent with previous 
reports (Kosakovsky Pond et al.,2005a; Lemey et al.,2007), evidence of variation in 
synonymous substitution rates was observed within and across HIV-1 genes (Figures 
3.4.1a and b).  There was significant variation between genes (p value = 2 x 10-7, from 
Levene’s test) with the least site-to-site variation in dS observed in vpu and the most 
in vpr followed by nef and env (Figure 3.4.1b). The variance of dS gives an indication 
of the extent of site-to-site synonymous rate heterogeneity within the different 
genomic regions (Table 3.4.1b). Evidence of strong purifying selection acting directly 
on the nucleotide sequence was found at twenty-three nucleotide motifs across the 
HIV-1 genome, based on pvalues obtained using the simulations. The nucleotide 
motifs found to be conserved (all listed per gene in Table 3.4.1b) either had 
previously reported known functions, were within regions with known functions or 
novel with no record of known function in the literature. In addition to motifs that are 
highly conserved i.e., with mean dS lower than that obtained from all simmulated 
datasets, thus with a pvalue <0.0001, sites that were observed to be conserved at the 
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Gene regions Akaike Information Criterion index (AIC) per Model 
 Dual Nonsynonymous Constant 
Gag 23862.95 23963.83 25889.10 
Pol 41504.20 41668.99 45642.96 
Vif 9794.65 9843.41 10502.37 
Vpr 9581.57 9692.29 10869.78 
Tat 2834.49 2878.99 3110.23 
Vpu 11701.57 11832.41 12938.54 
Env 45201.62 45422.72 48658.16 
Nef 13984.66 14061.46 14986.75 
Table 3.4.1a: AIC model selection index to show how different models fit to the data, 
The Dual Model, which allows dS to vary across sites has the lowest AIC (best fit to 
























Figure 3.4.1a; HIV-1 genome-wide plot of mean nonsynonymous substitution rates. 
A 30 codon sliding window was used. Regions coding for proteins in more than one 
frame are shaded in pink. The frames that were used in each region are shown in grey 




Figure 3.4.1b: Box-and-whisker plot showing variation of dS values per gene. 





































793 – 807  
898 – 903  
985 – 996  







1969 – 1974 
2002-2004 







5041 – 5097 
(pol/vif) 
 
4092 – 4094  
4764 – 4790  
4864 – 4866  
4926 – 4937  
 
2490-2495 
2850 – 2858 
3252 – 3257 
3304 – 3312 
3867 – 3881 
3966 – 3971 
vif 2.7 
 
5560 – 5619 
(vif/vpr) 
 -  - 
vpr 3.9 5833 – 5850 
(vpr/tat) 
5769 – 5777 
5794 - 5805  
 - 
tat 2.9 5968 – 6060 
(tat/rev) 
5855 – 5863 
5957 – 5968 
 -  
vpu 1.4 6223 – 6312 
(vpu/env) 
6101 – 6106 
6143 – 6151 
6167 – 6178 
 - 
env  3. 2 8380 – 8796 
(env/rev) 
7656 – 7667  
7834 – 7842  
8349 – 8354  
8376 – 8378  
7077 – 7082 
7125 – 7130 
7629 – 7634 
 
nef  3.6 
 
 
 -  
9067 – 9086  
9087 – 9093 
(nef/LTR) 
9183 – 9192 
(nef/LTR) 
9391 – 9399 
(nef/LTR) 
8869 – 8874 
8887 – 8892 
9121 – 9126 
9235 – 9237 
Table 3.4.1b Regions of the HIV-1 sequence that should be considered for exclusion 
in positive selection analysis studies, Co-ordinates are adapted from the HXB2 
numbering system. Dashes indicate that there are no sites within that category for a 
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3.4.2 Purifying selection pressure in known functional motifs 
 
Of the twenty-three highly conserved regions, fourteen (marked in black in Figures 
3.4.2a through to 3.4.2g) coincided exactly with well-characterized functional motifs.  
Sequence logos illustrating the conservation in each of these fourteen significantly 
conserved regions with known specific function are shown in Table 3.4.2. Four of the 
significantly conserved regions with known function were in the nef gene and 
coincided with the poly-purine tract (PPT), integrase attachment site, negative 
regulatory element and Ets-1 transcription factor binding site (Figure 3.4.2a) (with 
HXB2 coordinates 9066-9083, 9084-9091, 9183-9192 and 9391-9399 respectively). 
The PPT precedes the start of the LTR and is known to associate with the 3' LTR, 
serving as a primer for the initiation of HIV-1 plus strand DNA replication (Luo et 
al.,1990; Miles et al.,2005; Quinones-Mateu et al.,1998; Rausch et al.,2007). A 
previous detailed RT RNase-H binding analysis revealed that priming of the plus 
strand occurs specifically at the 3' end of the PPT, at the “GGGGGG” motif (Powell 
et al.,1996; Pullen et al.,1993; Rausch et al.,2004). The region adjacent to the 3' end 
of the PPT was also highly conserved. This region corresponds to the start of the 
3'LTR and contains the cleavage site of the PPT by RNAse H as well as the start of 
integrase attachment region for the integration of the viral genome into the genome of 
the host  (Brown et al.,1999; Masuda et al.,1998; Miles et al.,2005; Rausch et 
al.,2004).  Two codons in the central region of nef were highly variable, one 
dominated by G-to-A mutations in a sequence context consistent with APOBEC-
induced hypermutations when compared to the Group M ancestral sequence (Rose et 
al.,2000) (see Figure A3.4.2a in the Appendix) and the second had a high rate of 
synonymous and nonsynonymous substitutions (labeled “G-A” and “var” in Figure 
3.4.2a respectively). 
 
Two regions in vpr, a 3' splice acceptor site (Kammler et al.,2006) and an RNase-V1 
cleavage site (Jacquenet et al.,2001a; Jacquenet et al.,2001b) were also conserved 
(labeled ssa3 and rnase respectively in Figure 3.4.2b) at positions 5759-5777 and 
5794-5805 respectively. An additional two highly conserved regions were observed 
within the tat gene, one containing an exonic splicing silencer, ESS2 between 
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located at positions 5957 to 5968 (ess2 and ssa4b respectively in Figure 3.4.2c) 
(Kammler et al.,2006). 
 
These fourteen regions with known functions included one region consisting of fifteen 
nucleotides following the gag start codon, positions 793-807 of HXB2. This forms the 
fourth stem loop (sl4, Figure 3.4.2d) of the dimerization/encapsidation signal. The 
encapsidation signal is a four stem-loop structure which stretches from the 5' LTR and 
interacts with the nucleo-capsid protein, promoting formation of genomic RNA and 
blocking the initiation of transcription (Clever et al.,1995; Huthoff et al.,2004; 
Wilkinson et al.,2008).  
 
In the pol gene, two highly conserved regions with known functions were found. One 
corresponded to the first three nucleotides (HXB2 coordinate positions 4092-4094) of 
the 260 nucleotide long cis-repressive sequence (CRS; Figure 3.4.2e). The cis-
repressive sequence inhibits expression of structural protein mRNAs by preventing 
their transportation from the nucleus – a process that is reversed by the RRE 
(Cochrane et al.,1991; Schneider et al.,1997; Wolff et al.,2003). The other was found 
at the 3' end of the intragenic nuclease hypersensitive domain (hs7 in Figure 3.4.2e). 
The latter motif, located between positions 4926 and 4937 and labeled “ese” in Figure 
3.4.2e, is also located within HIV-1 exon 2 and the last six nucleotides, TGGAAA, of 
this conserved region form a known exonic splicing enhancer (ESE) of HIV mRNAs 
(Exline et al.,2008; Kammler et al.,2006; Krummheuer et al.,2001; Madsen et 
al.,2006; Schwartz et al.,1990a). 
 
Three of the highly conserved regions with known functions were in the env gene and 
included a nine-nucleotide long motif from position 7834 to 7842 within the RRE. 
The approximately two hundred nucleotides long RRE element within env, is known 
to interact with the Rev protein and facilitates the transport of late un-spliced and 
partially-spliced RNAs from the nucleus to the cytoplasm (Hadzopoulou-Cladaras et 
al.,1989; Peterson et al.,1996; Renwick et al.,1995). Although the RRE is associated 
with a long stretch of sequence that forms a well characterized secondary structure 
with various conserved domains (Phuphuakrat et al.,2003), only the nine nucleotides 
that bind Rev with highest affinity (Hung et al.,2000; Peterson et al.,1996) were 
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Also conserved within the env gene were the two splice site regions at the end of the 
tat/rev exon, positions 8349-8354 and 8376-8378, usually referred to as 7a/7b, and 7 
(“ss” in Figure 3.4.2f; (Kammler et al.,2006; Schwartz et al.,1990a; Schwartz et 






















Figure 3.4.2: Mean (blue) synonymous substitution rates observed across each HIV-1 
gene. Mean dS was calculated over sliding windows of three codons. Horizontal lines 
mark the most stringent (red) and less stringent (purple) significance thresholds.  
(a) dS across the nef gene. “G-A”; G-to-A hypermutations (see Figure A3.4.2a in the 
Appendix), ‘var’; highly variable region, ‘ppt’; poly-purine tract, “c”; PPT integrase 
attachment site, ‘nre’; start of the negative repressive sequence, ‘ets’; Ets-1 
transcription factor binding site.  (b) dS across the vpr gene. ‘ssa3’; 3' splice acceptor 
site A3, ‘rnase’; RNase-V1 cleavage site. (c) dS across the tat gene. ‘ess2’; exonic 
splicing silencer ESS2, ‘ssa4b’; 3' splice acceptor site A4b. (d) dS across the gag 
gene, ‘sl4’; the fourth stem loop of the encapsidation signal, ‘INS1’; a motif within 
the first inhibitory sequence region, ‘INS2’; a motif within the second inhibitory 
sequence region, (e) dS across the pol gene. ‘crs’; start of the cis-repressive sequence, 
horizontal dotted line is the nuclease hypersensitive region and sites ‘B’, ‘G’, ‘C’ and 
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and site-D respectively. ‘p1’and ‘p2’; conserved sites within nuclease hypersensitive 
region. “ese”; exonic splicing enhancer, (f) dS across the env gene. “n1” is the novel 
conserved site. The black dotted horizontal lines indicate poorly aligned regions that 
were excluded from the analysis. “rre”; rev-responsive element, *; the 9 nucleotides 
(5' GACGGUACA 3') which bind to the Rev protein with highest affinity, “ss”; splice 
site region for the tat and rev 3' exons, (g) dS across the vpu gene. ‘n2’, ‘n3’ and ‘n4’; 

















Table 3.4.2: Sequence motifs for the highly conserved regions with known function, 
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selection in HIV-1 genes. The range of coordinates on the HIV-1 genome for each 
motif is given in column 2. Numbers above each logo represent the degeneracy at 




3.4.3 Purifying selection pressure within sites with unknown functions 
 
The sequence logos for the remaining nine highly conserved regions are given in 
Table 3.4.3. Possible functions for another five were predicted based on the known 
functions of the sequence domains in which they were situated. In addition to the 
fourteen conserved regions with known functions, five motifs (marked in green in 
Figures 3.4.2d and e) without previously reported specific functions occurred within 
known functional domains. These include three short (3-6bp) motifs in the inhibitory 
(INS) sequence regions of gag (HXB2 positions 898-903, 985-996 and 1309-1314, 
Figure 3.4.2d). Previous in-vitro analyses have shown that short motifs within the 
approximately two hundred bp long INS regions, are responsible for the actual 
inhibition of mRNA expression (Schneider et al.,1997; Schwartz et al.,1992; Wolff et 
al.,2003). Although the three motifs we find within this region have not been 
specifically identified in-vitro, a computational study by Wolff et al (2003) showed 
that the INS sequences have several short functional motifs within them (Wolff et 
al.,2003).  The conserved sites we identified within INS1 and INS2 could serve the 
same inhibitory function. Functional assays elucidating the role of these sites in the 
inhibition of mRNA expression could help to determine the precise mechanisms by 
which inhibition occurs and whether these sites also play a role. In another previous 
study which analyzed the RNA secondary structure of the 5' region of HIV-1, these 
two regions, labelled ‘INS1’ in Figure 3.4.2d, were found to be involved in conserved 
Watson-Crick base-pairing (Paillart et al.,2002).  
 
The last two of the five conserved regions with unidentified specific functions were 
within the pol HS7. HS7 spans five hundred nucleotides, between positions 4481 and 
4982 of the HIV-1 genome, and has an LTR-like regulatory function (Goffin et 
al.,2005; Van Lint et al.,1994). Previous studies revealed four domains towards the 3' 
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transcription factors (TFs) and are also important for viral infectivity (Goffin et 
al.,2005; Van Lint et al.,1994).  In these studies, the Oct-1, Oct-2, PU.1, Sp1 and Sp3 
transcription factors were found to bind to at least one of the four identified sites. The 
two conserved regions we identified are outside these specific identified functional 
domains, but one of them at positions 4767-4790 (labeled “p1” in Figure 3.4.2e) 
showed potential binding to Oct-1 using the MATCH tool from the TRANSFAC 
database (Kel et al.,2003; Matys et al.,2003). Potential association with a transcription 
factor was not observed for the three nucleotides (positions 4864-4866) labelled ‘p2’ 
and its adjacent sites.  
 
The function of a novel twelve-nucleotide region with high degree of sequence 
conservation observed in the env gene and three other regions in vpu (marked in red in 
Figures 3.4.2f and g) has not been previously reported. One of these novel regions, the 
twelve nucleotide long motif in env, upstream of the RRE showed the highest degree 
of conservation of any region in the env gene (‘n1’ in Figure 3.4.2f; positions 7656-
7667 of HXB2) and therefore it would be interesting to determine its function in the 
context of the extensively analysed functions of the envelop protein. This sequence 
was sent to a collaborating laboratory at the National Institute of Infectious Diseases 
(NICD) (http://www.nicd.ac.za), for fitness assay analysis. In brief, this nucleotide 
sequence, located at positions 7656-7667 of the HXB2 reference HIV-1 genome was 
mutated at 3 different synonymous sites (positions 7662, 7664 and 7667). Each 
mutant virus was tested for infectivity and the rate of replication in comparison to a 
wildtype virus that was not subjected to any synonymous mutations (Figure 3.4.3). 
The details of the experiments performed at NICD are described in the publication 
that discusses the findings of this project (Ngandu et al.,2008). Preliminary analysis 
showed that synonymous mutations within this region had no significant effect on the 
fitness of the virus and only showed a slight decrease in the replication rate, but can 















Figure 3.4.3 Functional analysis of a novel region found in the env gene. The 
synonymous mutations were introduced at positions 7662 (7), 7664 (9) and 7667 (12) 
each time and compared against a wildtype strain p81. (a) Comparison of infectivity 
between wildtype (p81) and the mutants (b) rate of replication as measured by the 





Functional analyses of the three novel conserved regions in vpu, with HXB2 
coordinates 6101-6106, 6143-6151 and 6167-6178 (n2, n3, n4 in Figure 3.4.2g) are 
being considered. The protein products of vpu and env are known to be produced from 
a bicistronic transcript (Schwartz et al.,1990b) and the conserved regions in vpu may 














Table 3.4.3: Sequence motifs for the highly conserved regions with unknown specific 
function, the five regions with predicted functions and four novel with unknown 
functions found to be under strong purifying selection in HIV-1 genes. The range of 
coordinates on the HIV-1 genome for each motif is given in column 2. Numbers 
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3.4.4: Evidence of false inference of positive selection in the presence of purifying 
selection pressure 
 
As mentioned earlier, purifying selection is likely to cause false inference of positive 
selection (Hurst et al., 2001). To further assess this, the MG94 codon model (Muse et 
al., 1994) was used to detect positive selection in a subtype C gag coding sequence 
alignment described in one of the thesis publications and in Chapter 4 (Ngandu et 
al.,2007).  Sites with ω significantly greater than one, implying positive selection, 
overlapped significantly with sites that had lower than average dS values  (Fisher’s 
exact test odds ratio = 4.4; p value = 0.006; Figure 3.4.4). This is consistent with a 
substantial proportion of the positive selection signals resulting from conservation of 






Figure 3.4.4:  Evidence of overlap between high omega at a codon and low dS at the 
synonymous sites, positively selected sites at which a significantly low dS was 
observed at the synonymous sites. Positively selected sites are shown in black vertical 
















This is the first study to provide a detailed analysis of site-to-site variation in the rate 
of synonymous substitutions across the HIV-1 genome. In the past, site-to-site 
variation in dS in HIV-1 has been investigated in a single gene (Kosakovsky Pond et 
al.,2005a; Lemey et al.,2007). In another study, a single overall synonymous 
substitution rate for the entire genome was determined for comparison to other viral 
lineages (Hanada et al.,2004). The method for determining site-to-site synonymous 
rate variation used in this study is similar to an approach from a previous study 
(Kosakovsky Pond et al.,2005a), in that case only one HIV-1 gene, vif, was 
considered and sites that encode proteins in multiple reading frames were included. 
As a consequence, it was not clear whether the observed site-to-site rate variation 
resulted from variation in the synonymous rate or from selection acting on 
nonsynonymous substitutions in another reading frame.   
 
Here, all regions of the HIV genome that encode proteins in a single reading frame 
were analysed as well as the functions of nucleotide sequences that have the largest 
influence on synonymous substitution rate variation.  Previous studies have 
demonstrated that recombination causes false inference of positive selection. Since 
recombination affects tree topologies used in fitting phylogenetic models, it is also 
likely to cause biased estimates of dS. The recent development of methods to account 
for recombination in selection analyses (Scheffler et al.,2006) enabled the removal of 
recombination as a source of bias in the estimates of synonymous substitution rates in 
this study.  
 
All coding sites of the HIV-1 genome under the influence of purifying selection 
pressure were identified in this study. Substantial site-to-site variation in the rate of 
synonymous substitution with evidence of purifying selection pressure was observed 
within functional domains such as the Rev-responsive element. In addition to 
identifying putatively functional sites under purifying selection, these results 
contribute to the robustness of analyses of positive selection by identifying conserved 
synonymous sites that can cause false positive inference of selection. Conserved 
synonymous sites that can cause false detection of positive selection need to be either 
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be assumed to be evolving adaptively simply as a result of the purifying selection 
acting directly on the nucleotide sequence. Evidence of the tendency for sites with 
significantly low dS to appear to be positively selected was observed in subtype C 
gag. In addition, a study by Hurst & Pal also showed false detection of positive 
selection caused by purifying selection pressure acting on synonymous sites (Hurst et 
al.,2001). 
 
In many selection studies the synonymous rate is assumed to be constant.  However, 
negative selection acting on synonymous sites can potentially reduce gene-wide 
estimates of the synonymous rates below the neutral evolution rate. Comparison of 
site-specific nonsynonymous substitution rates against this underestimate of the 
neutral rate is likely to cause a proportion of the selectively neutral nonsynonymous 
sites to seem as though they are evolving adaptively.  A very stringent significance 
level cutoff was used here to identify the twenty-three regions within the HIV genome 
that have obviously reduced synonymous substitution rates. The rate of synonymous 
substitution was higher on average, in overlapping gene regions that encode proteins 
in more than one frame (p = 6 x 10-7 from Wilcoxon rank sum test; Figure 3.4a); 
however, lower dS was observed within some genome regions that are translated in 
multiple reading frames. Analysis of the most diverse sequence strains within subtype 
B and C revealed more highly conserved sites across the RRE and INS1 regions at the 
subtype level (Figure A3.5 in the Appendix). This indicates that false detection of 
positive selection is likely to increase in analysis carried out within a single subtype. 
For a more conservative analysis of selection, all the significantly conserved sites, i.e., 
including those conserved at 95% confidence (p value <0.05, listed in Table 3.4.1b) 
should be excluded from positive selection analyses along with sites that encode 
proteins in multiple frames. Sequence conservation around nucleotide sequence 
motifs with known functions and newly identified additional conserved nucleotide 
elements that do not fall within any currently characterized functional motifs are 
presented in Tables 3.4.1 and 3.4.2 and thus form a resource for future studies of 























The analysis discussed in this chapter has been published in one of the papers listed 
at the beginning of the thesis (Ngandu et al.,2007). The HIV-1 subtype C sequence 
data as well as the immunological responses data used in this study were provided by 
Dr. Clive Gray from the National Institute of Communicable Diseases in 
Johannesburg and Dr. Carolyn Williamson from the Institute of Infectious Diseases at 
the University of Cape Town. Therefore sections 4.3.1 through to 4.3.4 summarise the 
methods that were used by these collaborating laboratories to screen and isolate 




The cytotoxic T-lymphocyte immune response is important in controlling HIV-1 
replication in vivo. Protective immune responses directed against conserved and 
immunodominant peptides are ideal targets for anti-HIV vaccine design. This chapter 
assesses the relationship between the frequency of targeting of HIV-1 Nef and Gag 
proteins and sequence evolution patterns in order to identify conserved 
immunodominant regions. In addition, the relationship between observed and 
predicted CTL responses given the HLA genotypes of the infected individuals was 
investigated. Amino acid sequence variability was measured by calculating sequence 
entropy in sequence alignments and by estimating the rate of evolution at each codon 
site using maximum likelihood. Using a robust statistical approach, sites in the central 
part of the nef gene and gag p24 that were frequently targeted by the CTL response 
were shown to be evolutionarily conserved. By contrast, the immunodominant 
peptides within the gag p17 region tended to be highly variable. CTL responses 
observed in the subtype C infected cohort poorly conformed to predicted sequence 
motifs required for binding by the HLA A or B alleles found in the corresponding 
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CTL response contained predicted sequence motifs for the patient HLA. A 
comparable subtype B dataset showed a higher consistence between observed 
peptides that elicited a CTL response and patient HLA genotype (96% and 83% for 
Nef and Gag, respectively).  This difference between subtypes C and B was 
demonstrated to be due to poor characterisation of HLA alleles common in Southern 
African populations and the tendency for sequence motifs associated with HLA 
recognition to be over-specified for sequence variation found in the B clade. The HLA 
binding motifs are therefore likely to be biased towards certain populations and 
subtypes and this can have important implications for understanding immune escape 
and predicting vaccine efficacy in the context of populations primarily infected with 




The cytotoxic T-lymphocyte (CTL) immune pathway plays an important role in the 
control of viral replication in HIV-1 infected individuals (Betts et al.,1999; 
Letvin,1998; Moore et al.,2002). These immune responses are activated by antigenic 
peptides presented by human leukocyte antigens (HLAs) on the surface of infected 
cells. The HLA molecules are highly polymorphic and each molecule recognises 
peptides with specific sequence patterns known as anchor residue motifs (Madden et 
al.,1992). Some HLA molecules mediate CTL responses that confer resistance to 
disease progression yet others are associated with rapid progression to AIDS (Chen et 
al.,1997; Ross et al.,2002; Trachtenberg et al.,2003). 
  
The disease outcome, however, has been found not only to be a function of the HLA 
allele and immune response itself but also a characteristic of the specific targeted region 
(Maurer et al.,2008; Miura et al.,2008a; Pereyra et al.,2008). The proteins encoded by 
the different genes of the viral genome vary in immunogenicity with some failing to 
elicit measurable immune responses (Kiepiela et al.,2007). Certain regions of the viral 
sequence are able to mutate and escape the immune response. The effect of the resulting 
mutant on the fitness of the virus determines the rate of viral replication and hence viral 
load. Persistent immune responses against regions of the viral sequence that mutate to 
weaker strains and fail to revert to the fit wild type virus typically delay the progression 
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back to the wild type state can be disadvantageous to the host (Ross et al.,2002). Highly 
conserved regions that are targeted by immunodominant and protective immune 
responses across many individuals are ideal targets for vaccine design.  
 
The Nef and Gag proteins have the most immunodominant peptides across populations 
infected with different HIV-1 subtypes (Frahm et al.,2006; Masemola et al.,2004a). A 
negative relationship has been observed between amino acid sequence variation and the 
frequency of CTL recognition across HIV-1 proteins (Frahm et al.,2006; Yusim et 
al.,2002).  The amino acid sequence variation in most of these studies has been inferred 
by calculating the entropy at each site of an amino acid sequence alignment. Entropy is 
calculated such that each site in a sequence is assumed to be independent. However, 
adjacent sites within a peptide that is recognised by an HLA molecule are not 
functionally independent. Therefore a direct correlation between the entropy values per 
site and the measure of the frequency of recognition cannot be justified. To compare the 
entropy of frequently targeted sites to less frequently targeted sites, the length of the 
targeted peptides needs to be taken into account. In some studies, the mean of the 
entropy over nine amino acid positions (Yusim et al.,2002) has been used, thus 
assuming that all targeted peptides have the same length yet in reality the length ranges 
from 8 to 11 amino acids in length (Frahm et al.,2007).  
 
Even though most HIV-1 studies have focused on subtype B, subtype C poses the 
strongest challenge as it accounts for almost 50 percent of worldwide infections 
(Buonaguro et al.,2007). It is therefore important for vaccine design studies to pay more 
attention to the understanding of HIV-host viral relationship in subtype C infected 
populations. This chapter provides a detailed and more accurate analysis of the 
relationship between the CTL immune response and HIV-1 sequence variation using 
data consisting of CTL responses against the Nef and Gag proteins observed in a 
Southern Africa cohort, provided by collaborators at the South African National 
Institute of Communicable Disease (NICD). The extent to which predicted HLA 
binding motif data available in public databases is biased towards the better 
characterized HIV-1 B subtype was also investigated. This was done by determining the 
frequency with which an anchor residue motif associated with at least one of the HLA 
alleles of the host appear within peptides recognized by that host’s CTL response. The 
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individual does not prove that the observed immune response was mediated by that 
HLA allele. However, the absence from the targeted peptide of any sequence motif 
associated with the anchor residues of any of the HLA alleles of the host does imply 
missing information in the databases. Specifically, it implies that the anchor residues 
that have been bound by the HLA allele do not conform to the motif present in the 
database for that HLA allele. In order to investigate the extent to which known HLA 
anchor residue motifs are representative of all possible immune responses, we 
compared the fraction of CTL responses that can be accounted for by HLA anchor 
residue motifs between comparable subtype C and subtype B datasets. 
 
4.3 Materials and Methods 
 
4.3.1 Study subjects 
 
The data were isolated from sixty-four HIV-1 infected individuals enrolled in a study 
of HIV-1 infection from four southern African countries: Malawi, Zimbabwe, Zambia 
and South Africa. The data consists of cytotoxic T-lymphocyte immune responses 
observed against the Gag and Nef proteins (see Table 4.3.5) as well as autologous 
viral sequences. The methods of data collection and the determination of 
immunological responses have been published in a previous study from Dr. Gray’s 
laboratory as well as in the publications that report the findings of this study 
(Masemola et al.,2004a; Ngandu et al.,2007).  
 
4.3.2 Summary of screening immune response data 
 
Peptide sequences from regions observed to be targeted by the CTL response in HIV-
1 subtype C infected individuals were provided by Dr Clive Gray. The methods used 
for identifying and screening the peptides were described in detail in a publication 
from his research group (Masemola et al.,2004a). In summary, responses against Gag 
were screened using sixty-six synthetic peptides based on a consensus subtype C 
sequence from Zambia. Nef-specific responses were confirmed using fifty peptides 
based on the viral strain Du151. The peptides used were synthesized using Fmoc-
based solid phase chemistry (Natural and Medical Sciences Institute, University of 
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amino acids (for Gag) and 15 mers overlapping by 11 amino acids (for Nef). The 
immune responses to each peptide were confirmed in interferon-γ ELISpot assays. In 
ELISpot assays, PBMCs were plated on 96-well polyvinylidene difluoride plates that 
were coated with anti-IFNγ monoclonal antibody.  Peptides were added directly to the 
wells at various final concentrations, incubated under specified conditions and 
subsequently washed to remove unbound peptides and displaced antibody. 
Streptavidin horseradish peroxidase (Pharmingen, Cupertino) was added to the wells 
and the plates incubated to develop spots on bound peptides. Both negative and 
positive controls were used for comparison. The number of spots per well was 
counted using the Immunospot (Cellular Technology Ltd., Cleveland, USA) 
automated cell counter.  
 
4.3.3 Patient HLA allele data 
 
HLA genotypes from the subtype C cohort were provided by Dr Clive Gray (National 
Institute of Communicable Diseases). High resolution typing of HLA Class I A and B 
loci was also performed using sequencing-based typing kits and the resulting 
sequences and subsequent allele assignment performed using the MatchMaker™ 
Allele Identification Software (Applied Biosystems). Two HLA alleles from each of 
A and B loci were provided from each patient. Similarly, each patient from the 
subtype B infected cohort had two alleles for each of A and B HLA loci. The HLA 
allele frequencies in both datasets are listed in the appendix Table A4.3.2.  
 
4.3.4 Sequence data 
 
A total of one hundred and seven full-length nef and gag sequences were amplified 
and sequenced as described in a previous study from Prof. Williamson’s group 
(Bredell et al.,2007). In-frame alignments for each gene were generated using 
ClustalW with default parameter settings (Thompson et al.,2002). The GenBank 
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 4.3.5 Immune response data  
 
Sixty-eight and eighty responses were observed against Nef and Gag peptides 
respectively. The average length of the targeted Gag peptides was 20 amino acids long 
and that for Nef was 15 amino acids. A comparative HIV-1 subtype B dataset from the 
REACH (Reaching for Excellence in Adolescent Care and Health) study was obtained 
online for comparative purposes (Bansal et al.,2003; Sabbaj et al.,2003; Wilson et 
al.,2001) (Table 4.3.5). The forty-five patients infected with subtype B were of African 
American, Hispanic and Caucasian origins.  Thirty-one and thirty-nine Nef and Gag 
responses respectively, were observed from the subtype B cohort and the mean length 




 Subtype C Subtype B 
Number of patients 64 45 
Gene Gag Nef Gag Nef 
Number of responders 40 45 39 31 
Number of peptide responses 80 68 113 70 
Mean number of peptide 
responses per patient 
2 1.5 2.9 2.3 
Average peptide length 22 15 20 20 
Table 4.3.5: CTL responses observed against the Nef and Gag peptides in a Southern 
African subtye C infected cohort and a comparative subtype B infected cohort from a 




4.3.6 HLA anchor residue motif data 
 
HLA anchor residue motifs were obtained from the Los Alamos database (Korber et 
al.,2006), the SYFPEITHI database (Rammensee et al.,1999) and the HLA 
Ligand/Motif database (Sathiamurthy et al.,2003).  We used only motifs with at least 
two anchor residues. Motifs from other databases were presented within these three 
databases. All anchor residue motifs with lengths 8,9,10 and 11 and with at least two 

















4.3.7 Determination of amino acid variation and rate of sequence evolution 
 
 Amino acid sequence entropy was calculated at each site in the alignment. The 
mutation rates at a site across each gene were determined by estimating the dN/dS ratio 
(nonsynonymous to synonymous substitution rate ratio). The dN/dS ratio was calculated 
over the phylogenetic tree relating the sequences using the MG94 codon model (Muse 
et al.,1994) implemented in the HyPhy program (Kosakovsky Pond et al.,2005d). 
 
4.3.8 Statistical analysis 
 
A robust statistical method was developed to investigate whether the relationship 
between sequence variation and the frequency of epitope recognition could be the result 
of chance. For each peptide to which a CTL response was detected, the mean entropy of 
the sequence alignment within the region spanned by the peptide was calculated. To 
summarize the entropy of all of the regions targeted by CTL responses across all 
patients a statistic, referred to here as ‘weighted-mean entropy’ was calculated.  The 
weighted mean entropy was the average entropy of regions spanned by targeted 
peptides weighted by the number of patients that responded to the peptide.  The 
observed weighted-mean of the entropy was then compared to the same quantity 
calculated from randomized datasets. For the randomized datasets, a random position on 
the sequence alignment was assigned to each of the peptides 1000 times and the 
weighted-mean entropy recalculated for each replicate. This approach was similarly 




The number of individuals that showed a response to a peptide, here referred to as 
epitope density, spanning each site across a gene was determined. High epitope 
density indicates high frequency of CTL recognition of a peptide across different 
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response against a peptide spanning a site.  The observed epitope density is plotted 
against observed entropy values per site as well as against positive selection i.e. 
against dN/dS values greater than 1.  
 
4.4.1 Observed epitope density 
The most frequently targeted peptides were within the central regions of the Nef, Gag 
p17 and p24 protein regions. The terminal regions of Nef and the p16 region of Gag 
were poorly targeted. The frequencies with which a peptide was recognised by an 













































































































Figure 4.4.1: Epitope density (black) plotted across the HIV-1 Nef (a) and Gag (b) 
amino acid sequence position. (b) The p17, p24 and p16 regions of the gag gene are 
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4.4.2 Epitope density vs entropy 
 
Higher entropy values were generally observed at the terminal regions of Nef which had 
very low epitope density (Figure 4.4.2a). In gag, high entropy values which indicate 
high amino acid variation were observed in p16 and p17 despite the latter showing the 
presence of highly immunodominant peptides (Figure 4.4.2b). The frequently targeted 
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Figure 4.4.3: Positively selected sites (black vertical lines) vs epitope density (grey) 
















The dN/dS ratios were determined across both the nef and gag genes and positively 
selected sites, i.e., with dN/dS>1, an indication of adaptive evolution, were plotted 
against epitope density (Figure 4.4.3). A generally similar pattern was observed to that 
from the calculation of entropy. In nef, positively selected sites were only found at the 
poorly targeted terminal regions of the gene. Positively selected sites were scattered 
across the three different gag regions. However, in p24, the most immunodominant 
peptide regions were not under positive selection unlike in p17 where positively 
selected sites overlapped with sites frequently targeted by the CTL immune response 
(Figure 4.4.3(b)). 
 
4.4.4 Statistical analysis using randomized datasets 
 
The weighted mean entropy values from randomized datasets carried out seperately for 
each of Nef, Gag, gag p17, gag p24 and gag p16, used to assess whether the observed 
entropy and dN/dS values could be achieved by chance, are shown in Tables 4.4.4(a) 
and 4.4.4(b) and Figure 4.4.4. The different regions of the gag gene coding for different 
proteins differed in sequence variation patterns. In both entropy and the dN/dS rates, the 
values for the Nef and the Gag p24 were significantly lower than what would be 
expected by chance indicating that the frequently targeted peptides encoded by these 
gene regions are generally conserved (entropy: Nef=0.015, Gag p24 = 0.001; dN/dS: 


























Gene region Observed weighted mean entropy  P value 
Nef 0.198 0.015 
Gag 0.158 0.09 
Gag p24 0.0988 0.001 
Gag p17 0.242 0.753 
Gag p16 0.334 0.80 
Table 4.4.4 (a): Observed weighted mean entropy, P value is the proportion of 
weighted mean entropy values from the randomized datasets that were lower than the 




Gene region Observed weighted mean omega P value 
Nef 0.382 0.016 
Gag 0.361 0.14 
Gag p24 0.1552 0.002 
Gag p17 0.179 0.76 
Gag p16 0.56 0.94 
Table 4.4.4 (b):  Observed weighted mean dN/dS, P value is the proportion of 
weighted mean dN/dS rates from randomized datasets that were less than the observed 
























Figure 4.4.4 Histograms showing the distribution of weighted mean entropy and 
weighted mean dN/dS values obtained from the randomized datasets for both Nef and 
Gag whole proteins. (a) The frequency of entropy values from randomized datasets. 
(b) The frequency of dN/dS values from randomized datasets. In each case arrows 
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4.4.5 Relationship between observed CTL responses and patient HLA genotype 
 
CTL responses observed in the subtype C cohort poorly conformed to the patient 
HLA genotype as compared to the subtype B responses when considering predicted 
anchor residue motifs from the databases. Only 52.2% and 63.8% of the Nef and Gag 
responses respectively could potentially be linked to the patient HLA genotypes of 
classes A and B in this subtype cohort. In contrast, for the subtype B dataset 95.7% 
and 83.2% of the peptides recognized by CTL responses in nef and gag respectively, 
contained at least one of the anchor residue motifs restricted by HLA A and B alleles 




 Subtype C  Subtype B 
HLA A  
Nef peptides 17.4% 84.3% 
Gag peptides 45% 52.2% 
HLA B 
Nef peptides 39.1% 78.6% 
Gag peptides 42.5% 66.4% 
Table 4.4.5: Percentage of patient CTL responses to Nef and Gag peptides that 




Two possible reasons for the poor association observed between the anchor residue 
motifs corresponding to the patient HLA alleles and the peptides recognized by the 
CTL response in the subtype C in comparison to the subtype B dataset were explored. 
Firstly, the binding motifs restricted by HLA alleles that are at high frequency in the 
Southern African population could be poorly characterized. The weak conformity 
between the predicted anchor residue motifs associated with patient HLA genotype 
and the peptides recognised by the CTL response could be because the HLA alleles 
found at high frequencies in the subtype C infected cohort are less likely to be 
associated with predicted HIV binding motifs in the databases. Secondly, the reason 
could be a result of the predicted binding motifs, which are possibly too specific for 
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for sequences observed in subtype B viruses even though the differences between the 
subtype B and C sequences do not cause failure to bind to HLA molecules. These two 
possible alternative explanations were explored to determine whether they are not 
mutually exclusive and the observed effect have involved a combination of the two. 
 
4.4.5.1 Investigating the proportion of HLA alleles with characterized anchor residue 
motifs in the databases 
 
The proportion of patient HLA alleles that have predicted anchor residue motifs 
available in the databases was determined for each of the subtype B and C cohorts 
(Table 4.4.5.1). Alleles from the HLA-A loci that were frequent in the subtype B 
cohort were mostly present in the database with characterized binding motifs 
compared to those frequent in the subtype C infected cohort.  The HLA-B alleles 
frequent in the two cohorts were equally represented in the database. From a Fisher’s 
exact test, all HLA alleles from the subtype B infected cohort appeared to be 
significantly associated with presence of an anchor residue motif in the database 
compared to alleles from the subtype C cohort (p value = 0.03). The statistic remained 
significant when looking at HLA-A alleles alone but not for the HLA-B alleles (p 




HLA locus Subtype C Subtype B P value (Fisher’s 
exact test) 
HLA-A 59.7 76.7 0.01 
HLA-B 76.9 77.2 0.75 
HLA-A and HLA-B 66.8 76.4 0.03 
Table 4.4.5.1: Percentages of individual occurrences of HLA alleles within a cohort 
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4.4.5.2 Investigating whether the anchor residue motif data is subtype-specific 
 
The predicted HLA anchor residue motif data from the databases was used to 
determine patient HLA genotypes that conform to each observed CTL immune 
response. The motif predicted to be bound by each HLA allele from a patient was 
searched from the databases. For each patient, the HIV peptides observed to be 
targeted by the CTL immune response were then searched for the presence of the 
predicted anchor residue motifs restricted by each HLA allele. The distribution of 
HLA alleles with characterized anchor residue motifs available in the database as well 
as the proportion of the motifs that conformed to the observed CTL responses were 
compared between the subtypes B and C cohorts. 
 
The possible bias of anchor residue motifs towards subtype B sequences was 
determined taking into account the differences in the proportions of alleles with 
characterized motifs. If most of the anchor residue motifs in the database were 
predicted from conserved patterns observed in HIV-1 subtype B epitopes, then it is 
possible that the anchor residue motifs reflect sequence diversity observed in subtype 
B to a greater extent than they reflect subtype C diversity. In order to determine if this 
holds true, inter-subtype comparison was made between patients with the same 
number of HLA alleles with characterized anchor residue motifs from the database. 
Patients were therefore classified as having 4, 3, 2, 1 or no alleles for which there was 
an anchor residue motif in the databases in both the C and B subtype cohorts. The 
proportions of observed CTL responses that could potentially be linked to the patient 
HLA alleles through the presence of an anchor residue motif in the targeted peptide 
were compared between groups of patients with the same numbers of characterized 
HLA alleles. In overall, there was a positive correlation between the proportion of 
CTL responses that could be linked to patient HLA genotype and the number of the 
patient’s HLA alleles for which anchor residue motifs were available in the database 
in the case of Gag responses (one-way anova p values: subtype C =  0.002; subtype B 
= 0.0112). The same significant difference was not observed between the different 
groups for Nef responses. 
 
The average proportion of responses that could be linked to patient HLA alleles 
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the subtype C data than for the subtype B data when patients were stratified according 
to the number of their alleles represented in the binding motif databases (p value = 
0.02225, paired Wilcoxon rank-sum test). A two way ANOVA was carried out to test 
for an effect of subtype on the proportion of CTL responses that could be related to 
the patient HLA alleles when differences in the number of alleles that are in the 
databases were taken into account.  Since patients with the same number of 
characterized HLA alleles were compared, the proportion of responses associated 
with patient HLA were expect to be the same between the two subtypes if the motifs 
are not biased towards one of the subtypes. In both the Nef and Gag responses, higher 
fractions of the targeted peptides contained anchor residue motifs restricted by at least 
one of the patient’s HLA alleles compared to responses to subtype C peptides in 
groups of patients with same number of characterized HLA alleles (p values; Nef = 

























Figure 4.4.5.2: Proportion of CTL responses to peptides that contained an anchor 
residue motif for at least one of the patient’s HLA A or B alleles in  
subtype C (grey) and subtype B (black), (a) responses observed against Nef peptides, 
(b) responses observed against Gag peptides. Patients were classified by the number 

















The frequently targeted peptides in the middle region of the Nef protein sequence and 
the Gag p24 region appeared to be highly conserved, which is consistent with 
observations from previous studies (Gilbert et al.,2005; Masemola et al.,2004a; 
Mashishi et al.,2001; Yusim et al.,2002). However, the relationship between sequence 
diversity and the frequency of CTL recognition was not straightforward for Gag as p17, 
with a much greater number of variable sites, was also highly immunogenic. The Gag 
p16 region and the terminal regions of the Nef protein sequence were highly variable 
and poorly targeted by the immune response. In future, autologous peptides could be 
considered for a similar analysis since some autologous viral sequences from the 
patients show a possibility of immune escape from the CTL response. In this study, 
only a proportion of the reactive peptides (20.6% of nef responses and 32.5% of gag 
responses) showed 100% sequence similarity with the autologous virus in 28.9% and 
55% of Nef and Gag responders respectively. 
 
The presence of anchor residue motifs restricted by a patient’s HLA genotype in HIV-1 
peptides observed to be targeted by the CTL response was determined in order to relate 
patient HLA genotype to the observed immune responses. Presence of anchor residue 
motifs known to be targeted by an HLA allele within a peptide does not necessarily 
imply that the HLA allele directed that particular immune response. However, a 
targeted peptide lacking at least one motif associated with the HLA alleles of the host 
shows inadequacy of the HLA anchor residue motif data.  It was observed that HLA-A 
alleles common in Southern Africa were not well recorded in the databases and most of 
the anchor residue motifs were reflective of subtype B sequence peptides and failed to 
fully account for inter-subtype sequence diversity. However there were anchor residue 
motifs in the database for the majority of HLA-B alleles that were at high frequency in 
both the B and C cohorts. This could be because the HLA-B alleles are more 
extensively involved in presenting HIV peptides (Yusim et al.,2003) and are therefore 
better studied than other alleles. 
 
This difference in the length of the peptides could introduce a bias in the comparison 










  88 
 
 
allele, since some of the matches between the peptides and the HLA anchor residue 
motifs could be the result of chance. The Nef peptides from the subtype C dataset 
were shorter (mean length = 15 amino acids) than the Nef peptides used in the 
subtype B study (mean length = 20 amino acids). However, the difference in mean 
length of the peptides alone is unlikely to explain the difference between the subtypes 
as the Gag peptides from the subtype C study were on average longer than the Gag 
peptides from subtype B (mean length 22 and 20 amino acids, respectively) and the 
difference between subtypes in the number of peptides containing the expected anchor 
residue motifs is consistent across the two genes.  
 
Most of the anchor residue motifs used in this study were obtained from the Los 
Alamos database. These include motifs inferred using a variety of techniques. Some 
were determined from antigenic peptides endogenously bound to HLA molecule 
(Marsh et al.,2000).  In some cases experimentally derived motifs for a given HLA 
allele were extended to HLA alleles with identical side chains at the binding pocket 
residues (Yusim et al.,2003). The database also includes predicted HLA motifs based 
on the conserved patterns found in at least two optimal HIV epitopes presented by an 
HLA allele (Yusim et al.,2003). In this latter case, the HIV optimal epitopes have 
been obtained experimentally using interferon-γ ELISpot, Cromium release or 
intracellular cytokine staining assays (Frahm et al.,2004). Binding motifs determined 
in this way are likely to be biased towards the more studied subtype-B than subtype-C 
virus sequence diversity, and this could explain why the anchor residue motifs appear 
to be more consistent with CTL responses to subtype B than to subtype C.  
 
A more complete collection of HLA binding motifs would be useful for investigating 
viral escape from CD8+ T cell responses especially for studies focussing on 
developing effective anti-subtype C virus vaccines. Knowledge of the sequence 
motifs required for HLA binding can also be useful for monitoring vaccine efficacy. 
Breakthrough infections with mutations that are known to cause failure of patient 
HLA alleles to bind would suggest an effective immune response exerting selective 
pressure on the virus and could signal the spread of viral variants that have escaped 
the vaccine. Our results suggest that further efforts are required to elucidate the 
binding requirements of HLA alleles that are at relatively high frequency in South 
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of HLA alleles should take advantage of the global HIV-1 sequence diversity in order 
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Chapter 5  
 





Human leukocyte antigens (HLA) present antigenic peptides that are recognized by 
cytotoxic T–lymphocytes during T-cell immune responses.  Each HLA molecule 
requires the presence of a specific anchor residue motif in order to bind to a peptide. 
Immune escape mutations that occur at the anchor sites of peptides can hinder HLA 
recognition and binding. A mutation that allows escape from an immune response and 
which occurs at a site that is conserved due to functional or structural constraints is 
expected to revert to wildtype upon transmission to a host lacking the HLA allele 
required for the immune response. It has been suggested that HLA alleles that are 
frequent in a population are likely to force fixation of viral immune escape mutations 
and adaptation of the virus to the HLA allele. Such fixed escape mutations are 
expected to occur more often at variable sites of the HIV-1 sequence, which are not 
functionally conserved, because escape mutations at these sites do not involve a 
fitness cost to the virus. This hypothesis has been investigated using smaller study 
cohorts and limited to certain HIV-1 subtypes and proteins. HLA-directed immune 
escape mutations across all HIV-1 proteins isolated from six geographically distinct 
populations infected with one of the 3 most prevalent HIV-1 subtypes C, B and A1 
were analysed in this study. The objective of this study was to test whether there was 
a lack of anchor residue motifs for common HLA alleles within the variable sites of 
HIV-1, consistent with the fixation of escape mutations in non-conserved sites. Even 
though some HLA genotypes were common in more than one population, they were 
associated with fewer anchor residues in only some of these populations and not in all 
of them. Further analysis of conserved regions and rare HLAs showed that both 
common and rare HLA genotypes appeared to be associated with lack of anchor 
residues in conserved regions. Therefore, the evidence for fixation of escape 
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the opposing tendency for some alleles to cause functionally constrained regions to 




Human Leukocyte antigens (HLAs) of class I direct cytotoxic T-lymphocyte (CTL) 
immune responses by recognising, binding to and presenting antigenic peptides to the 
CTL cells (Madden et al.,1992). Each HLA molecule binds to antigenic peptides 
which contain a specific sequence pattern known as an ‘anchor residue motif’ 
(Rammensee et al.,1995; Saper et al.,1991). Both the presence of an anchor residue 
motif as well as the overall binding energy between an HLA molecule and a peptide 
determine whether the peptide can successfully be transported and presented to the 
CTL (Bihl et al.,2006; Sette et al.,1994). HLA molecules are therefore key 
components of the CTL immune response and have been found to be associated with 
either rapid progression or long-term non-progression in HIV-1 infected individuals 
(Kiepiela et al.,2007; Ngumbela et al.,2008). The HLA gene itself is highly 
polymorphic and encodes a diverse set of HLA alleles, hence enabling the CTL 
immune response to target many types of antigenic proteins (Marsh et al.,2000). 
Closely related HLA alleles that share overlapping anchor residue motif requirements 
for binding have been grouped under the same supertype (Sette et al.,1999). The 
frequencies of some HLA alleles and supertypes differ between ethnic groups 
resulting in some inter-population differences in the frequency of targeting specific 
peptides and motifs (Cao et al.,2001; Hammond et al.,2007; Hollenbach et al.,2001). 
 
The anchor residues given in anchor residue motifs are usually located at the second 
and C-terminal positions of peptides and directly contact the B and F binding pockets 
of the HLA binding groove respectively (Madden et al.,1992). It is at the binding 
pockets of the HLA groove that the highest binding affinity between the HLA and the 
peptide are obtained. The anchor residue motifs specify the most preferred binding 
residues at the anchor positions of peptides. These motifs can be used to predict CTL 
epitopes and to analyse immune escape patterns on HIV sequences. The presence of 
an anchor residue motif has been found to be associated with the presence of optimal 
CTL epitopes (Honeyborne et al.,2006; Nelson et al.,1997). It is not practical to use 
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amino acid variation is less restricted at the non-anchor sites such that peptides bound 
by a single HLA can vary. Anchor residue motifs are therefore the main determinants 
of HLA binding. Anchor residue motifs restricted by different HLA alleles have been 
deposited in various databases. The Los Alamos database (Korber et al.,2006) in 
particular accumulates anchor residue motifs from various sources, mainly from the 
SYFPEITHI database (Rammensee et al.,1999) and the HLA facts Book (Marsh et 
al.,2000).  
 
Loss of optimally binding residues at the anchor sites of a peptide can cause an 
overall low HLA-peptide binding affinity and failure to elicit an immune response. In 
HIV-1 infection, mutations away from the wild-type residues located at important 
binding positions of viral peptides have been observed and mostly result in poor or 
loss of immune responses (McMichael et al.,2002). Such immune escape mutations 
either become fixed with time or revert to wild type depending on the presence or 
absence of the causative HLA molecule in the infected host and/or functional 
constraints of the target peptide region (Carlson et al.,2008; Kelleher et al.,2001; 
Moore et al.,2002; Peyerl et al.,2004). Fixation of a mutant can occur if the HLA 
exerting the strong selection pressure is frequent in a population such that the virus is 
exposed to the same immune pressure after transmission to new hosts which prevents 
its reversion (Kawashima et al.,2009; Trachtenberg et al.,2003). In some cases, 
compensatory mutations have been found to occur at adjacent sites or regions that 
restore the fitness of the virus (Crawford et al.,2007).  The mutant residue can also 
become fixed if it enables the virus to adapt well to the host. Otherwise if the HLA 
allele causing an escape mutation is rare and the virus is transmitted to an individual 
lacking the HLA genotype, reversion to the wild-type residue is most likely to occur if 
the mutant compromises the fitness of the virus (Friedrich et al.,2004).  Therefore, not 
only the frequency of an allele determines the fate of an immune escape mutation but 
the functional importance of the targeted sequence region in maintaining the fitness of 
the virus.  
 
It has been suggested that HIV-1 can easily adapt to common HLA alleles which 
presumably target variable sites of the virus sequences and that individuals with rare 
HLA genotypes have an advantage (McMichael et al.,2002; Trachtenberg et 
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be under pressure to revert to wildtype in the absence of the causative HLA allele, it is 
expected that most mutations that become fixed occur at variable sites of the sequence 
which have no functional constraints. Studies on which these assumptions are based 
have been carried out on smaller datasets but the overall effect of all common HLA 
alleles in larger and different population across the most prevalent HIV-1 subtypes 
has not been assessed. This study set out to investigate HLA-driven immune escape 
mutations that cause loss of anchor residues in variable sites of HIV-1 sequences 
across the three most prevalent HIV-1 subtype sequences, C, B and A1 (Buonaguro et 
al.,2007). The specific objectives were to determine whether common HLA alleles 
within different populations are associated with fewer anchor residues than expected 
in variable sites of the different HIV-1 proteins. In addition, to evaluate whether loss 
of anchor residues frequently occurs at variable sites that are not likely to affect the 
fitness of the virus than at conserved regions. Evidence of positive selection pressure 
exerted by HLA alleles on known epitope regions is first evaluated in HIV-1 subtype 
C sequences from recently infected individuals from Southern Africa. The Nef and 
Gag proteins which contain peptides frequently targeted by the CTL response were 
used (Masemola et al.,2004a). Secondly, and on a larger scale, six major population 
groups infected with one of the three most prevalent HIV-1 subtypes were used to 
investigate HLA-directed loss of anchor residue motifs in variable sites. These 
populations include the developed countries infected with subtype B, i.e. America 
(US) and Australia (AU), Subtype C infected Brazilian (BR), Indian (IN) and South 
African (ZA) populations as well as the Kenyan (KE) population, infected with 
subtype A1.  
 
5.3 Materials and Methods 
 
5.3.1 Sequence data 
 
Subtype C nef and gag codon sequences from a recently infected cohort from 
Southern Africa were provided by a collaborating laboratory headed by Prof Carolyn 
Williamson. The sequence data is described in Chapter 4 and in a publication listed at 
the beginning of this thesis (Ngandu et al.,2007). Pre-aligned HIV-1 amino acid gene 
sequence alignments for each of the six larger population groups infected with either 
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al.,2005) (Table 5.3.1). Regions with gaps in majority of the sequences and those 
judged by eye to be poorly aligned were manually removed from the alignment. 
Individual sequences with large stretches of gaps were excluded.  
 
5.3.2 Determination of variable sites in HIV-1 sequences 
 
For the subtype C sequences isolated from the Southern African cohort, the mutation 
rates at a site across each of the nef and gag genes were determined by estimating the 
nonsynonymous to synonymous substitution rate ratio (ω). The ω ratio was estimated 
over the phylogenetic tree relating the sequences using the MG94 codon model (Muse 
et al.,1994), implemented in the HyPhy package (Kosakovsky Pond et al.,2005d). The 
rate4site program (Mayrose et al.,2004; Pupko et al.,2002) was used to determine the 
rate of evolution at amino acid sites for each HIV-1 gene sequence alignment for each 
of the population regions. This analysis was carried out separately for each gene 
within each of the six population groups, where sequences from a single population 
belonged to the same HIV-1 subtype. The rate4site program outputs a score per site as 
a measure of conservation. Low scores, i.e., less than zero, indicate evolutionary 
conserved sites and scores above zero indicate variable sites. Positive selection was 
not analysed in the global population datasets but only in the local Southern African 
cohort. In all the individual gene alignments within each population group, a 
consensus sequence was generated and analysed for the distribution of HLA anchor 
residue motifs,  
 
5.3.3 HLA anchor residue motif data 
 
HLA anchor residue motifs were obtained from the Los Alamos database (Korber et 
al.,2006) which collects motifs from the literature and from databases such as 
SYFPEITHI (Rammensee et al.,1999) and the HLA Ligand/Motif database 
(Sathiamurthy et al.,2003). Motifs from other databases were present within these 
databases. All anchor residue motifs with lengths 8,9,10 and 11 and with at least two 
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5.3.4 HLA allele frequency in different populations 
 
HLA allele frequencies in the six major population groups used were obtained from 
the dbMHC HLA anthropology database (Meyer et al.,2007). The database provides 
good estimates of HLA allele frequencies in different populations worldwide. The 
supertypes for each allele were obtained from the Los Alamos immunology database 
(Korber et al.,2006) and the HLA Facts Book (Marsh et al.,2000). An allele was 
regarded as common in a population if its predicted frequency is greater than 0.05. 
The population group data used is shown in Table 5.3.1. The HLA allele frequencies 
do not link directly to the individuals from whom the sequences were obtained, they 
are representative of the frequencies at the population level. The data for individual-
specific HLA genotypes is imiting for large analyses such as this and this issue has 




Population Region HIV-1 sequence 
subtype 
 
Mean number of 
sequences per 
gene 
Kenya (KE) A1 15 
America (US) B 18 
Australia (AU) B 17 
India (IN) C 16 
Brazil (BR) C 15 
South Africa (ZA) C 17 
Table 5.3.1: Populations for which the HIV-1 sequence data from the Los Alamos 
sequence database (Leitner et al.,2005) was analysed and for which the HLA 
frequency data was obtained from the dbMHC anthropology database (Meyer et 






The HLA-directed immune escape was first investigated using sequences from recent 
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selection, i.e. ω>1, within known epitope regions listed in the Los Alamos database 
(Frahm et al.,2008) was investigated (section 5.4.1). Secondly in section 5.4.2, the 
loss of anchor motifs from variable sites associated with common alleles (in this 
chapter alleles that occur at a frequency greater than 0.05 in a population are 
considered to be common in that population) as well as rare HLA alleles (frequency 
of 0.05 or less) and supertypes across different populations was investigated. 
However, due to the observation in our previous publication, also discussed in 
Chapter 4, the anchor residue motifs in the databases appear to be biased towards 
certain populations and HIV-1 subtypes. If the predicted data equally represents 
responses observed against all subtypes and populations, then a direct inter-population 
comparison of the distribution of HLA anchor residue motifs can be made to 
determine whether anchor residues are less frequent in sequences from populations 
where a HLA allele is common. However, a direct comparison of the frequency of a 
motif between sequences from a population where the allele is rare and one where it is 
common can produce biased results. This is possible when motifs in one sequence are 
missed as a result of the difference in the anchor residues recognised by the same 
allele between different subtype sequences when the motif was only predicted using 
one of the subtypes. Therefore the motif can appear to be lost in one sequence yet the 
epitope is recognized and the predicted motif used in the analysis is too specific for 
the other sequence from a different HIV-1 subtype. In order to avoid this bias, the 
direct inter-population comparison is avoided and rather the association of a 
common/rare allele with the frequency of motifs in variable compared to conserved 
sites within a single subtype/population is investigated. 
 
5.4.1 Positive selection within known epitope regions 
 
Three of the five positively selected sites in nef and seven out of nine in gag were 
found within some known CTL targeted epitope regions listed in the Los Alamos 
database (Frahm et al.,2008) (Figure 5.4.1). Of these, one of the three Nef epitopes 
and four out of the seven Gag epitopes were previously observed to have sites 
exhibiting amino acid polymorphisms associated with the restricting HLA alleles 
(Brumme et al.,2007; Brumme et al.,2008b). Sites that were found to be positively 
selected but overlap with regions that are prone to false detection of positive selection 

















Figure 5.4.1: Positively selected sites (black vertical lines) with ω >1 plotted across (a) 
Nef and (b) Gag amino acid sequence positions. Known optimal epitopes that overlap 
with positively selected sites are indicated above each corresponding site. Epitopes 
circled in black were also found to contain HLA-associated amino acid polymorphisms 
in previous studies by (Brumme et al.,2007; Brumme et al.,2008b). Sites with ω > 1 but 
which overlap with regions prone to false detection of positive selection (described in 
detail in Chapter 3) are shaded in grey and were not considered as positively selected in 















5.4.2 Determination of HLA-driven loss of anchor residue motifs in variable sites of 
HIV-1 sequences at the population level 
 
The adaptation of virus sequences to CTL immune responses directed by common 
HLA alleles was investigated by determining the loss of HLA anchor residue motifs 
from variable sites of the HIV-1 sequence. A consensus sequence was generated from 
each HIV-1 sequence set isolated from the corresponding (to the HLA frequency data) 
geographical regions. A fisher’s exact test was used to test whether a HLA allele or 
supertype is significantly associated with fewer anchor residue motifs in variable sites 
compared to conserved sites of a sequence. The test determines whether the HLA 
anchor residues within a motif (which is at the second and C-terminal positions for 
most motifs) are significantly associated with conserved sites as compared to variable 
sites. When the statistic shows a significant association of anchor residues with 
conserved sites, i.e. giving an odds ratio greater than 1 then it indicates that the 
variable sites significantly lack binding motifs for the particular HLA. The fewer 
anchor residue motifs than expected in variable sites of each HIV-1 gene was tested 
for all individual HLA alleles with anchor residue motifs available from the public 
databases. Each allele was tested against nine genes for each of the six population 
regions and the significant tests are given in Table 5.4.2.1. The analysis was also done 
by grouping all alleles of the same supertype since alleles within the same supertype 
share overlapping anchor residue motifs, hence in this way a single motif is evaluated 
once. The effect of common alleles (frequency greater than 0.05) within a supertype 
and that of rare alleles (frequency of 0.05 or less) was investigated separately (Figure 
5.4.2.2 and Table 5.4.2.2). The effect of rare HLA genotypes was also tested to 
determine whether immune escape at the population level results only from common 
HLA alleles. Q-values (Storey et al.,2004) were determined for all p values obtained 
from the fisher’s exact test to account for multiple hypothesis testing. A p value less 
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5.4.2.1 Loss of anchor residue motifs per HLA allele 
 
Of 2,140 tests carried out for individual HLA alleles, 8 showed significant differences 
in the frequency of anchor residue motifs between conserved and variable sites (after 
correction for multiple hypothesis testing). The difference in frequency of anchor 
residue motifs between conserved and variable sites was observed in the Env, Gag 
and Pol protein sequences and associated with HLA s A*0201, A*0301, A*6801, 
B*2705, B*5301 and B*0801. However, a reduced frequency of anchor residue 
motifs was not only observed in variable sites but in conserved sites as well and was 
not only restricted to common HLA alleles (Table 5.4.2.1). Fewer motifs in variable 
sites (odds ratio significantly greater than one) was only observed in two cases, one in 
Env associated with a common HLA A*0201 in AU and the other in pol associated 
with a rare B*5301 allele in IN. Two of the three significant tests observed along the 
Pol sequence were associated with a lower frequency of motifs in conserved sites 
(odds ratio significantly less than one) restricted by a common B*2705 (US) and a 
rare B*0801 allele (AU). All four significant tests in Gag resulted from a reduced 
frequency of motifs in conserved sites only and were associated with either HLA 




HLA aType    bGene Frequency Odds Ratio P value Q-value 
 
A*0201 A2 ENV, B, AU c0.127 d3.24 0.0004 0.16 
A*0301 A3 GAG, B, AU 0.014 0.4 0.0001 0.11 
A*0301 A3 GAG, C, ZA c0.055 0.45 0.0006 0.16 
A*6801 A3 GAG, B, AU 0.001 0.28 0.0002 0.14 
A*6801 A3 GAG, C, IN c0.08 0.31 0.0006 0.16 
B*2705 B27 POL, B, US c0.09 0.42 0.0005 0.16 
B*5301 B7 POL, C, IN 0.01 d inf 0.0005 0.16 
B*0801 B8 POL, B, AU 0.012 0.27 0.0001 0.11 
Table 5.4.2.1 HLA alleles and genes for which there was a significant difference in 
the frequency of anchor residue motifs between conserved and variable sites. a The 
corresponding supertype for each allele, b the gene, subtype and population region of 
the tested HIV-1 sequences, c the frequency of common alleles > 0.05), d Odds Ratio 















5.4.2.2 Results for anchor residue motifs per supertype 
 
The HLA alleles were grouped into nine supertypes namely A1, A2, A3, A24, B7, 
B27, B44, B58 and B62 according to the classification in the Los Alamos database 
and the HLA Facts Book (Korber et al.,2006; Marsh et al.,2000; Sette et al.,1999). 
The frequency of overlapping motifs restricted by common and rare alleles within 
each supertype was investigated. All significant tests are presented in Table 5.4.2.2. 
There were no significant differences between conserved and variable sites in the 
frequency of consensus motifs associated with alleles of the A1, B62 and B7 
supertypes (log odds ratios shown in the appendix). All tests for motifs restricted by 
rare and common alleles within each of the remaining six supertypes for each gene 
sequence per population group are presented in Figure 5.4.2.2. Similar to observations 
in individual alleles, significant tests were not restricted to fewer motifs in variable 
sites only nor associated with common supertypes only. No significant differences in 
the frequency of motifs between conserved and variable regions were observed in the 
Vpr and Vpu proteins. The Gag sequence had significantly fewer supertype anchor 
residue motifs in conserved sites as was the case when individual HLA alleles were 
considered separately. All but one of these significant tests were related to the HLA 
A3 supertype. The single significant test for Env was for the common A2 supertype 
alleles, which was associated with lack of motifs in variable sites (similarly to what 
was observed with the common A*0201 allele in the same AU dataset). The 
consensus motif restricted by rare alleles of the A2 supertype appeared to be less 
frequent in variable sites of the Nef sequences isolated from the subtype C infected 
Indian population. Significant differences in the frequency of motifs were observed in 
the Pol sequence. These included cases in which the frequency of motifs in variable 
sites was higher and cases in which it was lower than the frequency in conserved sites. 
The Rev, Tat and Vif proteins each showed a single significant test reflecting reduced 






















Frequency  aGene Odds Ratio P value Q-value 
A2 Common ENV, B, AU 3.24 0.0004 0.02 
A2 Rare NEF, C, IN 5.0 0.004 0.16 
A24 Rare POL, C, IN 1.99 0.005 0.19 
A3 Common GAG, A1, KE 0.58 0.019 0.20 
A3 Common GAG, B, US 0.6 0.021 0.20 
A3 Common GAG, C, ZA 0.53 0.005 0.20 
A3 Common POL, B, AU 1.71 0.012 0.20 
A3 Common POL, C, IN 0.65 0.013 0.20 
A3 Rare GAG, B, AU 0.41 0.0001 0.005 
A3 Rare GAG, C, ZA 0.35 0.001 0.02 
A3 Rare POL, B, US 0.63 0.012 0.11 
A3 Rare POL, C, BR 0.52 0.011 0.11 
A3 Rare REV, A1, KE 0.08 0.009 0.11 
B27 Common POL, B, US 0.55 0.002 0.03 
B27 Common VIF, B, US 0.3 0.002 0.03 
B44 Rare POL, B, US 1.59 0.002 0.10 
B58 Rare GAG, B, US 0.5 0.008 0.20 
B58 Rare TAT, C, BR 0.15 0.002 0.09 
Table 5.4.2.2: HLA supertypes and genes for which there was a significant difference 
in the frequency of anchor residue motifs between conserved and variable sites,  aGene 
name, HIV-1 subtype, Country Code given in Table 3.  A lower frequency of motifs 
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Figure 5.4.2.2: Log of the odds ratio values obtained from the association of fewer 
motifs with common alleles (blue) and rare alleles (red) within individual supertypes. 
Significant odds ratio values of association between common or rare alleles with 
fewer motifs are indicated by solid rectangles. Log odds ratios greater than 0 indicate 
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lack of motifs at variable sites and those less than 0 indicate lack of motifs at 
conserved sites. For the purposes of the plots, all infinite and zero odds ratio values 
were assigned the log values 3 and -3 respectively. All other log odds ratios were 
greater than -3 and less than 3. 
 
5.4.2.3 Consistency between individual HLA alleles and corresponding supertypes 
 
Results for five of the significant individual HLA allele tests were consistent with the 
corresponding supertypes that also showed significant results for the same protein and 
population region. Among the common HLA genotypes, the significant results from 
the A2 supertype could simply be a reflection of the effect of the common HLA-
A0201 allele as this allele has been previously reported to be associated with immune 
escape that causes evolution of the virus (Edwards et al.,2005). Among the tests that 
showed lack of anchor residues in conserved sites, the common B2705 allele showed 
a similar pattern with the corresponding group of common alleles of the B27 
supertype along the Pol gene from the subtype B-infected US population. The HLA-
B27 supertype has been previously found to be associated with immune responses that 
result in reduced viral loads. The common A3 and A*0301 genotypes were also 
associated with lack of motifs in conserved sites of the Gag sequence from subtype C 
infected ZA population. 
 
Two of the tests that were consistently significant between individual alleles and their 
supertypes were associated with rare HLA genotypes. The observation that the 
consensus motif shared by rare alleles of the A3 supertype was significantly less 
frequent in conserved sites of the Gag sequence from subtype B AU was consistent 
with results obtained from individual A3 rare alleles A0301 and A6801 in the same 
dataset. Although very few significant tests were observed, the gag gene consistently 
showed lower frequency of motifs in conserved sites in all six tests found to be 
significant regardless of population origin, subtype or HLA type. Gag is a conserved 
protein and most CTL epitopes are found in the highly conserved and immunogenic 
p24 region (Masemola et al.,2004b) and this could be the reason why in all cases the 

















In this study, some common HLA alleles were observed to be associated with fewer 
anchor residue motifs in variable sites of HIV-1 protein sequences, consistent with 
other previous observations that frequent HLA alleles cause fixation of immune 
escape mutations (Kawashima et al.,2009; Trachtenberg et al.,2003). However, this 
study was carried out on a larger scale, the data incorporating all HIV-1 genes and 
major pandemic subtypes from six distinct population regions. The large data size 
enabled the identification of rare patterns of HLA-directed immune escape mutations 
that have not been extensively reported in the past. One of these patterns is the lower 
frequency of anchor residue motifs than expected in conserved sites compared to 
variable sites. Generally, fixation of immune escape mutations is expected more 
frequently in variable sites that are not under functional constraints as compared to 
conserved sites. Therefore the frequency of anchor residues in conserved sites is not 
expected to be significantly lower than in variable sites. Another observation that has 
not been reported previously is that some rare HLA alleles were also associated with 
low frequencies of anchor residues. It can however be expected for rare HLA alleles, 
like common ones, to be associated with fewer motifs in variable sites since at such 
regions there is not always pressure to revert to wildtype in the absence of the 
causative HLA allele.  
 
The association of either common or rare HLA alleles with significantly fewer anchor 
residue motifs in conserved sites is not expected to be frequent. This tendency for 
some genes to show fewer motifs in conserved sites than expected in association with 
some HLA alleles could be explained by CTL-driven evolution of epitopes in 
functionally constrained regions of the virus. The immune response exerting strong 
selection pressure on epitopes located in the conserved sites does to some extent cause 
these sites to evolve faster than they otherwise would. An interesting observation 
from this study was that all significant tests for the Gag protein (comprising 50% of 
significant tests from individual HLA alleles and 33% from supertypes) showed fewer 
motifs in conserved sites.  This suggests that the immune response has a strong 
influence in the evolution of epitopes found in this protein, most of which are known 
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As observed in the study, strong immune responses mediated by either common or 
rare HLA alleles can cause evolution of epitopes that are located in functionally 
constrained sites. Therefore, the effect of all individual HLA alleles on the evolution 
of the virus sequence needs to be determined regardless of their frequency in a 
population. The selection pressure exerted by the immune response causing conserved 
regions to evolve more rapidly can affect the way in which HLA anchor residues 
located at these sites are classified. Such functionally constrained epitope regions can 
appear as though they are not under functional constraints. In the analysis of sequence 
variation per site, these functionally constrained sites can produce high variation rates 
and the anchor residues can be classified as being in non-functionally important 
variable sites. This can cause the frequency of anchor residues in conserved sites to 
appear as though it is low and that there is higher tendency for fixation of immune 
escape mutations to occur in conserved sites compared to variable sites.    
 
Some immune escape mutations either in conserved or variable sites can result in total 
loss of wild type anchor residue motifs and eventually failure of the specific immune 
response to target the region. This could have also affected this study because in such 
cases, epitope regions where fixation of mutant residues has occurred can appear as 
though they never contained CTL epitopes. Such regions can be mistakenly assumed 
to never been targeted by the immune response and not under immune selection 
pressure. These regions can be overlooked yet they contain important information 
with regard to the extent that the HIV-1 sequence evolves due to selection pressure 
exerted by the immune response. HIV-1 has been under selection from the human 
immune system since the early twentieth century when the virus was first transmitted 
from chimpanzees infected with simian immunodeficiency virus (SIVcpz) to humans. 
Therefore, there could be a number of regions across the HIV-1 genome especially in 
currently circulating viral sequences that have evolved over the years of HIV-1 
infection in humans and appear to lack potential CTL epitopes. Information regarding 
the extent of HIV adaptation to the human immune response since the cross-species 
transmission event can be lost in such cases.  
 
This study points to the complexity associated with analysis of HLA-related immune 
escape patterns in HIV-1 infection. It suggests that even though common HLA alleles 
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functional constraints in the HIV-1 sequence may not always determine the fate of an 
immune escape mutation. A further analysis is carried out in Chapter 6, in which the 
extent of selection pressure exerted by individual HLA alleles, regardless of HLA 
frequency and HIV-1 sequence constraints, is evaluated. The approach used is not 
affected by the potential misclassification of conserved regions and missing 
information discussed in the previous two paragraphs.  It is carried out in such a way 
that the effect of the immune response on the evolution of all targeted sites in the 
HIV-1 sequence since the cross-species event can be determined. The SIVcpz 
sequence closely related to HIV-1 is used to infer sites that were targeted by the 
immune response since the first exposure of the virus to humans before any evolution 
due to human immune responses occurred. The HLA-directed selection pressure is 
determined across all regions of the HIV-1 sequence, inferred to have contained HLA 




































Evidence of HIV-1 adaptation to host HLA alleles following chimp-
to-human transmission 
 
A paper was recently published (Ngandu et al, 2009) reporting findings from this 




Human leukocyte antigen (HLA) alleles can exert selection pressure on target peptide 
regions as they mediate cytotoxic T-lymphocyte immune responses against HIV-1 
proteins. Immune escape mutations that occur at targeted sites can compromise virus 
fitness and simultaneously enable the virus to adapt to the immune response of the 
infected host. HIV-1 was transmitted to humans from chimpanzees infected with 
simian immunodeficiency virus (SIVcpz) in the early twentieth century; however, 
HIV-1 immune escape mutations that occurred during the zoonosis event and enabled 
the virus to adapt to the recipient human host HLA alleles have been poorly studied to 
date. Yet the adaptation of HIV-1 to human immune responses following zoonosis 
provides an opportunity to study how pathogens adapt to newly infected hosts. Here, 
the extent of adaptation of HIV-1 to human HLAs during the initial exposure of the 
virus to the human host immune responses following the zoonosis event was 
investigated. A SIVcpz consensus sequence was generated and used to approximate 
the virus sequence that was initially transmitted to the human host.  A method based 
on HLA-peptide binding affinity was used to predict peptides that were potentially 
targeted by human HLA alleles on this sequence.  Only HLA alleles with solved 
crystal structures could be used in this approach. The branch of the phylogenetic tree 
leading to the common ancestor of all of the HIV-1 sequences was used to investigate 
selection pressure that may have been exerted by individual HLA alleles following the 
transmission event. The average selection coefficient along this branch was estimated 
using codon-based phylogenetic models. Two methods were used, the branch a priori 
which allowed the nonsynonymous to synonymous substitution rate ratio (ω) to vary 
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each branch of the phylogeny to the best fitting ω class. Evidence for adaptive 
evolution following the zoonosis event was observed at regions recognised by HLA 
A*6801 and A*0201. No evidence of adaptive evolution was observed along sites 
targeted by HLA-B*2705. Crystal structures of all HLA alleles involved in anti-HIV-
1 immune responses need to be solved in order to fully investigate the extent of 




Phylogenetic analysis indicates that the human immunodeficiency virus type 1 (HIV-
1) originated from simian immunodeficiency virus infecting chimpanzees (SIVcpz) 
through a chimpanzee-to-human zoonotic transmission (Gao et al.,1999; Korber et 
al.,2000; Sharp et al.,1999; Zhu et al.,1998). The natural hosts of the virus, the 
chimpanzee, have been observed to remain asymptomatic throughout infection despite 
high viral loads (Pandrea et al.,2008; Silvestri et al.,2007; Silvestri,2008). It is only 
until recently (Keele, 2009) that AIDS-related symptoms have been reported in the 
chimpanzee. In humans however, an increase in viral load is usually associated with 
progression to the acquired immuno-deficiency syndrome (AIDS) and subsequently 
death (Lemey et al.,2007; Michael et al.,1995; Musey et al.,1997; Saksela et al.,1994; 
Shearer et al.,1997).  The exact causes of these differences in host-viral relationships 
between the chimpanzee and humans are continuously being investigated by scientists 
worldwide. The causes of the difference in disease progression may involve either 
differences in the host and/or between the HIV-1 and the SIVcpz viruses. 
 
A cross-species zoonotic event is expected to be accompanied by mutations that 
enable the pathogen to adapt to the new host environment. Indeed, sequence changes 
have been identified in HIV-1 that are evidence of selection pressure associated with 
the genetics of the human host (Brumme et al.,2007; Choisy et al.,2004; Soares et 
al.,2008; Wain et al.,2007).  The cytotoxic T-lymphocyte (CTL) immune response 
directed against foreign antigens in particular plays a major role in exerting selective 
pressure on the antigenic proteins including those of HIV-1. The activation and 
characteristics of the immune responses against the virus have been found to differ 
remarkably between the two hosts (Bibollet-Ruche et al.,2008; Muller et al.,2006; 
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infection is characteristic in humans but the chimpanzee generally maintains a low 
level of immune activation (Bibollet-Ruche et al.,2008; Muller et al.,2006; Rutjens et 
al.,2003; Silvestri,2008). The human immune response therefore possibly exerts 
higher selection pressure on the virus sequence compared to immune responses of the 
natural host. However, the virus is still able to overcome the immune response and 
cause AIDS indicating that there are mutations which occurred immediately after the 
zoonotic transmission from chimpanzee to humans which enabled the virus to adapt to 
some extent to the human immune response.  
 
Despite the efforts that have been made in analyzing selective pressures exerted by 
specific immune responses in infected populations within the HIV-1 group M 
subtypes, there has been limited analysis of the effect of the human CTL immune 
response on the viral sequence during the process of establishment of the virus in 
humans following transmission from chimpanzee. Yet a detailed understanding of the 
HIV sequence changes that occurred following the zoonosis process as a result of 
selective pressure exerted by the human immune response can broaden current 
knowledge of HIV-1 pathogenesis as well as the adaptation of pathogens to the 
human host. If the selection pressure exerted by the human immune response was 
strong enough to cause positive selection of the targeted sites and subsequent fixation 
of the mutations, it may be possible to identify such signatures of adaptation to new 
host following zoonosis by comparing the inferred ancestral sequence or the 
consensus sequence of HIV-1 group M subtypes to the consensus sequence of 
SIVcpz.  
  
Anchor residue motifs can be used to predict epitopes bound by the various human 
leukocyte antigen (HLA) molecules in mediating CTL responses against HIV-1. 
However, successful binding, efficient transport and presentation of a peptide to a 
CTL depends on both the presence of the appropriate anchor residue motif and the 
overall affinity between the HLA binding groove and the peptide residues (Rovero et 
al.,1994; Sette et al.,1994). Therefore, the search for anchor residue motifs together 
with the prediction of the strength of binding between a HLA molecule can be used to 
best infer regions of the virus sequence that are likely targets of the CTL response in 
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as the HLA-peptide binding affinity (DiBrino et al.,1994; Falk et al.,1991; 
Rammensee et al.,1999; Schiewe et al.,2007). 
 
 In this study, the HLA target regions were predicted using a structure-based method 
that determines the strength of binding between a sequence and HLA molecules using 
amino acid pair-wise potentials. Only regions with the highest binding affinity and 
anchor residue motifs are selected to ensure that most of the optimal epitopes 
recognised in vivo are detected with minimal false positives. This study limits the 
analysis of selection pressure only to potential HLA target sites across the HIV-1 
genome so as to exclude sites that are not under selection pressure resulting from the 
CTL response. Models of codon sequence evolution were used to determine selection 
pressure in regions predicted to be targeted by specific HLA molecules. The methods 
employed for detecting selection pressure infer positive selection from the ratio of 
nonsynonymous substitution rates (dN) to synonymous substitution rates (dS) for 
individual branches in a phylogeny. Branch-specific analysis of selection pressure 
enabled the determination of whether there was evidence of strong selection pressure 
along the ancestral branch leading to the HIV sequences associated with each HLA 
allele. HIV-1 adaptation to HLA alleles with solved crystal structures is presented and 
this contributes to the understanding of how this pathogen adapted to the human host 
upon transmission.  
 
6.3 Materials and Methods 
 
6.3.1 Sequence data 
 
An alignment of HIV-1 group M reference genome sequences and chimpanzee 
sequences was downloaded from the Los Alamos database (Leitner et al.,2005). 
Regions with gaps in majority of the sequences and those judged by eye to be poorly 
aligned were manually removed from the alignment. Individual sequences with large 
stretches of gaps were excluded. Regions that were found to be under strong purifying 
selection at synonymous sites (as described in chapter 3) were removed from the 
alignment. The resulting alignment consisted of 9 chimpanzee sequences and 32 HIV-
1 sequences starting from codon 1 of the gag gene ending with the nef stop codon. 
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'AB253421', 'AB253429', 'AF286238', 'AF286237', 'K03455', 'AY173951', 
'AY331295', 'DQ853463', 'U52953', 'U46016', 'AY772699', 'K03454', 'AY253311', 
'U88824', 'AF077336', 'AF005494', 'AF075703', 'AJ249238', 'AF377956', 'AF084936', 
'AF061641', 'U88826', 'AY612637', 'AF190127', 'AF190128', 'AF005496', 
'AF082394', 'AF082395', 'AJ249235', 'AJ249239', 'U42720', 'DQ373066', 'AF103818', 
'AY169968', 'DQ373065', 'DQ373064', 'DQ373063', 'X52154' and 'AF447763'. We 
used HyPhy to build a phylogenetic tree from the alignment using a neighbour joining 
method and the pairwise distances calculated using maximum likelihood (Kosakovsky 

















Figure 6.3.1: The phylogenetic tree of the 32 HIV-1 group M reference sequences 
and 9 SIVcpz sequences from the Los Alamos database comprising of all coding 
genes (Leitner et al.,2005). The chimpanzee sequence names start with ‘CPZ’ and the 
group M sequences, from branch “B”, start with the subtype name. The branch 
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6.3.2 Predicting HLA binding regions 
 
PREDEP (Altuvia et al.,2004), a structure-based method for predicting HLA binding 
peptides was used to determine potential binding regions across the genome. The 
consensus chimpanzee sequence was used to predict the best HLA binding regions 
because it has not been exposed to the human HLA selection pressure. Consequently, 
it may be possible to detect epitopes in the chimpanzee sequence eliminated from 
HIV-1 shortly after transmission to humans.  PREDEP does not require knowledge of 
known HLA-binding peptides hence is not biased towards any particular organism. 
The program requires solved crystal structures of the HLA molecules as well as 
knowledge of amino acid residues on the binding groove that interact with each 
position of the antigenic peptide sequence. Amino acid pair-wise potentials are used 
to determine the strength of binding between the peptide and the amino acids in the 
HLA binding groove based on backbone and side-chain interactions.  
 
A score for each HLA-peptide interaction is calculated as the sum of amino acid pair-
wise potentials between each peptide residue and the interacting residues of the HLA 
binding groove. The lower the score, the better the peptide binds to the HLA binding 
groove. Peptides with very low interaction scores have strong binding affinities to the 
HLA molecule hence are most likely to be targeted and successfully presented to 
CTLs in-vivo. A test of PREDEP performance showed that 80% of the top 15 
percentile best binders were known optimal HLA binding peptides (Altuvia et 
al.,2004).  In this study, only the top 5% of best binding regions containing the amino 
acid residues known to give optimal binding at the major binding pockets, i.e. 
peptides that matched the HLA anchor residue motifs, were taken for further analysis. 
All potential binding regions across the chimpanzee consensus sequence were 
predicted in this manner for each HLA allele. The downloaded HIV and chimpanzee 
reference sequence alignment was then edited for each HLA allele by taking only the 
sites in the alignment that fell within the potential binding regions predicted in the 
chimpanzee consensus sequence. This resulted in a new alignment for each HLA 
allele consisting of only the regions of the sequence likely to be bound by the HLA 
allele. In this way, the extent of selective pressure exclusively exerted by immune 
responses mediated by each individual HLA alleles could be evaluated. In particular, 
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labelled ‘B’ in Figure 6.3.1, because it represents the sequence that encountered the 
first human immune responses immediately after the chimpanzee-to-human cross-
species transmission event. 
 
6.3.3 A priori analysis of selection pressure along the HIV branch compared to the 
SIV branch 
 
The BranchAPriori model (Yang,1998) was used to determine whether there is high 
selection pressure on the branch (‘B’ in Figue 6.3.1), leading to the HIV sequences. 
For each HLA-related alignment described in the previous section, selection pressure 
along this branch was compared to the rest of the branches in the tree. Therefore, this 
particular branch was selected a priori. The program outputs a p value derived from 
the difference in the log likelihood between the null and the alternative models. The 
null model assumes a single global dN/dS ratio (ω) across the tree and ω for the 
selected branch leading to HIV-1 sequences is unconstrained in the alternative model. 
This a priori analysis however has the disadvantage that it assumes that all the other 
branches in the rest of the tree are under uniform selection pressure. The power of the 
analysis can be weakened for instance when there is actually strong among-branch 
heterogeneity in selection pressure between the branches in the rest of the tree 
(Yang,1998). It is therefore preferable to consider models that allow selection 
pressure along all branches in the tree to vary in order to construct a more realistic 
null model.  
 
6.3.4 Branch-by-branch analysis of selection pressure 
 
GABranch, a genetic algorithm (Kosakovsky Pond et al.,2005b) implemented in 
HyPhy was used to determine branch-specific selection pressure across the entire 
phylogeny of SIV and HIV-1 sequences. The genetic algorithm allows among branch 
variation in selection pressure across the entire tree. It calculates selection pressure 
along each branch of a tree and hence can be used to determine which branches of a 
tree are evolving under positive selection pressure. We therefore set out to determine 
whether there is positive selection pressure on the branch leading to HIV-1 sequences 
from the SIVcpz-HIV-1 ancestral node for each of the HLA alleles being analyzed. 
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determined using a maximum likelihood-based tool available in HyPhy (Kosakovsky 
Pond et al.,2005d). The GABranch algorithm first searches for the best fitting codon 
model for the phylogeny. All possible codon models are tested with varying ω rate 
classes starting with a model with a single rate class, i.e. a model that tests whether all 
the branches of the tree evolve uniformly. Models with more than 1 rate class are then 
tested whereby the evolutionary rate of each tree branch is tested for fit to each of the 
rate classes before assigning to the best fitting rate class. An Akaike Information 
Criterion weight (AIC) is calculated for each model based on its fit to the data in 
comparison to the model that assumes uniform selection across all the branches, i.e., 
the single rate model. The model with the best fit to the data as indicated by the 
lowest AIC is selected. The branches that fall under each ω rate class of the best 
fitting model are indicated on the phylogeny. Additionally for each branch, the 
averaged proportion of all tested models that showed support for dN > dS i.e., ω>1, 
for each branch i.e. all tested model that indicated that ω was significantly greater 




6.4.1 Prediction of HLA binding regions in the chimp sequence 
 
Of the six HLA alleles for which crystal structure and peptide binding preferences 
have been analyzed using Predep (http://bioinfo.md.huji.ac.il/marg/Teppred/mhc-
bind/index.html), only HLAs A0201, A6801 and B2705 showed strong binding to 
regions of the SIVcpz consensus sequence which also contained the preferred anchor 
residue motifs. The total length of the overlapping 9mer peptide regions predicted to 
be the best binders, i.e. within the best five percent scores, for each HLA molecule 
across the chimp genome are given in Table 6.4.1. These predicted binding sites were 





















Anchor residue motif1 Binding regions for positive 
selection analysis 
A0201 .[AILTVM]……[AILTVM] 395 codons 
A6801 [AILTVM]……[RK]. 345 codons 
B2705 .RK……LFYRKHMI. 148 codons 
Table 6.4.1 Sequence data for the regions predicted to have potential HLA binding 
peptides. 1 The anchor residue motifs were predicted from HLA-peptide structural 
conformations in Predep, residues in square brackets are the most preferred at the 




6.4.2 BranchApriori analysis of differential selection between the HIV and SIV 
lineages 
 
The predicted binding regions for each HLA allele were tested for differential 
selection pressure between the HIV lineage and the SIV branches by estimating ω 
along the branch leading to the HIV-1 sequences. The ω was found to be higher in the 
branch leading to the HIV sequences compared to the SIVcpz branches although in 
both lineages it was greater than one (Table 6.4.2). Significant ω differences were 
observed only for HLA A6801 with a ω of 3.5 in the branch leading to the HIV-1 
sequences and 1.6 in the rest of the tree (p value = 0.04).  Selection pressure acting 
along the HIV-1 branch for sites associated with A0201 (ω = 2.5) was very high but 
failed to differ significantly from SIVcpz (ω = 1.2, p value = 0.08). For sites 
associated with B2705, there was no significant difference between HIV-1 and 
SIVcpz branches with no indication of positive selection pressure in HIV-1 and 
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Allele HIV branch ω Rest of the tree ω p value 
A0201 2.5 1.2 0.08 
A6801 3.5 1.6 0.04 
B2705 1.0 1.1 0.65 




6.4.3 Branch-by-branch analysis of selection pressure using the GABranch algorithm 
 
All possible codon models were run on the sequence alignments of predicted binding 
regions from each HLA allele and output given for the best fitting model. The ω rate 
classes for the best fitting model as well as the number of branches that fit to each 
class are given in Table 6.4.3. The proportion of models that have a high support for 
ω>1 for each branch is also given and highlighted in Figures 6.2a-c. No model 
support for ω>1 was observed on any branch in the phylogeny generated from the 
HLA B2705 (Figure 6.4.3c) predicted binding sites, suggesting that this allele may 
not have exerted strong selection pressure on the HIV-1 sequence. The values of ω 
along the branch leading to HIV-1 (from node 18 in Figure 6.2) as well as the 
proportion of models that showed support for ω>1 are shown in Table 6.4.3. The 
results strongly agreed with those observed from the a priori analysis. Selection 
pressure observed along the branch leading to HIV-1 sequences containing potential 
HLA-A6801 binding sites (from node 18) was high (ω = 1.15). A very high 
proportion of the tested models (0.996) showed a high support for ω>1 along this 
branch. There was also evidence of strong selection pressure along the HIV-1 branch 
for regions associated with targeting of HLA A0201 (ω = 1.14) and 0.996 of models 
showed support for ω>1. The mean omega values and model support data for all the 



















HLA allele  ω rate classes (number of 
branches)1 
  ω HIV-12  
(from node 18) 
Prob(ω>1)3 HIV-1  
A0201 1.14 (33), 0.62 (46) 1.14 0.996 
A6801 1.15 (42), 0.60 (31), 0.23(6) 1.15  0.996  
B2705 0.52 (79) 0.52  0.06 
Table 6.4.3 The best fitting models determined from the Genetic algorithm analysis 
1Number of branches (out of a total of 79) that fall under each ω rate class are given in 
brackets. 2The ω values are means over results from all the models. 3Prob (ω>1) is the 
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Figure 6.4.3: (a) Branch-by-branch selection pressure for regions predicted to be 
targeted by HLA-A0201. (b)Branch-by-branch selection pressure for regions 
predicted to be targeted by HLA-A6801. (c) Branch-by-branch selection pressure for 
regions predicted to be targeted by HLA-B2705. ω classes for each branch are shown 
in the colours given in the legends. The percentage of models that support ω>1 are 






The Predep program provides binding predictions for only a limited number of HLA 
molecules with solved crystal structures as well as preferred binding anchor residue 
motifs that were predicted from HLA-peptide structural conformations. Amongst 
these, only A0201, A6801 and B2705, were found to bind strongly to some regions of 
the consensus SIVcpz genome. Although higher ω was observed along the branch of 
the tree leading to the HIV sequences for HLAs A0201 and A6801 target sites using 
the BranchApriori analysis, strong selection pressure was still observed in the rest of 
the phylogeny. Selection pressure associated with A6801 was significantly higher in 
HIV-1 compared to the rest of the phylogeny (HIV ω = 3.5 versus 1.6, p value = 
0.04). The difference observed for HLA A0201 was weaker (HIV ω = 2.5 versus 1.2, 
p value = 0.08). There was no significant evidence of differential selection pressure 
acting on the HIV-1 branch for the regions recognized by HLA B2705 with both ω 
values close to 1.  
 
We ran the GABranch genetic algorithm to determine whether there is high selection 
pressure along the HIV-1 branch when ω is allowed to vary along each branch in the 
tree. This analysis does not assume that certain branches in the tree are under the same 
selection pressure as is the case in the a priori analysis, hence GABranch gives a 
more unbiased analysis of what is actually happening at each branch of the tree. The 
observations made in the branch-by-branch selection analysis were consistent with 
those obtained from the branch a priori analysis. A high mean ω was observed along 











those for A0201 with strong support for ω>1 from 99.6% of the tested models in both 
datasets. No evidence for strong selection pressure was observed at the HIV-1 branch 
or across the entire phylogeny in the case of HLA B2705 dataset.  
 
It is interesting, however, that in both the a priori and GABranch analyses, there was 
no evidence for selection pressure for the HLA-B2705 alignment along the HIV-1 
branch, nor any other branch. None of the tested models, including the best fitting 
one, showed any support for ω>1in all the branches of the phylogeny for the HLA 
B2705 dataset. The B27 alleles is associated with delayed progression to AIDS in 
HIV-1 infected individuals (McNeil et al.,1996). Delayed progression to AIDS has 
been found to be associated with persistent strong positive selection pressure at 
specific sites (Ross et al.,2002), as a result of reduced viral replication indicating that 
the positively selected sites are important for the fitness of the virus. One possible 
explanation to the observed B2705 result in this study is that the allele could have 
caused positive selection in only a few sites and this however became negligible since 
the given ω values are an average over all tested sites of the sequence.  
 
Positive selection pressure was observed for the HIV-1 branch in the a priori analysis 
of the HLA-A0201 dataset and the GABranch analysis with very high support for 
ω>1. The HLA-A0201 allele is the most frequent in the Caucasian populations and 
many studies have been carried out to determine its effect on HIV disease progression 
(Marsh et al.,2000). Even though the allele recognizes immunodominant peptide 
regions of the HIV-1 sequence, it has previously been shown that it fails to exert 
strong selection pressure on some virus peptides during chronic infection (Brander et 
al.,1998). Some studies have also shown that the outcome of an immune response 
does not only depend on the HLA molecule but also on the specific peptide sequences 
that are targeted (Borghans et al.,2007; Maurer et al.,2008; Miura et al.,2008b; 
Nelson et al.,1997; Pereyra et al.,2008). In this study, all of the epitopes in the 
ancestral SIV genome that were mostly strongly predicted to have been bound by host 
HLA alleles, following transmission to human, were analysed. The results observed 
here suggest that immune escape mutations that occurred for HLA A0201 mediated 











fitness cost to the virus. Rather they possibly became fixed, thus enabling the virus to 
adapt to the human immune response.  
 
HLA A6801 appeared to exert strong selection pressure on the HIV-1 ancestral 
branch compared to the rest of the tree. High support (99.6% of the tested models) for 
ω > 1 was observed at the ancestral HIV branch.   This allele has anchor residue motif 
restrictions that are shared within the HLA A3 supertype, the second most frequent 
supertype in the human population (Sette et al.,1999). The HLA A6801 allele itself 
has been found to target the Tat protein which is expressed in the early stages of the 
HIV-1 lifecycle and CTL responses to this protein cause a significant reduction in 
disease progression rate (van Baalen et al.,1997). Escape mutations from the CTL 
immune response have also been identified within Tat at the population level causing 
reduced viral loads (Allen et al.,2000; Cao et al.,2003). The virus possibly adapted 
well to the A6801 responses early after the cross-species transmission event at sites 
that do not affect the replication of the virus and the recently observed association 
with a reduction in viral load indicates that there were also functionally important 
sites that contained A6801 epitopes that possibly failed to adapt to the immune 
response.   
 
The results from this study suggest that HIV-1 adapted to CTL responses directed by 
HLAs A6801 and A0201, which are amongst the most common HLA genotypes in 
humans. It is therefore likely that the virus was frequently exposed to selection 
pressure exerted by common immune responses during initial exposure to the human 
host following transmission of the virus from chimpanzees. There was no evidence 
for strong selection pressure exerted by the HLA B2705 which is a generally rare 
genotype in the human population with extremely low frequencies in the African 
populations (Solberg et al.,2008; Trachtenberg et al.,2003).  It is important to note 
that, not just the frequency of an allele could have had an effect but the functional 
importance of the targeted sites can also determine success or failure of fixation of an 
immune escape mutation that can allow the virus to adapt to its new host. This is the 
first study that analyses HLA-associated selection pressure following the transmission 
from chimpanzee to human across all potential target sites of the HIV-1 genome 
associated with alleles whose crystal structures have been solved. There are currently 










preferences of all human leukocyte antigens involved in CTL responses against HIV-
1 need to be determined in order to expand analyses such as the one done here. The 
full analysis of the extent of HIV-1 adaptation to the human host following zoonosis 
will aid in better understanding of how pathogens adapt to the human host and can 













































Four related studies that contribute to the understanding of HIV-1 evolution and 
pathogenesis in humans are presented in this thesis. Each involved challenges and 
limitations, which are discussed in this chapter.  
 
7.1 Quantification of functional sites that are under purifying selection pressure 
and functional analysis of conserved novel synonymous sites of the HIV-1 
nucleotide sequence 
 
In chapter 3, twenty-three motifs were found to be highly conserved showing 
evidence of purifying selection pressure acting on synonymous sites of the HIV-1 
nucleotide sequence. Exhaustive searches of the literature were made in order to 
identify functions of all the regions that were highly conserved. The majority of the 
identified conserved sites were within functional regions that are well documented in 
the literature; however, the total number of sites that function at the nucleotide level is 
unknown. Even though many functional motifs are known in the HIV-1 nucleotide 
sequence, there is no database that collects and annotates all of them to provide a 
single consolidated resource. It was therefore not possible to quantify the proportion 
of known and novel functional sites that are under purifying selection pressure across 
the coding regions of the HIV-1 genome using the method applied here.  
 
To date, preliminary functional analysis has been carried out on one of the four novel 
regions (i.e. one in the env gene and three along the vpu gene). The twelve-nucleotide 
region in the env gene was sent for functional analysis in a collaborating laboratory. 
In the preliminary results, synonymous mutations at these conserved sites appeared to 
slightly lower the replication rate of the mutant virus in comparison to the wildtype. 
There are plans to carry out replicated experiments to verify the accuracy of these 
preliminary results and determine whether there are significant differences between 












7.2 More studies are required to determine HLA alleles and their binding 
preferences from populations of the developing countries  
 
As observed in Chapter 4 of this thesis, the HLA and anchor residue motif data 
associated with the Southern African population is limited in the database. Yet that 
from a subtype B infected cohort from North America is well characterized. HIV-1 
subtype B is prevalent in the world’s most developed countries, North America, 
Australia and parts of Europe (Peeters et al.,2000). Yet HIV prevalence is highest in 
Sub-Saharan Africa, a region mostly infected by subtype C. HIV-1 subtype C is 
responsible for almost half of the world’s HIV-1 infections and deaths. Even though 
this analysis was based on two small cohorts, the differences between the two datasets 
does suggest that characterisation of HLA alleles involved in CTL immune responses 
against HIV-1 subtype C has not been completed comprehensively to date. Adequate 
HLA binding motif data for at least the most frequent immune responses against 
subtype C sequences is required in the databases. This will be useful for studies 
directed towards understanding immune responses in these populations and hence 
contribute towards the design of vaccines that are effective in the most affected 
populations. The curbing of the AIDS pandemic can be achieved much faster by 
focussing on populations where there is the highest prevalence of HIV-1 infections 
like the Southern African region. It is also possible that many studies are being carried 
out on HIV-1 subtype C sequences in this region but the results are not being 
deposited into public databases. There may, therefore, also be a need for researchers 
in this region to publish their research work and deposit more data into the publicly 
accessible databases. 
 
7.3 Limitations of the HLA allele frequency data 
 
As mentioned in section 2.8.2, there are no large publicly available datasets that 
provide both HIV-1 autologous sequence and HLA data of the same individual. In 
addition, the HLA allele frequencies in different populations are estimated from very 
small sample sizes. The ethnic groups of the individuals from whom the HIV-1 
sequences were isolated are not given but instead the country, yet HLA allele 











allele frequency used was that estimated for a country as provided in the HLA allele 
frequency database, dbMHC (Meyer et al.,2007) in correspondence to the countries 
from which HIV-1 sequences available in the Los Alamos sequence database (Leitner 
et al.,2005) were isolated. Therefore the frequencies used in this study are estimates 
for a particular country and may not provide a good estimate of the HLA frequencies 
of the individuals from whom the viruses were isolated since different ethnic groups 
cohabit in a single country. Although the project managed to identify alleles with 
strong effects on the distribution of anchor residue motifs across HIV-1 sequences 
from different populations, the allele frequencies may not be accurate and this could 
have affected the classification of the HLA alleles as either common or rare in a 
population. This still however does not affect the presence or absence of an anchor 
residue motif in a sequence. However, the effect of the frequency of a HLA allele 
could have been clearer if the ethnic groups of the individuals from whom the HIV-1 
sequences were obtained were identified in the sequence database.  
 
7.4 There are currently very few HLA alleles with solved crystal structures 
 
In chapter 6, regions that are bound by HLA alleles were identified using a method 
based on binding energy between the HLA molecule and the protein sequence. In this 
way, all the regions potentially subjected to selection pressure exerted by a specific 
HLA allele and the CTL immune response were analysed. This approach was not 
affected by poor characterisation of anchor residue motifs. However the PREDEP 
method (Altuvia et al.,2004) used is only applicable for a limited number of HLA 
alleles with solved crystal structures. There are currently few HLA alleles of class 1 
with solved crystal structures. The method used here incorporated all the currently 
available HLA crystal structures. However, these structures and their features are 
embedded into the program code making it difficult to incorporate new HLA crystal 
structures as these become available. Programs using a similar approach as PREDEP 
but with flexible codes that allow the user to enter additional solved crystal structures 















7.5 The novel achievements of this research work 
 
Despite the challenges and limitations highlighted above, each of the projects 
presented in this thesis provide a novel finding. In the first a consolidated list of all 
synonymous sites of the HIV-1 coding regions which are under purifying selection 
pressure were identified. These regions are conserved across all the 11 subtypes of 
HIV-1 group M infecting humans. It is therefore evident that purifying selection 
pressure acting upon these sites is very strong since it causes conservation across all 
the subtypes. This shows that even though the virus has a high mutation rate, some 
regions are too critical for its viability to even accommodate many synonymous 
changes. The results of this work are also important for studies that analyse positive 
selection in coding regions of HIV-1 sequences by helping them identify and possibly 
avoid false positives in their analyses. When positive selection is inferred from a 
comparison of synonymous and non-synonymous substitution rates, purifying 
selection pressure acting at the synonymous sites can lower the synonymous 
substitution rate and cause the dN/dS ratio to be greater than 1, implying positive 
selection, even if there is no positive selection acting on the codon. The results of this 
research project were published and made available as a resource for other 
researchers.  
 
In the second case, even though HIV-1 subtype C is the most prevalent world-wide, 
most scientific studies have been focused on subtype B. It is known that there is an 
average of 25% inter-subtype sequence difference (Buonaguro et al.,2007) but the 
accuracy of immune response data predicted using only subtype B in studying 
immune responses observed against other subtypes has not been extensively 
evaluated. This project managed to show that the HLA anchor residue motif data in 
the databases that is specific to HIV-1 is biased towards subtype B. In addition, the 
anchor residue motifs do not always accommodate the sequence variation that exists 
between different subtype sequences as observed by the fact that almost 50% of the 
subtype C peptides that were targeted by the CTL response did not contain the 
required HLA anchor residue motifs.  
 
The third study was related to the effect of common HLA alleles in driving immune 











regions of the virus that are not under strong functional constraint may have 
permanently lost anchor residue motifs required for presentation by common human 
HLA alleles. Many reports have been published on the effect of common HLA alleles 
in causing HIV-1 to adapt to the immune response. Here, the relationship between 
HLA allele frequency and the number of their anchor residue motifs across HIV-1 
proteins in major infected global populations was evaluated. Some HLA alleles that 
were less frequent in a population were also found to be associated with fewer motifs 
in variable regions and contributed to the evolution of conserved regions of the HIV-1 
sequence. Therefore, not only common HLA alleles but some rare ones involved in 
directing the less frequent immune responses are involved in shaping the evolution of 
conserved regions of the HIV-1 sequence. 
 
Adaptation of the HIV-1 sequence to HLA alleles within infected populations through 
immune escape mutations and positive selection has been widely evaluated. However, 
sequence changes that occurred to enable HIV-1 to adapt to the recipient human host 
immune responses following the zoonotic transmission from chimpanzee has not been 
considered. The fourth study presented here set out to find evidence for the adaptation 
of HIV-1 to common human HLA alleles with solved crystal structures following the 
zoonosis event. Despite the limited number of HLA alleles with known crystal 
structures, the extent of selection pressure on the targeted regions of the alleles with 
solved structures was successfully evaluated. The results showed evidence that the 
virus did adapt to CTL immune responses directed by specific HLA alleles after 
initial transmission to the human host. In this study in particular, adaptation was 
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Figure A3.4.2a: G-A mutations in a variable region in the nef gene, Mutations 
observed in reference sequences in comparison to Group M ancestral sequence 
identified using the hypermut tool available in the Los Alamos database. The highly 















Figure A3.5: Highly conserved regions observed at the subtype level, dS across 
subtypes B and C gag and env genes showing more conserved sites at the subtype 
sequence level within the INS regions in gag and RRE in env. Black horizontal lines 
















Table A4.3.5 HLA allele frequency in Subtype B and C cohorts used in this study 
HLA Allele Subtype B Subtype C 
A*0101 0.044444 0.007813 
A*0201 0.166667 0.039063 
A*0202 0.022222 0.015625 
A*0205 0.011111 0.046875 
A*0207 0.011111 Nil 
A*0217 0.011111 Nil 
A*0209 Nil 0.007813 
A*03 Nil 0.007813 
A*0301 0.1 0.007813 
A*1101 0.022222 Nil 
A*2301 0.1 0.109375 
A*2402 0.044444 0.015625 
A*2601 0.033333 Nil 
A*29 Nil 0.03125 
A*2902 0.011111 0.140625 
A*2911 Nil 0.007813 
A*30 Nil 0.007813 
A*3001 0.044444 0.0625 
A*3002 0.088889 0.148438 
A*3004 0.011111 0.03125 
A*3201 0.022222 0.007813 
A*3301 0.033333 Nil 
A*3303 0.011111 0.007813 
A*3304 0.011111 Nil 
A*3402 0.022222 0.054688 
A*36 Nil 0.007813 
A*3601 Nil 0.039063 
A*4301 Nil 0.023438 
A*6601 0.022222 0.023438 
A*6801 0.022222 0.023438 
A*6802 0.011111 0.070313 
A*74 Nil 0.007813 
A*7401 0.055556 0.0625 
A*7402 Nil 0.007813 
A*7403 0.011111 Nil 
A*8001 0.011111 0.023438 
B*0702 0.044444 0.03125 
B*0801 0.055556 0.0625 
B*13 Nil 0.070313 
B*14 0.022222 0.023438 
B*1402 0.022222 0.007813 
B*15 Nil 0.007813 
B*1501 0.033333 0.015625 
B*1503 0.011111 0.109375 
B*1510 Nil 0.046875 











B*1530 0.011111 Nil 
B*18 Nil 0.007813 
B*1801 0.011111 0.03125 
B*2705 0.022222 0.007813 
B*35 0.011111 Nil 
B*3501 0.066667 0.023438 
B*3503 0.011111 Nil 
B*3801 0.011111 Nil 
B*3902 0.011111 Nil 
B*3910 Nil 0.007813 
B*40 0.011111 Nil 
B*4001 0.011111 Nil 
B*4002 0.022222 Nil 
B*4101 Nil 0.015625 
B*4102 0.011111 Nil 
B*4201 0.033333 0.085938 
B*4202 Nil 0.007813 
B*44 Nil 0.007813 
B*4402 0.022222 Nil 
B*4403 0.033333 0.117188 
B*4501 0.088889 Nil 
B*45 Nil 0.0625 
B*4901 0.033333 0.007813 
B*5101 0.033333 Nil 
B*5301 0.1 0.03125 
B*5308 Nil 0.007813 
B*5601 0.011111 Nil 
B*57 Nil 0.046875 
B*5701 0.022222 Nil 
B*5703 0.055556 Nil 
B*58 Nil 0.03125 
B*5801 0.022222 0.046875 
B*5802 0.022222 0.078125 
B*7020 Nil 0.007813 
B*81 Nil 0.007813 
B*8101 0.066667 0.023438 



























































































































































































































Figure A5.4.2.2 Log of the odds ratio values obtained from the association of fewer 
motifs with common alleles (grey) and rare alleles (black) within individual 
supertypes where no significant associations were found, a; A1 supertype, b; B62 











at variable sites and those less than 0 indicate lack of motifs at conserved sites. For 
the purposes of the plots, all infinite and zero odds ratio values were assigned the log 




Table A6.4.3a: Model Averaged Branch dN/Ds for HLA A0201: branches with high 
model-averaged support for dN>dS are shown in bold 
Branch Name Mean Std.Dev. 2.5% Median 97.5% Prob{dN>dS}† 
CPZ_US_85_CPZUS_AF103818 0.630 0.027 0.612 0.628 0.648 0.003 
CPZ_CM_05_SIVCPZEK505_DQ373065 1.113 0.055 1.046 1.120 1.162 0.988 
Node4 1.113 0.054 1.047 1.120 1.163 0.989 
CPZ_CM_05_SIVCPZMT145_DQ373066 0.639 0.070 0.612 0.628 0.685 0.023 
CPZ_GA_88_GAB1_X52154 0.630 0.032 0.612 0.628 0.649 0.005 
CPZ_CM_01_SIVCPZCAM13_AY169968 1.116 0.044 1.051 1.120 1.163 0.994 
Node9 0.637 0.059 0.612 0.628 0.681 0.016 
Node7 0.724 0.186 0.616 0.632 1.119 0.200 
Node3 0.634 0.055 0.611 0.628 0.652 0.014 
CPZ_CD_90_ANT_U42720 1.117 0.034 1.053 1.120 1.163 0.997 
CPZ_TZ_01_TAN1_AF447763 0.629 0.023 0.611 0.628 0.649 0.002 
Node12 1.113 0.052 1.046 1.120 1.161 0.988 
Node2 1.107 0.081 0.984 1.119 1.163 0.974 
CPZ_CM_05_SIVCPZLB7_DQ373064 0.679 0.139 0.614 0.630 1.101 0.099 
CPZ_CM_05_SIVCPZMB66_DQ373063 1.078 0.133 0.632 1.116 1.159 0.918 
Node15 0.673 0.141 0.612 0.629 1.127 0.093 
A1_RW_92_92RW008_AB253421 1.117 0.050 1.052 1.120 1.163 0.996 
A1_UG_92_92UG037_AB253429 1.078 0.135 0.628 1.116 1.161 0.917 
A1_KE_94_Q23_17_AF004885 1.109 0.068 1.036 1.119 1.163 0.982 
Node24 0.651 0.104 0.612 0.628 1.114 0.047 
Node22 1.099 0.144 0.629 1.119 1.163 0.953 
A1_AU_PS1044_DAY0_DQ676872 1.115 0.055 1.048 1.120 1.163 0.991 
Node21 1.087 0.121 0.628 1.118 1.162 0.936 
A2_CD_97_97CDKTB48_AF286238 1.093 0.105 0.635 1.117 1.159 0.948 
A2_CY_94_94CY017_41_AF286237 0.634 0.054 0.611 0.628 0.652 0.013 
Node28 0.647 0.091 0.612 0.629 1.090 0.039 
Node20 1.093 0.110 0.631 1.118 1.162 0.948 
G_BE_96_DRCBL_AF084936 0.633 0.046 0.612 0.628 0.651 0.010 
G_KE_93_HH8793_12_1_AF061641 1.087 0.120 0.631 1.117 1.160 0.937 
G_PT_PT2695_AY612637 0.631 0.041 0.611 0.628 0.650 0.007 
Node34 9.241 285.455 0.628 1.117 1.162 0.930 
G_NG_92_92NG083_U88826 0.641 0.078 0.612 0.628 1.060 0.028 











Node31 0.658 0.117 0.612 0.629 1.120 0.062 
Node19 0.649 0.097 0.612 0.629 1.091 0.044 
C_ET_86_ETH2220_U46016 0.630 0.033 0.611 0.628 0.649 0.005 
C_BR_92_BR025_D_U52953 1.112 0.059 1.045 1.120 1.163 0.987 
Node42 0.639 0.075 0.611 0.628 0.675 0.024 
C_ZA_04_SK164B1_AY772699 0.642 0.079 0.612 0.629 1.059 0.030 
Node41 0.666 0.128 0.612 0.629 1.121 0.077 
J_SE_93_SE7887_AF082394 17.020 398.613 0.645 1.119 1.163 0.971 
J_SE_94_SE7022_AF082395 16.396 390.728 0.642 1.119 1.163 0.969 
Node46 1.106 0.077 0.960 1.119 1.162 0.973 
Node40 0.656 0.112 0.612 0.629 1.121 0.057 
H_BE_93_VI991_AF190127 1.105 0.077 0.895 1.118 1.161 0.970 
H_CF_90_056_AF005496 0.630 0.030 0.612 0.628 0.649 0.004 
H_BE_93_VI997_AF190128 0.640 0.073 0.612 0.628 0.677 0.024 
Node51 0.643 0.084 0.612 0.628 1.081 0.031 
Node49 0.855 0.236 0.618 0.645 1.142 0.469 
Node39 0.647 0.102 0.611 0.628 1.098 0.043 
K_CD_97_EQTB11C_AJ249235 0.669 0.130 0.612 0.629 1.100 0.086 
K_CM_96_MP535_AJ249239 1.079 0.134 0.630 1.118 1.162 0.917 
Node57 0.653 0.108 0.612 0.629 1.114 0.051 
F2_CM_97_CM53657_AF377956 1.112 0.057 1.044 1.120 1.162 0.987 
Node56 0.640 0.074 0.612 0.628 0.682 0.024 
F1_FR_96_MP411_AJ249238 0.630 0.036 0.611 0.628 0.649 0.005 
F1_BE_93_VI850_AF077336 0.778 0.217 0.616 0.634 1.128 0.314 
F1_BR_93_93BR020_1_AF005494 1.096 0.104 0.636 1.119 1.162 0.953 
Node64 0.655 0.112 0.612 0.628 1.121 0.056 
F1_FI_93_FIN9363_AF075703 0.656 0.109 0.612 0.629 1.101 0.057 
Node63 0.649 0.100 0.611 0.628 1.110 0.044 
Node61 1.109 0.071 1.032 1.120 1.163 0.980 
Node55 1.100 0.097 0.638 1.119 1.163 0.960 
B_TH_90_BK132_AY173951 0.678 0.143 0.612 0.630 1.107 0.107 
B_US_98_1058_11_AY331295 0.736 0.196 0.614 0.632 1.127 0.227 
Node71 0.638 0.069 0.611 0.628 0.661 0.021 
B_FR_83_HXB2_LAI_IIIB_BRU_K03455 0.629 0.028 0.611 0.628 0.648 0.003 
Node70 0.808 0.230 0.614 0.636 1.138 0.376 
B_US_98_15384_1_DQ853463 1.113 0.050 1.047 1.120 1.163 0.989 
Node69 1.103 0.088 0.639 1.119 1.163 0.968 
D_TZ_01_A280_AY253311 0.627 0.027 0.611 0.628 0.647 0.002 
D_CD_83_ELI_K03454 0.631 0.036 0.611 0.628 0.649 0.006 
D_UG_94_94UG114_U88824 0.631 0.035 0.611 0.628 0.649 0.005 
Node78 0.647 0.092 0.612 0.629 1.088 0.040 
Node76 0.630 0.032 0.612 0.628 0.649 0.005 











Node54 0.645 0.089 0.612 0.628 1.092 0.035 
Node38 1.065 0.155 0.625 1.116 1.163 0.888 





Table A6.4.3b: Model Averaged Branch dN/Ds for HLA A6801: branches with high 
model-averaged support for dN>dS are shown in bold 
Branch Name Mean Std.Dev. 2.5% Median 97.5% Prob{dN>dS}† 
CPZ_US_85_CPZUS_AF103818 1.129 0.032 1.066 1.134 1.171 0.999 
CPZ_CM_05_SIVCPZEK505_DQ373065 1.122 0.063 1.052 1.133 1.168 0.986 
Node5 1.103 0.115 0.607 1.132 1.168 0.952 
CPZ_CD_90_ANT_U42720 1.122 0.061 1.053 1.133 1.166 0.987 
CPZ_TZ_01_TAN1_AF447763 0.598 0.043 0.543 0.598 0.625 0.007 
Node8 1.127 0.042 1.062 1.134 1.170 0.995 
Node4 1.102 0.120 0.602 1.132 1.169 0.950 
CPZ_CM_05_SIVCPZMT145_DQ373066 1.103 0.111 0.617 1.132 1.157 0.951 
CPZ_GA_88_GAB1_X52154 0.628 0.120 0.549 0.600 1.087 0.064 
CPZ_CM_01_SIVCPZCAM13_AY169968 1.122 0.065 1.052 1.134 1.170 0.986 
Node13 1.114 0.090 0.619 1.133 1.170 0.972 
Node11 0.328 0.152 0.218 0.242 0.602 0.008 
Node3 1.128 0.042 1.065 1.134 1.171 0.997 
CPZ_CM_05_SIVCPZMB66_DQ373063 0.600 0.056 0.541 0.598 0.628 0.010 
Node2 1.124 0.077 1.054 1.134 1.171 0.987 
CPZ_CM_05_SIVCPZLB7_DQ373064 0.611 0.087 0.545 0.599 1.049 0.032 
A1_RW_92_92RW008_AB253421 0.601 0.064 0.542 0.598 0.630 0.014 
A1_KE_94_Q23_17_AF004885 0.605 0.082 0.541 0.599 0.646 0.022 
Node23 0.593 0.110 0.262 0.598 1.045 0.026 
A1_UG_92_92UG037_AB253429 0.591 0.061 0.532 0.598 0.625 0.005 
Node22 3.610 159.511 0.241 1.131 1.169 0.908 
A1_AU_PS1044_DAY0_DQ676872 0.695 0.194 0.588 0.604 1.119 0.189 
Node21 1.092 0.141 0.597 1.132 1.168 0.931 
A2_CD_97_97CDKTB48_AF286238 0.596 0.048 0.540 0.598 0.625 0.006 
A2_CY_94_94CY017_41_AF286237 1.111 0.100 0.612 1.133 1.170 0.966 
Node28 0.600 0.078 0.538 0.598 0.633 0.018 
Node20 7.889 259.986 1.059 1.134 1.171 0.992 
G_BE_96_DRCBL_AF084936 0.620 0.107 0.547 0.600 1.080 0.048 
G_NG_92_92NG083_U88826 1.117 0.089 1.033 1.133 1.170 0.978 
Node32 0.599 0.100 0.334 0.598 0.656 0.025 











G_PT_PT2695_AY612637 0.594 0.041 0.540 0.598 0.623 0.003 
Node35 0.951 0.266 0.539 1.125 1.169 0.672 
Node31 0.285 0.106 0.208 0.236 0.560 0.000 
Node19 1.117 0.089 1.011 1.133 1.170 0.976 
C_ET_86_ETH2220_U46016 1.123 0.068 1.053 1.134 1.171 0.987 
C_BR_92_BR025_D_U52953 1.126 0.052 1.059 1.134 1.171 0.993 
Node42 0.291 0.113 0.211 0.236 0.567 0.001 
C_ZA_04_SK164B1_AY772699 1.116 0.084 0.999 1.133 1.170 0.975 
Node41 1.109 0.107 0.605 1.133 1.169 0.963 
K_CD_97_EQTB11C_AJ249235 1.127 0.072 1.059 1.134 1.171 0.992 
K_CM_96_MP535_AJ249239 0.595 0.072 0.533 0.598 0.628 0.012 
Node47 1.114 0.095 0.615 1.133 1.170 0.972 
F1_FR_96_MP411_AJ249238 0.594 0.034 0.541 0.598 0.622 0.002 
F1_BE_93_VI850_AF077336 0.604 0.090 0.538 0.599 0.873 0.025 
F1_BR_93_93BR020_1_AF005494 1.117 0.083 1.028 1.133 1.169 0.978 
Node54 1.097 0.138 0.561 1.133 1.169 0.943 
F1_FI_93_FIN9363_AF075703 1.146 0.474 1.063 1.134 1.171 0.995 
Node53 0.607 0.090 0.540 0.599 1.083 0.027 
Node51 1.125 0.061 1.059 1.134 1.171 0.991 
F2_CM_97_CM53657_AF377956 1.123 0.061 1.055 1.134 1.171 0.988 
Node50 0.604 0.093 0.537 0.598 1.063 0.026 
Node46 0.839 0.266 0.549 0.616 1.155 0.465 
Node40 0.655 0.190 0.501 0.600 1.142 0.129 
B_TH_90_BK132_AY173951 0.597 0.053 0.541 0.598 0.626 0.008 
B_FR_83_HXB2_LAI_IIIB_BRU_K03455 1.117 0.083 1.021 1.134 1.171 0.977 
Node62 0.316 0.163 0.218 0.238 0.601 0.019 
B_US_98_15384_1_DQ853463 1.118 0.079 1.034 1.134 1.170 0.979 
Node61 0.309 0.156 0.212 0.237 0.599 0.018 
B_US_98_1058_11_AY331295 0.588 0.049 0.507 0.598 0.622 0.001 
Node60 1.114 0.094 0.625 1.133 1.169 0.972 
D_TZ_01_A280_AY253311 0.596 0.045 0.540 0.598 0.624 0.005 
D_CD_83_ELI_K03454 0.615 0.106 0.541 0.599 1.113 0.041 
Node68 1.115 0.095 0.617 1.133 1.171 0.972 
D_UG_94_94UG114_U88824 0.608 0.086 0.541 0.599 1.056 0.027 
Node67 1.116 0.088 0.976 1.133 1.170 0.975 
Node59 0.602 0.064 0.542 0.599 0.631 0.014 
Node39 0.315 0.151 0.213 0.238 0.598 0.012 
J_SE_93_SE7887_AF082394 1.104 0.124 0.600 1.133 1.171 0.956 
J_SE_94_SE7022_AF082395 0.603 0.090 0.537 0.599 0.948 0.024 
Node73 1.099 0.121 0.605 1.132 1.167 0.944 
H_BE_93_VI991_AF190127 1.117 0.084 1.016 1.133 1.170 0.976 
H_CF_90_056_AF005496 1.104 0.115 0.605 1.132 1.168 0.955 











Node78 0.595 0.077 0.527 0.598 0.629 0.013 
Node76 0.630 0.131 0.546 0.600 1.127 0.069 
Node72 1.111 0.106 0.607 1.133 1.170 0.968 
Node38 1.100 0.123 0.597 1.132 1.169 0.947 
Node18 1.128 0.040 1.064 1.134 1.171 0.996 
 
Table A6.4.3c: Model Averaged Branch dN/Ds for HLA B2705: branches with high 
model-averaged support for dN>dS are shown in bold 
Branch Name Mean Std.Dev. 2.5% Median 97.5% Prob{dN>dS}† 
C_ET_86_ETH2220_U46016 0.506 0.020 0.468 0.515 0.529 0.000 
C_BR_92_BR025_D_U52953 0.506 0.025 0.468 0.515 0.529 0.000 
Node5 0.507 0.046 0.466 0.515 0.532 0.001 
C_ZA_04_SK164B1_AY772699 0.508 0.026 0.473 0.515 0.534 0.000 
Node4 0.516 0.060 0.475 0.515 0.652 0.008 
K_CD_97_EQTB11C_AJ249235 17.789 414.835 0.476 0.515 0.971 0.016 
K_CM_96_MP535_AJ249239 0.506 0.020 0.468 0.515 0.529 0.000 
Node10 0.504 0.041 0.466 0.515 0.531 0.000 
F1_FR_96_MP411_AJ249238 0.508 0.044 0.468 0.515 0.531 0.004 
F1_BR_93_93BR020_1_AF005494 0.508 0.032 0.468 0.515 0.533 0.000 
Node15 74.891 859.119 0.473 0.515 0.688 0.019 
F1_FI_93_FIN9363_AF075703 0.509 0.035 0.474 0.515 0.544 0.000 
Node14 0.505 0.027 0.468 0.515 0.529 0.000 
F1_BE_93_VI850_AF077336 0.539 0.115 0.477 0.515 0.936 0.012 
F2_CM_97_CM53657_AF377956 0.509 0.030 0.473 0.515 0.545 0.000 
Node19 9.339 297.041 0.468 0.515 0.529 0.002 
Node13 0.513 0.062 0.468 0.515 0.546 0.003 
Node9 0.524 0.070 0.475 0.515 0.800 0.000 
Node3 2.385 136.929 0.468 0.515 0.531 0.005 
J_SE_93_SE7887_AF082394 0.507 0.049 0.468 0.515 0.545 0.000 
J_SE_94_SE7022_AF082395 62.748 786.222 0.474 0.515 0.829 0.020 
Node22 0.516 0.053 0.475 0.515 0.657 0.001 
Node2 0.505 0.023 0.468 0.515 0.529 0.000 
H_BE_93_VI991_AF190127 0.512 0.069 0.468 0.515 0.534 0.006 
H_CF_90_056_AF005496 0.503 0.032 0.466 0.515 0.529 0.000 
H_BE_93_VI997_AF190128 0.508 0.024 0.475 0.515 0.542 0.000 
Node27 0.515 0.061 0.472 0.515 0.617 0.006 
Node25 0.505 0.029 0.468 0.515 0.529 0.000 
Node1 0.514 0.065 0.475 0.515 0.607 0.006 
CPZ_US_85_CPZUS_AF103818 0.566 0.135 0.481 0.515 0.979 0.017 











Node34 0.520 0.138 0.474 0.515 0.607 0.007 
CPZ_CM_05_SIVCPZMT145_DQ373066 0.532 0.105 0.475 0.515 0.875 0.014 
CPZ_GA_88_GAB1_X52154 0.548 0.110 0.481 0.515 0.909 0.001 
CPZ_CM_01_SIVCPZCAM13_AY169968 0.547 0.138 0.475 0.515 1.036 0.035 
Node39 0.521 0.071 0.475 0.515 0.792 0.005 
Node37 0.507 0.029 0.473 0.515 0.532 0.000 
Node33 77.942 876.219 0.475 0.515 1.232 0.043 
CPZ_CD_90_ANT_U42720 0.514 0.039 0.475 0.515 0.648 0.000 
CPZ_TZ_01_TAN1_AF447763 0.512 0.043 0.468 0.515 0.565 0.000 
Node42 0.604 0.177 0.488 0.516 1.086 0.050 
Node32 38.390 614.142 0.473 0.515 0.916 0.021 
CPZ_CM_05_SIVCPZLB7_DQ373064 0.508 0.025 0.473 0.515 0.538 0.000 
Node31 0.514 0.059 0.468 0.515 0.714 0.000 
CPZ_CM_05_SIVCPZMB66_DQ373063 0.506 0.023 0.468 0.515 0.531 0.000 
Node30 0.512 0.049 0.472 0.515 0.546 0.001 
A1_RW_92_92RW008_AB253421 0.509 0.030 0.475 0.515 0.546 0.000 
A1_KE_94_Q23_17_AF004885 0.504 0.049 0.421 0.515 0.536 0.000 
Node51 0.505 0.029 0.468 0.515 0.529 0.000 
A1_AU_PS1044_DAY0_DQ676872 0.512 0.038 0.475 0.515 0.607 0.000 
Node50 0.506 0.026 0.468 0.515 0.531 0.000 
A1_UG_92_92UG037_AB253429 0.506 0.022 0.468 0.515 0.529 0.000 
A2_CD_97_97CDKTB48_AF286238 0.531 0.096 0.473 0.515 0.904 0.001 
A2_CY_94_94CY017_41_AF286237 0.504 0.032 0.461 0.515 0.528 0.000 
Node57 0.506 0.025 0.468 0.515 0.529 0.000 
Node55 8.063 274.786 0.468 0.515 0.529 0.001 
Node49 0.524 0.282 0.468 0.515 0.536 0.005 
G_BE_96_DRCBL_AF084936 0.505 0.025 0.468 0.515 0.529 0.000 
G_NG_92_92NG083_U88826 0.513 0.068 0.468 0.515 0.555 0.007 
Node62 18.052 418.486 0.468 0.515 0.531 0.003 
G_PT_PT2695_AY612637 0.506 0.022 0.468 0.515 0.529 0.000 
Node61 13.033 353.648 0.468 0.515 0.532 0.005 
G_KE_93_HH8793_12_1_AF061641 0.506 0.027 0.468 0.515 0.529 0.000 
Node60 0.506 0.024 0.468 0.515 0.531 0.000 
Node48 0.509 0.036 0.473 0.515 0.543 0.001 
B_TH_90_BK132_AY173951 0.561 0.225 0.480 0.515 1.006 0.026 
B_FR_83_HXB2_LAI_IIIB_BRU_K03455 0.502 0.032 0.444 0.515 0.527 0.000 
Node70 4.174 191.289 0.475 0.515 0.607 0.005 
B_US_98_15384_1_DQ853463 0.507 0.031 0.468 0.515 0.531 0.000 
Node69 0.490 0.075 0.188 0.514 0.528 0.000 
B_US_98_1058_11_AY331295 0.506 0.028 0.468 0.515 0.529 0.000 
Node68 0.509 0.031 0.474 0.515 0.549 0.000 
D_TZ_01_A280_AY253311 0.497 0.053 0.280 0.515 0.528 0.000 











Node76 0.508 0.044 0.468 0.515 0.531 0.002 
D_CD_83_ELI_K03454 0.502 0.032 0.441 0.515 0.527 0.000 
Node75 0.509 0.029 0.474 0.515 0.544 0.000 
Node67 0.505 0.029 0.468 0.515 0.529 0.000 
Node47 0.513 0.050 0.475 0.515 0.633 0.001 
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